data_1kqk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kqk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 107.801 -1.185 . . . . 10.0 107.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.43 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 71' ' ' LYS . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.487 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.545 ' CD ' ' HZ3' ' A' ' 63' ' ' LYS . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HZ3' ' CD ' ' A' ' 59' ' ' GLU . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HZ3' ' CD ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 8' ' ' ASP . 25.6 tptt . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' CD ' ' HZ3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HZ3' ' CD ' ' A' ' 59' ' ' GLU . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.401 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.153 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 1.153 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 69' ' ' LYS . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.728 -1.212 . . . . 10.0 107.728 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? . . . . . 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.925 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.925 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.652 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? . . . . . 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 103.539 -2.763 . . . . 10.0 103.539 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.949 -1.024 . . . . 10.0 108.321 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.3 p 54.41 -177.11 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.534 1.133 . . . . 10.0 111.045 -174.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -146.92 152.44 38.68 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 168.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -129.64 -45.93 1.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.63 -164.74 32.54 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.579 -1.408 . . . . 10.0 109.579 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.16 31.94 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 117.686 0.743 . . . . 10.0 112.493 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -159.11 54.38 0.41 Allowed 'General case' 0 C--O 1.227 -0.101 0 O-C-N 121.208 -0.933 . . . . 10.0 109.62 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 42.1 56.09 3.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.429 1.092 . . . . 10.0 111.355 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 t -127.7 -43.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.814 0.845 . . . . 10.0 111.276 -165.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt 71.05 -68.24 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.584 1.554 . . . . 10.0 111.117 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.37 155.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.858 1.663 . . . . 10.0 113.131 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.92 -159.08 30.7 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.88 -1.288 . . . . 10.0 109.88 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 . . . . . 0 C--O 1.248 0.991 0 N-CA-C 105.547 -2.02 . . . . 10.0 105.547 171.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.8 p -91.18 -177.61 4.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.138 0.975 . . . . 10.0 109.287 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.13 -164.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 163.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -125.47 -146.92 0.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.6 95.98 2.08 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.335 -1.506 . . . . 10.0 109.335 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.64 153.82 12.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.89 0.845 . . . . 10.0 111.865 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 52.06 72.97 0.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.901 1.28 . . . . 10.0 113.27 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -149.69 113.06 4.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.79 -1.189 . . . . 10.0 107.79 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.5 t -80.03 -28.28 39.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.772 -1.109 . . . . 10.0 112.868 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -161.4 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.548 1.139 . . . . 10.0 109.887 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.97 -57.88 11.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.46 0.704 . . . . 10.0 112.148 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.43 93.43 1.83 Allowed Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.742 -160.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.104 1.762 . . . . 10.0 106.534 154.722 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.8 p -66.63 162.6 20.71 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.715 0.406 . . . . 10.0 110.241 170.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -92.08 132.54 36.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 162.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -127.1 -51.73 1.42 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.97 -143.3 7.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.64 -1.384 . . . . 10.0 109.64 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 155.23 15.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.964 0.906 . . . . 10.0 110.359 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.83 63.42 1.94 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.509 1.524 . . . . 10.0 113.051 168.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.88 112.31 3.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.574 1.549 . . . . 10.0 107.568 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -88.61 -73.4 0.5 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.149 1.78 . . . . 10.0 110.911 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.5 mp 54.48 80.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.395 1.878 . . . . 10.0 110.562 -173.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.39 133.91 56.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 163.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.37 179.42 32.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 106.345 -2.702 . . . . 10.0 106.345 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.857 -2.021 . . . . 10.0 105.688 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -70.96 173.91 6.85 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.936 -0.765 . . . . 10.0 108.936 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.16 -178.97 3.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.064 1.345 . . . . 10.0 107.801 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -124.49 -51.55 1.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.13 -164.29 32.42 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.046 -1.622 . . . . 10.0 109.046 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -165.53 40.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.198 0.523 . . . . 10.0 111.37 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -162.06 54.11 0.23 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.926 -0.484 . . . . 10.0 110.792 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 44.93 63.32 1.76 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.387 1.475 . . . . 10.0 111.796 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -111.42 40.18 2.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.244 1.018 . . . . 10.0 110.954 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.5 mp -35.25 -62.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.35 1.86 . . . . 10.0 112.77 -172.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.7 153.33 23.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.902 0.881 . . . . 10.0 109.388 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.81 -138.39 9.5 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.564 -2.384 . . . . 10.0 104.564 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -158.59 161.81 37.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.257 -2.498 . . . . 10.0 104.257 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -132.6 147.18 52.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.43 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -131.08 -51.07 1.03 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.53 129.37 5.27 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.691 -1.363 . . . . 10.0 109.691 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.44 -65.33 1.02 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 177.16 -47.29 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 126.114 1.766 . . . . 10.0 106.336 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.91 -59.88 0.43 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.139 1.776 . . . . 10.0 109.353 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 t -46.46 -55.8 6.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.74 2.416 . . . . 10.0 112.14 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.45 -84.75 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.445 0.698 . . . . 10.0 109.338 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.93 -97.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -97.21 -33.4 5.99 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 120.957 -1.09 . . . . 10.0 111.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.109 -1.424 . . . . 10.0 110.184 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.0 p -73.56 172.03 12.1 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -133.2 151.3 51.95 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.24 -53.9 2.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.55 -147.28 9.05 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.253 -1.539 . . . . 10.0 109.253 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -138.14 146.42 42.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.11 1.364 . . . . 10.0 108.019 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 68.19 123.25 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.675 1.99 . . . . 10.0 113.496 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -31.62 -61.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.6 1.96 . . . . 10.0 113.254 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.8 p 44.5 48.42 8.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.883 1.673 . . . . 10.0 112.198 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -45.73 105.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.991 1.316 . . . . 10.0 112.714 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.8 175.46 11.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.43 159.46 35.6 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.662 -0.975 . . . . 10.0 110.662 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 105.028 -2.212 . . . . 10.0 105.028 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 107.044 -1.465 . . . . 10.0 107.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 66.77 172.14 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.938 0.774 . . . . 10.0 108.961 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -156.22 155.02 31.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 71' ' ' LYS . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.487 ' CD ' ' HZ3' ' A' ' 67' ' ' LYS . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.545 ' CD ' ' HZ3' ' A' ' 63' ' ' LYS . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HZ3' ' CD ' ' A' ' 59' ' ' GLU . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HZ3' ' CD ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 8' ' ' ASP . 25.6 tptt -120.37 -72.34 0.69 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.93 172.4 23.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.887 -1.285 . . . . 10.0 109.887 -170.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -173.89 50.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 10.0 109.389 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -67.67 -58.18 5.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.078 -0.389 . . . . 10.0 110.703 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t70 170.21 -64.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.087 2.155 . . . . 10.0 107.077 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -137.65 -44.75 0.54 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.2 1.4 . . . . 10.0 112.677 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.5 171.85 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 63.72 58.23 1.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.719 1.207 . . . . 10.0 110.634 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.98 121.23 10.63 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.828 -0.909 . . . . 10.0 110.828 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.716 -1.135 . . . . 10.0 111.156 174.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mtt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p 57.54 -166.38 0.14 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.514 1.134 . . . . 10.0 110.292 -168.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.03 127.27 26.32 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -110.87 -54.81 2.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.22 -150.75 20.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.332 -1.907 . . . . 10.0 108.332 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.14 152.49 38.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.409 1.484 . . . . 10.0 109.263 -176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -125.74 -49.18 1.63 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.8 0.84 . . . . 10.0 111.709 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.6 t0 6.28 78.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 128.102 2.561 . . . . 10.0 115.326 -166.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.7 t -155.68 -61.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 tt -87.66 168.12 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.285 0.634 . . . . 10.0 109.86 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -56.89 -57.14 13.81 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.183 1.393 . . . . 10.0 111.109 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.47 -169.29 34.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 108.144 -1.983 . . . . 10.0 108.144 -173.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.87 -2.014 . . . . 10.0 105.578 -175.002 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.1 p -111.31 -108.68 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.717 1.144 . . . . 10.0 109.478 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -123.54 -179.2 4.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 166.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' CD ' ' HZ3' ' A' ' 63' ' ' LYS . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HZ3' ' CD ' ' A' ' 59' ' ' GLU . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -48.63 2.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.32 137.5 2.41 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.224 -0.512 . . . . 10.0 112.431 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -77.68 62.23 2.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.707 1.203 . . . . 10.0 110.725 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.66 165.54 16.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.467 0.707 . . . . 10.0 109.707 165.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -142.17 96.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 164.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -171.89 66.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.015 2.126 . . . . 10.0 108.114 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.0 mt -67.06 134.32 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.65 162.7 36.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.584 -1.265 . . . . 10.0 107.584 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.96 -76.63 0.56 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.099 -1.2 . . . . 10.0 110.099 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 125.505 1.522 . . . . 10.0 113.316 171.141 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 p -159.29 175.03 13.89 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.51 -2.033 . . . . 10.0 105.51 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -98.42 -168.09 1.6 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.091 1.314 . . . . 10.0 108.353 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.49 -34.54 1.04 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.1 47.14 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -156.6 45.75 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.438 0.637 . . . . 10.0 110.956 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -165.51 137.42 4.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.535 -1.283 . . . . 10.0 107.535 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.88 85.0 1.74 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.361 1.464 . . . . 10.0 107.086 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t -171.3 76.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.774 -0.579 . . . . 10.0 111.137 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp 49.65 54.05 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.83 1.252 . . . . 10.0 111.23 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -73.32 158.4 35.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.026 0.931 . . . . 10.0 110.649 165.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.84 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.988 0.755 . . . . 10.0 114.988 163.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.268 2.627 . . . . 10.0 109.021 176.297 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.855 -0.795 . . . . 10.0 108.855 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 p -113.58 159.96 19.05 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -107.59 -165.64 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.8 1.24 . . . . 10.0 107.996 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -120.58 -53.86 2.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.3 39.14 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -161.74 37.54 0.13 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 122.547 1.165 . . . . 10.0 110.844 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 47.93 0.85 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.453 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 55.17 3.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.27 162.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -82.36 -65.04 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.15 -0.452 . . . . 10.0 112.124 -166.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 63.55 175.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.274 1.03 . . . . 10.0 111.733 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.42 -173.68 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.005 . . . . 10.0 111.637 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.67 -123.06 2.06 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.095 1.331 . . . . 10.0 112.137 -174.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.926 2.09 . . . . 10.0 105.677 -176.058 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.221 -1.399 . . . . 10.0 107.221 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -139.24 165.07 28.15 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -118.5 178.54 4.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' HZ3' ' CG ' ' A' ' 75' ' ' ASP . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 -51.66 2.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.61 86.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.381 0.537 . . . . 10.0 112.935 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.0 51.91 1.2 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.783 -0.833 . . . . 10.0 112.143 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -175.7 66.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.41 0.684 . . . . 10.0 110.866 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' CG ' ' HZ3' ' A' ' 4' ' ' LYS . 44.1 t0 30.55 64.73 0.16 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.109 2.164 . . . . 10.0 113.934 174.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.2 p -126.42 61.58 1.3 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.79 0.836 . . . . 10.0 109.336 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mt -63.88 134.08 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.74 93.59 0.11 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -77.64 0.02 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.561 -0.577 . . . . 10.0 114.035 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.293 -1.813 . . . . 10.0 109.421 -167.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 116.259 -1.829 . . . . 10.0 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 p -98.34 -122.86 0.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.604 1.093 . . . . 10.0 108.297 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.83 141.16 52.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -125.8 -54.0 1.54 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.94 -125.37 1.34 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.046 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 66.12 -27.02 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.284 2.634 . . . . 10.0 116.289 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.64 81.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.772 0.829 . . . . 10.0 111.503 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -168.11 118.09 0.78 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.581 2.752 . . . . 10.0 105.593 -170.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.2 m -120.05 44.26 2.47 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.697 1.199 . . . . 10.0 111.04 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.5 tt -131.21 75.79 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.505 1.122 . . . . 10.0 108.522 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -38.66 -57.93 1.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.95 1.7 . . . . 10.0 112.121 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.32 -126.09 7.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.096 0.855 . . . . 10.0 112.347 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.246 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.439 -0.791 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 p 58.01 -179.86 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.885 0.874 . . . . 10.0 111.816 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -135.2 175.14 9.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -129.34 -133.26 0.22 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.03 -148.18 23.82 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.792 0.724 . . . . 10.0 112.118 -170.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 71.99 -123.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.881 1.672 . . . . 10.0 109.27 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 40.83 65.99 0.71 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.806 1.642 . . . . 10.0 111.631 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 39.08 54.17 2.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.823 2.049 . . . . 10.0 112.509 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -131.44 -56.35 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.113 . . . . 10.0 109.981 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.8 mt 68.38 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.123 1.369 . . . . 10.0 109.122 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.22 171.67 15.57 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.571 1.548 . . . . 10.0 108.423 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -106.53 -66.55 0.65 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.26 0.457 . . . . 10.0 113.832 -163.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 . . . . . 0 C--O 1.249 1.074 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -175.714 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 mtt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p 63.59 153.35 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.087 1.355 . . . . 10.0 110.867 -160.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -161.36 163.97 30.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.614 1.165 . . . . 10.0 107.869 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -132.23 -52.84 0.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.22 105.8 0.76 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.337 0.97 . . . . 10.0 114.196 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -97.38 -66.35 0.91 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.211 1.404 . . . . 10.0 110.799 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 44.42 48.52 8.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.685 1.594 . . . . 10.0 113.757 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.9 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.785 1.634 . . . . 10.0 109.091 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 t -167.62 -48.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.273 1.029 . . . . 10.0 111.362 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.1 mp 25.83 67.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.611 2.364 . . . . 10.0 112.815 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.34 125.56 8.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -82.35 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.625 0.648 . . . . 10.0 113.567 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 117.584 -1.198 . . . . 10.0 109.307 -164.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -154.24 -176.21 5.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 105.391 -2.078 . . . . 10.0 105.391 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.39 175.95 9.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 167.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 69' ' ' LYS . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' NZ ' ' OE2' ' A' ' 10' ' ' GLU . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -132.11 -52.21 0.96 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.26 147.73 18.5 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.3 -73.03 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.289 1.435 . . . . 10.0 108.168 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 61.25 60.74 1.69 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.273 1.029 . . . . 10.0 109.583 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t0 50.42 52.07 15.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.196 1.398 . . . . 10.0 111.655 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -62.48 -58.6 7.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.541 0.571 . . . . 10.0 112.541 -167.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt 38.65 69.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.169 1.788 . . . . 10.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -132.92 168.08 19.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.038 0.935 . . . . 10.0 109.749 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.57 83.97 0.11 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.307 -2.317 . . . . 10.0 107.307 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.625 -1.655 . . . . 10.0 109.038 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 105.004 -2.221 . . . . 10.0 105.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 t -69.31 171.89 7.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.87 1.214 . . . . 10.0 108.571 159.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.88 -165.94 1.43 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 128.408 2.683 . . . . 10.0 107.728 174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -128.14 -49.69 1.32 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.69 -179.33 41.94 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.551 -1.42 . . . . 10.0 109.551 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.74 42.98 0.18 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.084 0.442 . . . . 10.0 111.674 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -164.86 73.92 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.522 1.153 . . . . 10.0 111.281 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.23 74.82 0.34 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.795 1.638 . . . . 10.0 107.925 165.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.0 t -161.63 -75.31 0.05 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.295 1.438 . . . . 10.0 109.486 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.13 -39.3 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 123.64 0.776 . . . . 10.0 111.064 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.42 -47.38 49.58 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -48.68 120.97 7.29 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.024 -0.83 . . . . 10.0 111.024 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.006 2.122 . . . . 10.0 105.648 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.318 -0.993 . . . . 10.0 108.318 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.5 p -124.5 172.32 9.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.478 1.511 . . . . 10.0 107.134 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -134.94 151.58 50.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -126.97 -38.95 1.98 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 149.35 113.77 0.69 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.94 -0.647 . . . . 10.0 111.564 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 67.55 2.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.168 0.987 . . . . 10.0 109.439 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -55.48 -45.77 76.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.591 0.756 . . . . 10.0 111.894 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 21.34 79.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.108 2.563 . . . . 10.0 114.784 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -157.28 63.39 0.49 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.4 pt 43.95 45.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.634 1.574 . . . . 10.0 112.57 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.51 157.65 44.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.524 1.13 . . . . 10.0 107.987 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.78 107.59 0.22 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.415 -2.274 . . . . 10.0 107.415 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.239 -1.839 . . . . 10.0 107.319 -167.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 p -102.05 166.65 10.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -116.17 -164.5 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -128.7 -56.16 1.21 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.79 -112.55 0.48 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.958 0.799 . . . . 10.0 114.371 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.81 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.447 1.899 . . . . 10.0 110.86 -162.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.19 -51.76 0.08 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.663 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 37.07 78.29 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.035 2.134 . . . . 10.0 111.378 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m 49.88 51.84 15.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.787 1.635 . . . . 10.0 111.864 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.28 6.5 tt 42.96 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.857 2.063 . . . . 10.0 112.415 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 69.49 132.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.033 1.733 . . . . 10.0 111.988 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.35 -170.46 37.13 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.057 -1.217 . . . . 10.0 110.057 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.593 1.557 . . . . 10.0 110.491 -174.456 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -86.41 146.49 26.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -102.59 -173.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -141.41 32.42 1.69 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.4 -162.94 48.17 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.981 -2.047 . . . . 10.0 107.981 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.75 103.76 2.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.861 -170.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 117.84 103.81 0.0 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 128.142 2.577 . . . . 10.0 111.472 163.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.61 71.17 0.05 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 127.531 2.333 . . . . 10.0 109.911 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.26 53.8 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.224 1.41 . . . . 10.0 109.239 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.9 mt 77.48 117.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.502 1.921 . . . . 10.0 110.458 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.72 -68.36 0.61 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.066 1.347 . . . . 10.0 107.569 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.37 136.77 3.4 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.638 -1.785 . . . . 10.0 108.638 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.429 -1.748 . . . . 10.0 110.183 -166.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.45 159.01 25.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.546 1.538 . . . . 10.0 109.763 175.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -128.61 -179.96 5.35 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 173.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -112.33 -57.5 2.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.71 179.49 40.54 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.239 -1.545 . . . . 10.0 109.239 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.18 108.3 7.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.091 0.956 . . . . 10.0 109.186 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.67 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.244 1.818 . . . . 10.0 112.753 171.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -126.6 80.52 1.94 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.525 1.13 . . . . 10.0 110.377 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -75.07 -39.15 61.01 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 122.056 -0.402 . . . . 10.0 111.909 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -44.29 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -171.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -174.87 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.065 1.346 . . . . 10.0 108.68 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.84 -74.29 2.49 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.354 -1.098 . . . . 10.0 110.354 -177.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.838 -1.553 . . . . 10.0 109.213 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tpt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.48 150.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.874 2.069 . . . . 10.0 111.485 -173.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -157.5 156.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -125.25 -49.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.63 -141.57 7.03 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.25 -1.54 . . . . 10.0 109.25 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -156.3 162.76 40.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.219 1.408 . . . . 10.0 109.066 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 59.48 90.59 0.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.896 1.678 . . . . 10.0 113.824 178.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -95.99 90.07 5.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -155.87 74.09 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.067 168.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 tt 43.28 57.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.661 1.584 . . . . 10.0 111.517 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -64.25 -60.49 3.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.827 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.16 -76.8 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.129 -1.034 . . . . 10.0 115.297 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.417 ' HE ' ' C ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 116.724 -1.608 . . . . 10.0 109.79 -155.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -77.69 174.28 11.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.598 0.759 . . . . 10.0 109.218 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -129.49 156.92 43.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.673 1.989 . . . . 10.0 105.66 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -132.76 21.12 4.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.96 80.97 1.14 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.745 -1.342 . . . . 10.0 109.745 174.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.47 64.32 0.85 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.618 1.167 . . . . 10.0 111.451 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -130.77 31.97 4.43 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.628 1.571 . . . . 10.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 72.63 78.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.075 1.75 . . . . 10.0 112.77 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m 64.24 70.31 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.857 1.263 . . . . 10.0 110.203 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt 38.41 -144.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.649 1.58 . . . . 10.0 111.373 -163.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -164.14 136.32 4.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 103.826 -2.657 . . . . 10.0 103.826 165.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.21 -119.5 1.3 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.32 0.964 . . . . 10.0 111.895 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 CA-C-O 116.055 -1.926 . . . . 10.0 106.298 -172.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.5 p -62.56 128.72 37.32 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.979 1.718 . . . . 10.0 108.772 175.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.31 168.74 22.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.085 1.754 . . . . 10.0 106.508 -170.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -138.21 -149.18 0.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.83 86.8 1.46 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.256 -1.138 . . . . 10.0 110.256 -169.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.08 137.09 18.03 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 122.233 -0.569 . . . . 10.0 111.528 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 62.44 106.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.712 2.005 . . . . 10.0 114.894 -170.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.18 93.52 6.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 166.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -129.9 -52.42 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.694 171.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 pt -147.28 51.69 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.933 0.893 . . . . 10.0 109.842 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -75.03 161.62 29.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 176.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.41 59.87 0.68 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.15 0.881 . . . . 10.0 112.394 -165.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.725 1.61 . . . . 10.0 110.978 -167.64 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 107.692 -1.225 . . . . 10.0 107.692 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p 52.55 -169.62 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.604 0.761 . . . . 10.0 112.332 -167.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.68 175.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 161.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -139.58 25.09 2.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.78 -122.82 14.42 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 -176.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.19 152.13 29.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.471 1.908 . . . . 10.0 108.839 -171.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.14 -50.71 21.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 10.0 110.227 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 17.59 59.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.286 2.234 . . . . 10.0 114.64 -162.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 62.36 27.89 16.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.868 1.433 . . . . 10.0 114.868 173.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 mt -1.99 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.919 2.488 . . . . 10.0 114.407 -179.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.61 -64.33 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.074 1.349 . . . . 10.0 107.818 177.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.88 -174.76 42.85 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.311 -1.916 . . . . 10.0 108.311 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.8 ttt-85 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.06 -1.924 . . . . 10.0 109.522 -174.281 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -144.61 165.51 27.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -129.43 140.02 51.45 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 129.023 2.929 . . . . 10.0 103.539 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -134.88 15.06 3.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.06 111.0 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.78 60.76 1.34 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 10.0 111.448 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.39 85.46 0.65 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.61 0.719 . . . . 10.0 109.238 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -75.5 43.09 0.23 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.674 1.989 . . . . 10.0 110.715 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -172.61 91.56 0.11 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -171.003 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 tt -161.67 -53.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.024 0.93 . . . . 10.0 110.456 178.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 58.26 4.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.313 1.045 . . . . 10.0 111.226 176.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.19 -162.65 29.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.399 0.523 . . . . 10.0 112.953 -176.04 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.458 ' HE ' ' C ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.243 -2.132 . . . . 10.0 105.243 175.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.7 p -80.42 -179.29 7.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 124.526 1.141 . . . . 10.0 109.05 171.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.67 152.23 38.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 161.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -124.01 -54.19 1.72 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.83 -166.01 33.69 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -174.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.57 54.58 0.61 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.684 0.754 . . . . 10.0 111.252 -175.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -158.0 133.21 8.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.659 -0.65 . . . . 10.0 110.625 -176.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -44.29 -66.07 0.43 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.606 1.562 . . . . 10.0 111.414 171.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.87 87.5 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.493 1.917 . . . . 10.0 106.972 173.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.5 78.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.839 -0.801 . . . . 10.0 108.839 -173.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -147.25 -175.22 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.207 2.203 . . . . 10.0 106.256 168.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.07 163.26 33.7 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.877 2.071 . . . . 10.0 110.186 -177.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 106.32 -1.733 . . . . 10.0 106.32 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.3 p -122.14 133.39 54.75 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.25 -2.5 . . . . 10.0 104.25 161.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -152.47 174.39 13.94 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -125.63 -45.46 1.77 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.55 -174.1 43.62 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.966 -1.253 . . . . 10.0 109.966 -176.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.08 47.59 1.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 10.0 109.762 -177.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -162.59 160.83 26.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.925 1.29 . . . . 10.0 108.281 170.349 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.67 -24.71 26.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.924 2.09 . . . . 10.0 111.933 173.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 p -76.52 -69.2 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.621 0.768 . . . . 10.0 111.22 -168.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.9 mt 72.02 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 126.708 2.003 . . . . 10.0 109.547 -168.468 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -145.74 136.22 24.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.357 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.01 -126.46 1.52 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 116.018 -1.944 . . . . 10.0 105.962 -175.812 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 67' ' ' LYS . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 10' ' ' GLU . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.509 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.441 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 68' ' ' LEU . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 61' ' ' VAL . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB1' HH11 ' A' ' 20' ' ' ARG . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.426 HH11 ' HB1' ' A' ' 16' ' ' ALA . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.428 HD13 ' HB1' ' A' ' 34' ' ' ALA . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.4 HG13 ' HB1' ' A' ' 18' ' ' ALA . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 68' ' ' LEU . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 61' ' ' VAL . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HG ' ' HG ' ' A' ' 17' ' ' CYS . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.448 HG23 HG12 ' A' ' 61' ' ' VAL . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 21' ' ' ILE . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 68' ' ' LEU . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD13 ' OH ' ' A' ' 66' ' ' TYR . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.483 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' VAL . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 107.801 -1.185 . . . . 10.0 107.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 39' ' ' ALA . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 37' ' ' ASN . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 68' ' ' LEU . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' NH2' ' A' ' 20' ' ' ARG . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' ' SG ' ' A' ' 17' ' ' CYS . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' PHE . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.6 tptt . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.424 ' HE1' HG21 ' A' ' 36' ' ' VAL . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG23 HG22 ' A' ' 61' ' ' VAL . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 21' ' ' ILE . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG21 ' HE1' ' A' ' 12' ' ' MET . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 21' ' ' ILE . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' CE1' HG23 ' A' ' 54' ' ' VAL . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' HG ' ' HG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 64' ' ' LEU . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 68' ' ' LEU . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' OH ' ' A' ' 66' ' ' TYR . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.589 ' HE1' HG11 ' A' ' 36' ' ' VAL . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG12 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HG2' HG23 ' A' ' 36' ' ' VAL . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 12' ' ' MET . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 21' ' ' ILE . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 17' ' ' CYS . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 61' ' ' VAL . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 68' ' ' LEU . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CD2' HD21 ' A' ' 68' ' ' LEU . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 43' ' ' VAL . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' A' ' 36' ' ' VAL . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 21' ' ' ILE . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 9' ' ' ILE . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 45' ' ' VAL . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 61' ' ' VAL . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 7' ' ' PHE . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 21' ' ' ILE . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 7' ' ' PHE . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 68' ' ' LEU . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 61' ' ' VAL . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 54' ' ' VAL . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.054 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.054 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 25' ' ' LEU . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HE ' HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 21' ' ' ILE . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 7' ' ' PHE . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.548 HD13 ' OH ' ' A' ' 66' ' ' TYR . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 61' ' ' VAL . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.576 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 61' ' ' VAL . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 21' ' ' ILE . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 40' ' ' LEU . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 7' ' ' PHE . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 21' ' ' ILE . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.728 -1.212 . . . . 10.0 107.728 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' HH21 ' A' ' 20' ' ' ARG . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.566 HH21 ' HB1' ' A' ' 16' ' ' ALA . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 25' ' ' LEU . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 21' ' ' ILE . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' A' ' 24' ' ' ARG . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? . . . . . 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 64' ' ' LEU . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 24' ' ' ARG . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 68' ' ' LEU . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.475 HD13 ' OH ' ' A' ' 66' ' ' TYR . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 43' ' ' VAL . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 9' ' ' ILE . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 21' ' ' ILE . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 43' ' ' VAL . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.489 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.724 HG21 HD13 ' A' ' 68' ' ' LEU . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.724 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 68' ' ' LEU . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.542 HD13 ' OH ' ' A' ' 66' ' ' TYR . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' OH ' HD13 ' A' ' 64' ' ' LEU . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG21 ' A' ' 61' ' ' VAL . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? . . . . . 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 103.539 -2.763 . . . . 10.0 103.539 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB2' ' SD ' ' A' ' 12' ' ' MET . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD13 ' HB1' ' A' ' 34' ' ' ALA . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 18' ' ' ALA . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' A' ' 36' ' ' VAL . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 22' ' ' GLU . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.471 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG12 HD11 ' A' ' 9' ' ' ILE . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 58' ' ' LYS . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.949 -1.024 . . . . 10.0 108.321 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.3 p 54.41 -177.11 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.534 1.133 . . . . 10.0 111.045 -174.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -146.92 152.44 38.68 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 168.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.509 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.441 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 68' ' ' LEU . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 61' ' ' VAL . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -129.64 -45.93 1.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.63 -164.74 32.54 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.579 -1.408 . . . . 10.0 109.579 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.16 31.94 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 117.686 0.743 . . . . 10.0 112.493 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -159.11 54.38 0.41 Allowed 'General case' 0 C--O 1.227 -0.101 0 O-C-N 121.208 -0.933 . . . . 10.0 109.62 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 42.1 56.09 3.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.429 1.092 . . . . 10.0 111.355 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 t -127.7 -43.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.814 0.845 . . . . 10.0 111.276 -165.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt 71.05 -68.24 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.584 1.554 . . . . 10.0 111.117 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.37 155.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.858 1.663 . . . . 10.0 113.131 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.92 -159.08 30.7 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.88 -1.288 . . . . 10.0 109.88 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 . . . . . 0 C--O 1.248 0.991 0 N-CA-C 105.547 -2.02 . . . . 10.0 105.547 171.63 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.8 p -91.18 -177.61 4.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.138 0.975 . . . . 10.0 109.287 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.13 -164.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 163.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB1' HH11 ' A' ' 20' ' ' ARG . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.426 HH11 ' HB1' ' A' ' 16' ' ' ALA . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.428 HD13 ' HB1' ' A' ' 34' ' ' ALA . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.4 HG13 ' HB1' ' A' ' 18' ' ' ALA . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 68' ' ' LEU . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 61' ' ' VAL . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -125.47 -146.92 0.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.6 95.98 2.08 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.335 -1.506 . . . . 10.0 109.335 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.64 153.82 12.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.89 0.845 . . . . 10.0 111.865 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 52.06 72.97 0.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.901 1.28 . . . . 10.0 113.27 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -149.69 113.06 4.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.79 -1.189 . . . . 10.0 107.79 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.5 t -80.03 -28.28 39.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.772 -1.109 . . . . 10.0 112.868 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -161.4 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.548 1.139 . . . . 10.0 109.887 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.97 -57.88 11.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.46 0.704 . . . . 10.0 112.148 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.43 93.43 1.83 Allowed Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.742 -160.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.104 1.762 . . . . 10.0 106.534 154.722 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.8 p -66.63 162.6 20.71 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.715 0.406 . . . . 10.0 110.241 170.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -92.08 132.54 36.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 162.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.448 HG23 HG12 ' A' ' 61' ' ' VAL . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 21' ' ' ILE . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 68' ' ' LEU . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD13 ' OH ' ' A' ' 66' ' ' TYR . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.483 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' VAL . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -127.1 -51.73 1.42 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.97 -143.3 7.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.64 -1.384 . . . . 10.0 109.64 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 155.23 15.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.964 0.906 . . . . 10.0 110.359 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.83 63.42 1.94 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.509 1.524 . . . . 10.0 113.051 168.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.88 112.31 3.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.574 1.549 . . . . 10.0 107.568 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -88.61 -73.4 0.5 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.149 1.78 . . . . 10.0 110.911 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . 3.5 mp 54.48 80.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.395 1.878 . . . . 10.0 110.562 -173.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.39 133.91 56.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 163.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.37 179.42 32.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 106.345 -2.702 . . . . 10.0 106.345 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.857 -2.021 . . . . 10.0 105.688 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -70.96 173.91 6.85 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.936 -0.765 . . . . 10.0 108.936 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.16 -178.97 3.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.064 1.345 . . . . 10.0 107.801 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 39' ' ' ALA . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 37' ' ' ASN . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 68' ' ' LEU . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -124.49 -51.55 1.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.13 -164.29 32.42 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.046 -1.622 . . . . 10.0 109.046 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -165.53 40.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.198 0.523 . . . . 10.0 111.37 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -162.06 54.11 0.23 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.926 -0.484 . . . . 10.0 110.792 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 44.93 63.32 1.76 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.387 1.475 . . . . 10.0 111.796 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -111.42 40.18 2.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.244 1.018 . . . . 10.0 110.954 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 77' ' ' ILE . 3.5 mp -35.25 -62.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.35 1.86 . . . . 10.0 112.77 -172.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.7 153.33 23.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.902 0.881 . . . . 10.0 109.388 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.81 -138.39 9.5 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.564 -2.384 . . . . 10.0 104.564 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -158.59 161.81 37.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.257 -2.498 . . . . 10.0 104.257 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -132.6 147.18 52.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -131.08 -51.07 1.03 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.53 129.37 5.27 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.691 -1.363 . . . . 10.0 109.691 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.44 -65.33 1.02 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 177.16 -47.29 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 126.114 1.766 . . . . 10.0 106.336 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.91 -59.88 0.43 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.139 1.776 . . . . 10.0 109.353 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 t -46.46 -55.8 6.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.74 2.416 . . . . 10.0 112.14 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.45 -84.75 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.445 0.698 . . . . 10.0 109.338 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.93 -97.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -97.21 -33.4 5.99 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 120.957 -1.09 . . . . 10.0 111.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.109 -1.424 . . . . 10.0 110.184 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.0 p -73.56 172.03 12.1 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -133.2 151.3 51.95 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.24 -53.9 2.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.55 -147.28 9.05 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.253 -1.539 . . . . 10.0 109.253 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -138.14 146.42 42.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.11 1.364 . . . . 10.0 108.019 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 68.19 123.25 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.675 1.99 . . . . 10.0 113.496 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -31.62 -61.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.6 1.96 . . . . 10.0 113.254 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.8 p 44.5 48.42 8.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.883 1.673 . . . . 10.0 112.198 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -45.73 105.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.991 1.316 . . . . 10.0 112.714 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.8 175.46 11.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.43 159.46 35.6 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.662 -0.975 . . . . 10.0 110.662 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 105.028 -2.212 . . . . 10.0 105.028 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 107.044 -1.465 . . . . 10.0 107.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 66.77 172.14 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.938 0.774 . . . . 10.0 108.961 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -156.22 155.02 31.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' NH2' ' A' ' 20' ' ' ARG . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' ' SG ' ' A' ' 17' ' ' CYS . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' PHE . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -120.37 -72.34 0.69 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.93 172.4 23.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.887 -1.285 . . . . 10.0 109.887 -170.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -173.89 50.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 10.0 109.389 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -67.67 -58.18 5.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.078 -0.389 . . . . 10.0 110.703 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t70 170.21 -64.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.087 2.155 . . . . 10.0 107.077 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -137.65 -44.75 0.54 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.2 1.4 . . . . 10.0 112.677 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.5 171.85 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 63.72 58.23 1.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.719 1.207 . . . . 10.0 110.634 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.98 121.23 10.63 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.828 -0.909 . . . . 10.0 110.828 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.716 -1.135 . . . . 10.0 111.156 174.92 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mtt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p 57.54 -166.38 0.14 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.514 1.134 . . . . 10.0 110.292 -168.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.03 127.27 26.32 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.424 ' HE1' HG21 ' A' ' 36' ' ' VAL . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG23 HG22 ' A' ' 61' ' ' VAL . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 21' ' ' ILE . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG21 ' HE1' ' A' ' 12' ' ' MET . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 21' ' ' ILE . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -110.87 -54.81 2.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.22 -150.75 20.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.332 -1.907 . . . . 10.0 108.332 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.14 152.49 38.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.409 1.484 . . . . 10.0 109.263 -176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -125.74 -49.18 1.63 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.8 0.84 . . . . 10.0 111.709 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.6 t0 6.28 78.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 128.102 2.561 . . . . 10.0 115.326 -166.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.7 t -155.68 -61.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 tt -87.66 168.12 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.285 0.634 . . . . 10.0 109.86 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -56.89 -57.14 13.81 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.183 1.393 . . . . 10.0 111.109 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.47 -169.29 34.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 108.144 -1.983 . . . . 10.0 108.144 -173.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.87 -2.014 . . . . 10.0 105.578 -175.002 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.1 p -111.31 -108.68 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.717 1.144 . . . . 10.0 109.478 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -123.54 -179.2 4.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 166.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' CE1' HG23 ' A' ' 54' ' ' VAL . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 64' ' ' LEU . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 68' ' ' LEU . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' OH ' ' A' ' 66' ' ' TYR . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -48.63 2.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.32 137.5 2.41 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.224 -0.512 . . . . 10.0 112.431 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -77.68 62.23 2.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.707 1.203 . . . . 10.0 110.725 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.66 165.54 16.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.467 0.707 . . . . 10.0 109.707 165.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -142.17 96.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 164.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -171.89 66.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.015 2.126 . . . . 10.0 108.114 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.0 mt -67.06 134.32 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.65 162.7 36.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.584 -1.265 . . . . 10.0 107.584 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.96 -76.63 0.56 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.099 -1.2 . . . . 10.0 110.099 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 125.505 1.522 . . . . 10.0 113.316 171.141 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 p -159.29 175.03 13.89 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.51 -2.033 . . . . 10.0 105.51 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -98.42 -168.09 1.6 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.091 1.314 . . . . 10.0 108.353 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.589 ' HE1' HG11 ' A' ' 36' ' ' VAL . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG12 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HG2' HG23 ' A' ' 36' ' ' VAL . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 12' ' ' MET . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 21' ' ' ILE . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 17' ' ' CYS . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 61' ' ' VAL . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.49 -34.54 1.04 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.1 47.14 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -156.6 45.75 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.438 0.637 . . . . 10.0 110.956 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -165.51 137.42 4.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.535 -1.283 . . . . 10.0 107.535 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.88 85.0 1.74 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.361 1.464 . . . . 10.0 107.086 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t -171.3 76.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.774 -0.579 . . . . 10.0 111.137 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp 49.65 54.05 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.83 1.252 . . . . 10.0 111.23 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -73.32 158.4 35.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.026 0.931 . . . . 10.0 110.649 165.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.84 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.988 0.755 . . . . 10.0 114.988 163.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.268 2.627 . . . . 10.0 109.021 176.297 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.855 -0.795 . . . . 10.0 108.855 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 p -113.58 159.96 19.05 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -107.59 -165.64 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.8 1.24 . . . . 10.0 107.996 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 68' ' ' LEU . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -120.58 -53.86 2.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.3 39.14 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -161.74 37.54 0.13 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 122.547 1.165 . . . . 10.0 110.844 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 47.93 0.85 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.453 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 55.17 3.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.27 162.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -82.36 -65.04 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.15 -0.452 . . . . 10.0 112.124 -166.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 63.55 175.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.274 1.03 . . . . 10.0 111.733 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.42 -173.68 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.005 . . . . 10.0 111.637 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.67 -123.06 2.06 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.095 1.331 . . . . 10.0 112.137 -174.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.926 2.09 . . . . 10.0 105.677 -176.058 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.221 -1.399 . . . . 10.0 107.221 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -139.24 165.07 28.15 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -118.5 178.54 4.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CD2' HD21 ' A' ' 68' ' ' LEU . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 43' ' ' VAL . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' A' ' 36' ' ' VAL . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 21' ' ' ILE . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 9' ' ' ILE . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 -51.66 2.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.61 86.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.381 0.537 . . . . 10.0 112.935 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.0 51.91 1.2 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.783 -0.833 . . . . 10.0 112.143 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -175.7 66.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.41 0.684 . . . . 10.0 110.866 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.1 t0 30.55 64.73 0.16 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.109 2.164 . . . . 10.0 113.934 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.2 p -126.42 61.58 1.3 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.79 0.836 . . . . 10.0 109.336 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mt -63.88 134.08 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.74 93.59 0.11 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -77.64 0.02 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.561 -0.577 . . . . 10.0 114.035 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.293 -1.813 . . . . 10.0 109.421 -167.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 116.259 -1.829 . . . . 10.0 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 p -98.34 -122.86 0.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.604 1.093 . . . . 10.0 108.297 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.83 141.16 52.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 45' ' ' VAL . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 61' ' ' VAL . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 7' ' ' PHE . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 21' ' ' ILE . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -125.8 -54.0 1.54 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.94 -125.37 1.34 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.046 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 66.12 -27.02 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.284 2.634 . . . . 10.0 116.289 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.64 81.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.772 0.829 . . . . 10.0 111.503 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -168.11 118.09 0.78 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.581 2.752 . . . . 10.0 105.593 -170.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.2 m -120.05 44.26 2.47 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.697 1.199 . . . . 10.0 111.04 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.5 tt -131.21 75.79 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.505 1.122 . . . . 10.0 108.522 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -38.66 -57.93 1.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.95 1.7 . . . . 10.0 112.121 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.32 -126.09 7.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.096 0.855 . . . . 10.0 112.347 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.246 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.439 -0.791 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 p 58.01 -179.86 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.885 0.874 . . . . 10.0 111.816 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -135.2 175.14 9.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 7' ' ' PHE . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 68' ' ' LEU . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 61' ' ' VAL . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -129.34 -133.26 0.22 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.03 -148.18 23.82 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.792 0.724 . . . . 10.0 112.118 -170.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 71.99 -123.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.881 1.672 . . . . 10.0 109.27 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 40.83 65.99 0.71 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.806 1.642 . . . . 10.0 111.631 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 39.08 54.17 2.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.823 2.049 . . . . 10.0 112.509 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -131.44 -56.35 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.113 . . . . 10.0 109.981 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.8 mt 68.38 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.123 1.369 . . . . 10.0 109.122 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.22 171.67 15.57 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.571 1.548 . . . . 10.0 108.423 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -106.53 -66.55 0.65 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.26 0.457 . . . . 10.0 113.832 -163.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 . . . . . 0 C--O 1.249 1.074 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -175.714 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 mtt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p 63.59 153.35 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.087 1.355 . . . . 10.0 110.867 -160.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -161.36 163.97 30.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.614 1.165 . . . . 10.0 107.869 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 54' ' ' VAL . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 25' ' ' LEU . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HE ' HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 21' ' ' ILE . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 7' ' ' PHE . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.548 HD13 ' OH ' ' A' ' 66' ' ' TYR . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 61' ' ' VAL . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -132.23 -52.84 0.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.22 105.8 0.76 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.337 0.97 . . . . 10.0 114.196 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 75' ' ' ASP . 26.1 tt0 -97.38 -66.35 0.91 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.211 1.404 . . . . 10.0 110.799 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 44.42 48.52 8.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.685 1.594 . . . . 10.0 113.757 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -179.9 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.785 1.634 . . . . 10.0 109.091 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 t -167.62 -48.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.273 1.029 . . . . 10.0 111.362 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 77' ' ' ILE . 3.1 mp 25.83 67.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.611 2.364 . . . . 10.0 112.815 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.34 125.56 8.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -82.35 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.625 0.648 . . . . 10.0 113.567 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 117.584 -1.198 . . . . 10.0 109.307 -164.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -154.24 -176.21 5.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 105.391 -2.078 . . . . 10.0 105.391 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.39 175.95 9.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 167.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.576 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 61' ' ' VAL . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 21' ' ' ILE . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 40' ' ' LEU . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 7' ' ' PHE . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 21' ' ' ILE . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -132.11 -52.21 0.96 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.26 147.73 18.5 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.3 -73.03 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.289 1.435 . . . . 10.0 108.168 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 61.25 60.74 1.69 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.273 1.029 . . . . 10.0 109.583 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t0 50.42 52.07 15.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.196 1.398 . . . . 10.0 111.655 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -62.48 -58.6 7.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.541 0.571 . . . . 10.0 112.541 -167.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt 38.65 69.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.169 1.788 . . . . 10.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -132.92 168.08 19.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.038 0.935 . . . . 10.0 109.749 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.57 83.97 0.11 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.307 -2.317 . . . . 10.0 107.307 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.625 -1.655 . . . . 10.0 109.038 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 105.004 -2.221 . . . . 10.0 105.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 t -69.31 171.89 7.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.87 1.214 . . . . 10.0 108.571 159.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 pm0 -86.88 -165.94 1.43 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 128.408 2.683 . . . . 10.0 107.728 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -128.14 -49.69 1.32 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.69 -179.33 41.94 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.551 -1.42 . . . . 10.0 109.551 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.74 42.98 0.18 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.084 0.442 . . . . 10.0 111.674 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -164.86 73.92 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.522 1.153 . . . . 10.0 111.281 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.23 74.82 0.34 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.795 1.638 . . . . 10.0 107.925 165.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.0 t -161.63 -75.31 0.05 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.295 1.438 . . . . 10.0 109.486 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.13 -39.3 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 123.64 0.776 . . . . 10.0 111.064 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.42 -47.38 49.58 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -48.68 120.97 7.29 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.024 -0.83 . . . . 10.0 111.024 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.006 2.122 . . . . 10.0 105.648 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.318 -0.993 . . . . 10.0 108.318 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.5 p -124.5 172.32 9.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.478 1.511 . . . . 10.0 107.134 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -134.94 151.58 50.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' HH21 ' A' ' 20' ' ' ARG . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.566 HH21 ' HB1' ' A' ' 16' ' ' ALA . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -126.97 -38.95 1.98 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 149.35 113.77 0.69 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.94 -0.647 . . . . 10.0 111.564 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 67.55 2.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.168 0.987 . . . . 10.0 109.439 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -55.48 -45.77 76.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.591 0.756 . . . . 10.0 111.894 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 21.34 79.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.108 2.563 . . . . 10.0 114.784 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -157.28 63.39 0.49 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.4 pt 43.95 45.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.634 1.574 . . . . 10.0 112.57 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.51 157.65 44.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.524 1.13 . . . . 10.0 107.987 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.78 107.59 0.22 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.415 -2.274 . . . . 10.0 107.415 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.239 -1.839 . . . . 10.0 107.319 -167.579 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 p -102.05 166.65 10.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -116.17 -164.5 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 25' ' ' LEU . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 21' ' ' ILE . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' A' ' 24' ' ' ARG . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -128.7 -56.16 1.21 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.79 -112.55 0.48 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.958 0.799 . . . . 10.0 114.371 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.81 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.447 1.899 . . . . 10.0 110.86 -162.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.19 -51.76 0.08 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.663 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 37.07 78.29 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.035 2.134 . . . . 10.0 111.378 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m 49.88 51.84 15.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.787 1.635 . . . . 10.0 111.864 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.28 6.5 tt 42.96 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.857 2.063 . . . . 10.0 112.415 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 69.49 132.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.033 1.733 . . . . 10.0 111.988 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.35 -170.46 37.13 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.057 -1.217 . . . . 10.0 110.057 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.593 1.557 . . . . 10.0 110.491 -174.456 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -86.41 146.49 26.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -102.59 -173.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -141.41 32.42 1.69 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.4 -162.94 48.17 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.981 -2.047 . . . . 10.0 107.981 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.75 103.76 2.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.861 -170.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 117.84 103.81 0.0 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 128.142 2.577 . . . . 10.0 111.472 163.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.61 71.17 0.05 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 127.531 2.333 . . . . 10.0 109.911 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.26 53.8 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.224 1.41 . . . . 10.0 109.239 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.9 mt 77.48 117.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.502 1.921 . . . . 10.0 110.458 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.72 -68.36 0.61 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.066 1.347 . . . . 10.0 107.569 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.37 136.77 3.4 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.638 -1.785 . . . . 10.0 108.638 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.429 -1.748 . . . . 10.0 110.183 -166.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.45 159.01 25.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.546 1.538 . . . . 10.0 109.763 175.033 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -128.61 -179.96 5.35 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 173.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 64' ' ' LEU . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 24' ' ' ARG . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -112.33 -57.5 2.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.71 179.49 40.54 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.239 -1.545 . . . . 10.0 109.239 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.18 108.3 7.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.091 0.956 . . . . 10.0 109.186 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.67 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.244 1.818 . . . . 10.0 112.753 171.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -126.6 80.52 1.94 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.525 1.13 . . . . 10.0 110.377 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -75.07 -39.15 61.01 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 122.056 -0.402 . . . . 10.0 111.909 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -44.29 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -171.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -174.87 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.065 1.346 . . . . 10.0 108.68 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.84 -74.29 2.49 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.354 -1.098 . . . . 10.0 110.354 -177.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.838 -1.553 . . . . 10.0 109.213 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tpt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.48 150.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.874 2.069 . . . . 10.0 111.485 -173.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -157.5 156.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 68' ' ' LEU . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.475 HD13 ' OH ' ' A' ' 66' ' ' TYR . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -125.25 -49.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.63 -141.57 7.03 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.25 -1.54 . . . . 10.0 109.25 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -156.3 162.76 40.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.219 1.408 . . . . 10.0 109.066 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 59.48 90.59 0.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.896 1.678 . . . . 10.0 113.824 178.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -95.99 90.07 5.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -155.87 74.09 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.067 168.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 tt 43.28 57.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.661 1.584 . . . . 10.0 111.517 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -64.25 -60.49 3.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.827 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.16 -76.8 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.129 -1.034 . . . . 10.0 115.297 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 116.724 -1.608 . . . . 10.0 109.79 -155.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -77.69 174.28 11.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.598 0.759 . . . . 10.0 109.218 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -129.49 156.92 43.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.673 1.989 . . . . 10.0 105.66 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 43' ' ' VAL . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 9' ' ' ILE . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 21' ' ' ILE . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -132.76 21.12 4.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.96 80.97 1.14 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.745 -1.342 . . . . 10.0 109.745 174.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.47 64.32 0.85 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.618 1.167 . . . . 10.0 111.451 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -130.77 31.97 4.43 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.628 1.571 . . . . 10.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 72.63 78.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.075 1.75 . . . . 10.0 112.77 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m 64.24 70.31 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.857 1.263 . . . . 10.0 110.203 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt 38.41 -144.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.649 1.58 . . . . 10.0 111.373 -163.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -164.14 136.32 4.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 103.826 -2.657 . . . . 10.0 103.826 165.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.21 -119.5 1.3 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.32 0.964 . . . . 10.0 111.895 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 CA-C-O 116.055 -1.926 . . . . 10.0 106.298 -172.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.5 p -62.56 128.72 37.32 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.979 1.718 . . . . 10.0 108.772 175.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.31 168.74 22.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.085 1.754 . . . . 10.0 106.508 -170.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 43' ' ' VAL . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.489 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.724 HG21 HD13 ' A' ' 68' ' ' LEU . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.724 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -138.21 -149.18 0.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.83 86.8 1.46 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.256 -1.138 . . . . 10.0 110.256 -169.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.08 137.09 18.03 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 122.233 -0.569 . . . . 10.0 111.528 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 62.44 106.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.712 2.005 . . . . 10.0 114.894 -170.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.18 93.52 6.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 166.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -129.9 -52.42 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.694 171.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 pt -147.28 51.69 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.933 0.893 . . . . 10.0 109.842 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -75.03 161.62 29.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 176.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.41 59.87 0.68 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.15 0.881 . . . . 10.0 112.394 -165.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.725 1.61 . . . . 10.0 110.978 -167.64 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 107.692 -1.225 . . . . 10.0 107.692 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p 52.55 -169.62 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.604 0.761 . . . . 10.0 112.332 -167.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.68 175.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 161.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 68' ' ' LEU . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.542 HD13 ' OH ' ' A' ' 66' ' ' TYR . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' OH ' HD13 ' A' ' 64' ' ' LEU . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG21 ' A' ' 61' ' ' VAL . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -139.58 25.09 2.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.78 -122.82 14.42 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 -176.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.19 152.13 29.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.471 1.908 . . . . 10.0 108.839 -171.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.14 -50.71 21.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 10.0 110.227 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 17.59 59.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.286 2.234 . . . . 10.0 114.64 -162.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 62.36 27.89 16.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.868 1.433 . . . . 10.0 114.868 173.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 mt -1.99 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.919 2.488 . . . . 10.0 114.407 -179.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.61 -64.33 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.074 1.349 . . . . 10.0 107.818 177.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.88 -174.76 42.85 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.311 -1.916 . . . . 10.0 108.311 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.8 ttt-85 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.06 -1.924 . . . . 10.0 109.522 -174.281 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -144.61 165.51 27.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -129.43 140.02 51.45 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 129.023 2.929 . . . . 10.0 103.539 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB2' ' SD ' ' A' ' 12' ' ' MET . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD13 ' HB1' ' A' ' 34' ' ' ALA . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 18' ' ' ALA . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -134.88 15.06 3.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.06 111.0 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.78 60.76 1.34 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 10.0 111.448 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.39 85.46 0.65 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.61 0.719 . . . . 10.0 109.238 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -75.5 43.09 0.23 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.674 1.989 . . . . 10.0 110.715 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -172.61 91.56 0.11 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -171.003 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 tt -161.67 -53.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.024 0.93 . . . . 10.0 110.456 178.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 58.26 4.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.313 1.045 . . . . 10.0 111.226 176.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.19 -162.65 29.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.399 0.523 . . . . 10.0 112.953 -176.04 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.243 -2.132 . . . . 10.0 105.243 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.7 p -80.42 -179.29 7.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 124.526 1.141 . . . . 10.0 109.05 171.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.67 152.23 38.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 161.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' A' ' 36' ' ' VAL . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 22' ' ' GLU . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.471 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG12 HD11 ' A' ' 9' ' ' ILE . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -124.01 -54.19 1.72 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.83 -166.01 33.69 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -174.012 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.57 54.58 0.61 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.684 0.754 . . . . 10.0 111.252 -175.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -158.0 133.21 8.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.659 -0.65 . . . . 10.0 110.625 -176.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -44.29 -66.07 0.43 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.606 1.562 . . . . 10.0 111.414 171.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.87 87.5 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.493 1.917 . . . . 10.0 106.972 173.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.5 78.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.839 -0.801 . . . . 10.0 108.839 -173.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -147.25 -175.22 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.207 2.203 . . . . 10.0 106.256 168.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.07 163.26 33.7 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.877 2.071 . . . . 10.0 110.186 -177.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 106.32 -1.733 . . . . 10.0 106.32 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.3 p -122.14 133.39 54.75 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.25 -2.5 . . . . 10.0 104.25 161.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -152.47 174.39 13.94 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' OE2' HD11 ' A' ' 77' ' ' ILE . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 58' ' ' LYS . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -125.63 -45.46 1.77 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.55 -174.1 43.62 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.966 -1.253 . . . . 10.0 109.966 -176.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.08 47.59 1.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 10.0 109.762 -177.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -162.59 160.83 26.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.925 1.29 . . . . 10.0 108.281 170.349 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.67 -24.71 26.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.924 2.09 . . . . 10.0 111.933 173.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 p -76.52 -69.2 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.621 0.768 . . . . 10.0 111.22 -168.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' OE2' ' A' ' 6' ' ' GLU . 48.9 mt 72.02 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 126.708 2.003 . . . . 10.0 109.547 -168.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -145.74 136.22 24.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.357 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.01 -126.46 1.52 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 116.018 -1.944 . . . . 10.0 105.962 -175.812 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 . . . . . 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.509 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' ND2' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD12 ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.441 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 68' ' ' LEU . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 61' ' ' VAL . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt . . . . . 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB1' HH11 ' A' ' 20' ' ' ARG . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.518 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.426 HH11 ' HB1' ' A' ' 16' ' ' ALA . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.428 HD13 ' HB1' ' A' ' 34' ' ' ALA . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.4 HG13 ' HB1' ' A' ' 18' ' ' ALA . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 68' ' ' LEU . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 61' ' ' VAL . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HG ' ' HG ' ' A' ' 17' ' ' CYS . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.448 HG23 HG12 ' A' ' 61' ' ' VAL . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 21' ' ' ILE . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 68' ' ' LEU . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 HD13 ' OH ' ' A' ' 66' ' ' TYR . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.483 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' VAL . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 107.801 -1.185 . . . . 10.0 107.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 39' ' ' ALA . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 37' ' ' ASN . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 68' ' ' LEU . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' NH2' ' A' ' 20' ' ' ARG . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' ' SG ' ' A' ' 17' ' ' CYS . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' PHE . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.6 tptt . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.424 ' HE1' HG21 ' A' ' 36' ' ' VAL . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.545 HG23 HG22 ' A' ' 61' ' ' VAL . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 21' ' ' ILE . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG21 ' HE1' ' A' ' 12' ' ' MET . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 21' ' ' ILE . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' CE1' HG23 ' A' ' 54' ' ' VAL . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' HG ' ' HG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' HG ' ' HG ' ' A' ' 14' ' ' CYS . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 64' ' ' LEU . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 68' ' ' LEU . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' OH ' ' A' ' 66' ' ' TYR . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.589 ' HE1' HG11 ' A' ' 36' ' ' VAL . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG12 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HG2' HG23 ' A' ' 36' ' ' VAL . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 12' ' ' MET . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 21' ' ' ILE . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 17' ' ' CYS . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 61' ' ' VAL . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 . . . . . 0 N--CA 1.447 -0.617 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 68' ' ' LEU . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 . . . . . 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CD2' HD21 ' A' ' 68' ' ' LEU . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 43' ' ' VAL . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' A' ' 36' ' ' VAL . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 21' ' ' ILE . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 9' ' ' ILE . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 45' ' ' VAL . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 61' ' ' VAL . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 40' ' ' LEU . 16.5 t30 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 7' ' ' PHE . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 21' ' ' ILE . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.297 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 7' ' ' PHE . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 68' ' ' LEU . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 61' ' ' VAL . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 54' ' ' VAL . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.054 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.054 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 25' ' ' LEU . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HE ' HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 21' ' ' ILE . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 7' ' ' PHE . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.548 HD13 ' OH ' ' A' ' 66' ' ' TYR . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 61' ' ' VAL . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt . . . . . 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.576 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 61' ' ' VAL . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 21' ' ' ILE . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 40' ' ' LEU . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 7' ' ' PHE . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 21' ' ' ILE . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.728 -1.212 . . . . 10.0 107.728 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 . . . . . 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' HH21 ' A' ' 20' ' ' ARG . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.566 HH21 ' HB1' ' A' ' 16' ' ' ALA . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 25' ' ' LEU . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 21' ' ' ILE . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' A' ' 24' ' ' ARG . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt . . . . . 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 . . . . . 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 1.037 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? . . . . . 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 64' ' ' LEU . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 40' ' ' LEU . 16.5 t30 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 24' ' ' ARG . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt . . . . . 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 68' ' ' LEU . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.475 HD13 ' OH ' ' A' ' 66' ' ' TYR . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 43' ' ' VAL . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 9' ' ' ILE . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 21' ' ' ILE . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 106.508 -1.664 . . . . 10.0 106.508 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 43' ' ' VAL . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.489 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.724 HG21 HD13 ' A' ' 68' ' ' LEU . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.724 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 68' ' ' LEU . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.542 HD13 ' OH ' ' A' ' 66' ' ' TYR . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.542 ' OH ' HD13 ' A' ' 64' ' ' LEU . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG21 ' A' ' 61' ' ' VAL . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? . . . . . 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.438 -1.043 0 N-CA-C 103.539 -2.763 . . . . 10.0 103.539 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB2' ' SD ' ' A' ' 12' ' ' MET . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.615 HD13 ' HB1' ' A' ' 34' ' ' ALA . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 18' ' ' ALA . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 14' ' ' CYS . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' A' ' 36' ' ' VAL . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 22' ' ' GLU . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.42 HD21 ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.471 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.601 HG12 HD11 ' A' ' 9' ' ' ILE . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt . . . . . 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 58' ' ' LYS . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp . . . . . 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 117.949 -1.024 . . . . 10.0 108.321 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.3 p 54.41 -177.11 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.534 1.133 . . . . 10.0 111.045 -174.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -146.92 152.44 38.68 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.174 -1.788 . . . . 10.0 106.174 168.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -98.85 142.71 30.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.121 -1.807 . . . . 10.0 106.121 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.1 139.25 30.37 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.862 -1.903 . . . . 10.0 105.862 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.32 129.1 48.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 103.069 -2.937 . . . . 10.0 103.069 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.509 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 8.5 m-85 -134.66 149.98 50.59 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.172 1.389 . . . . 10.0 110.041 -171.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -103.69 126.96 51.16 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 mt -110.98 131.04 63.27 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 CA-C-N 118.627 0.649 . . . . 10.0 110.958 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.37 123.8 43.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.436 0.694 . . . . 10.0 109.565 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.78 -19.5 8.39 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.669 1.128 . . . . 10.0 114.092 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.416 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 5.7 ptm -73.06 74.31 1.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.379 1.09 . . . . 10.0 111.958 -177.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -73.22 -18.87 61.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 120.907 -1.121 . . . . 10.0 111.467 -172.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 p -119.03 153.13 35.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.781 0.719 . . . . 10.0 112.021 176.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.4 -30.61 68.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.996 -1.065 . . . . 10.0 111.04 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.94 -35.33 80.33 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.825 -0.607 . . . . 10.0 111.443 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 m -55.7 -58.42 7.89 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 108.861 -0.792 . . . . 10.0 108.861 173.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -49.85 -54.78 17.3 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.157 0.983 . . . . 10.0 110.885 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -38.41 68.65 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.935 -0.478 . . . . 10.0 111.888 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -39.97 87.98 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 110.261 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.1 mt -59.39 -52.57 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -52.39 -44.7 65.47 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.946 0.403 . . . . 10.0 110.158 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.33 -54.09 45.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.952 0.901 . . . . 10.0 111.778 174.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -57.9 -49.93 75.06 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.544 -0.723 . . . . 10.0 111.11 176.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.6 mt -54.53 -50.72 67.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.742 1.217 . . . . 10.0 109.921 -177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -52.6 -37.42 58.12 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 123.931 0.893 . . . . 10.0 111.498 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -70.2 -14.01 62.44 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 118.495 -0.764 . . . . 10.0 112.91 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -80.29 140.29 16.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 119.524 1.056 . . . . 10.0 109.467 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -81.73 126.41 31.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.671 1.188 . . . . 10.0 110.263 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.0 23.83 56.5 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.04 0.829 . . . . 10.0 112.597 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.75 145.19 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.924 -1.139 . . . . 10.0 107.924 164.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.12 -51.03 4.36 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -170.45 172.95 5.8 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 107.383 -1.34 . . . . 10.0 107.383 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -179.23 61.13 0.12 Allowed Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.567 1.147 . . . . 10.0 112.935 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.62 128.0 11.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.214 1.943 . . . . 10.0 110.58 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -84.37 127.47 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 124.014 0.926 . . . . 10.0 109.31 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' ND2' HD12 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -100.56 98.24 8.85 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.498 -0.752 . . . . 10.0 110.838 -170.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.7 71.75 1.01 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.391 1.076 . . . . 10.0 111.307 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.64 -57.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.395 1.078 . . . . 10.0 109.535 165.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD12 ' ND2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -83.44 -10.25 58.51 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.397 1.079 . . . . 10.0 110.263 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 76.6 27.44 0.79 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.436 1.894 . . . . 10.0 110.455 174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.6 m -126.6 155.99 41.63 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.175 1.39 . . . . 10.0 109.677 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.6 142.48 37.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 C-N-CA 125.302 1.441 . . . . 10.0 107.995 168.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.6 m -106.52 96.14 6.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.681 -1.6 . . . . 10.0 106.681 172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -83.53 133.52 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.897 0.879 . . . . 10.0 108.658 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -121.59 124.61 44.77 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -158.67 -175.45 5.32 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 123.154 0.581 . . . . 10.0 110.605 -174.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -114.53 129.63 24.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.947 0.899 . . . . 10.0 110.853 169.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.44 66.17 7.96 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.46 2.773 . . . . 10.0 109.11 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -144.94 -60.08 0.36 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.417 -0.957 . . . . 10.0 108.417 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.01 -27.91 21.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.506 0.139 . . . . 10.0 110.671 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.48 174.87 7.11 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.357 1.463 . . . . 10.0 109.658 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.8 m -153.36 155.2 36.0 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.572 0.749 . . . . 10.0 110.031 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.509 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.7 p -55.65 -47.72 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 C-N-CA 123.917 0.887 . . . . 10.0 110.308 177.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -39.32 81.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.625 1.17 . . . . 10.0 111.978 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -65.66 -58.98 4.43 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.441 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -62.16 -32.47 73.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.731 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.56 -54.13 19.87 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.393 -0.595 . . . . 10.0 109.393 171.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -59.0 -39.88 83.2 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 110.176 -0.305 . . . . 10.0 110.176 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.46 92.1 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.568 0.747 . . . . 10.0 111.129 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 68' ' ' LEU . 61.3 t -66.83 -50.79 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 173.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -54.1 -39.28 66.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 110.202 -0.296 . . . . 10.0 110.202 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.76 -31.93 18.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.708 1.203 . . . . 10.0 112.801 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.11 -27.64 39.14 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.882 -0.58 . . . . 10.0 111.524 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.95 -54.82 0.74 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 118.747 0.703 . . . . 10.0 112.209 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 155.27 29.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.248 0.546 . . . . 10.0 111.031 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.28 156.35 17.87 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.162 0.985 . . . . 10.0 108.997 -175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 61' ' ' VAL . 5.7 tt -143.79 151.84 40.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.994 -1.484 . . . . 10.0 106.994 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -154.81 166.48 33.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.062 1.745 . . . . 10.0 108.201 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.44 149.07 49.19 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.064 0.546 . . . . 10.0 111.382 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -129.64 -45.93 1.18 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.643 1.577 . . . . 10.0 111.827 173.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.63 -164.74 32.54 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.579 -1.408 . . . . 10.0 109.579 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -166.16 31.94 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 117.686 0.743 . . . . 10.0 112.493 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -159.11 54.38 0.41 Allowed 'General case' 0 C--O 1.227 -0.101 0 O-C-N 121.208 -0.933 . . . . 10.0 109.62 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 42.1 56.09 3.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.429 1.092 . . . . 10.0 111.355 172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.7 t -127.7 -43.6 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.814 0.845 . . . . 10.0 111.276 -165.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 mt 71.05 -68.24 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 125.584 1.554 . . . . 10.0 111.117 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.37 155.7 0.08 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.858 1.663 . . . . 10.0 113.131 -176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.92 -159.08 30.7 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.88 -1.288 . . . . 10.0 109.88 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 . . . . . 0 C--O 1.248 0.991 0 N-CA-C 105.547 -2.02 . . . . 10.0 105.547 171.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 mtt . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.8 p -91.18 -177.61 4.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.138 0.975 . . . . 10.0 109.287 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.13 -164.09 1.11 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 163.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -138.67 134.09 33.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.797 2.839 . . . . 10.0 105.809 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.52 153.78 49.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.87 134.58 40.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 106.259 -1.756 . . . . 10.0 106.259 -173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -127.49 160.89 30.1 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.446 1.099 . . . . 10.0 110.557 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.0 132.96 46.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 103.608 -2.738 . . . . 10.0 103.608 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.07 144.25 16.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.46 107.07 14.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 173.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.42 -70.86 0.32 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.896 0.76 . . . . 10.0 114.021 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 20.0 mtp 32.8 73.23 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.858 2.063 . . . . 10.0 115.266 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.5 p -71.36 -32.6 68.71 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.761 -0.587 . . . . 10.0 111.243 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 21.7 p -151.0 164.14 37.11 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.126 0.57 . . . . 10.0 109.509 175.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.73 39.03 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.881 -0.512 . . . . 10.0 111.761 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB1' HH11 ' A' ' 20' ' ' ARG . . . -64.69 -29.89 70.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.217 -0.896 . . . . 10.0 111.696 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.9 m -56.39 -56.26 23.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.458 1.026 . . . . 10.0 108.926 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.518 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -50.07 -55.22 15.76 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.731 -1.122 . . . . 10.0 109.866 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -55.81 -41.95 74.92 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.765 -0.585 . . . . 10.0 112.195 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.426 HH11 ' HB1' ' A' ' 16' ' ' ALA . 3.0 mpt_? -57.79 -40.13 79.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 120.783 -1.198 . . . . 10.0 109.98 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -50.14 78.94 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 108.755 -0.832 . . . . 10.0 108.755 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -55.97 -46.74 78.55 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 118.294 0.497 . . . . 10.0 110.42 -176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -56.01 -54.5 44.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 122.704 0.402 . . . . 10.0 111.69 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -59.61 -42.4 92.54 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.431 -0.793 . . . . 10.0 112.044 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.428 HD13 ' HB1' ' A' ' 34' ' ' ALA . 14.9 mt -57.26 -52.02 67.02 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.314 1.045 . . . . 10.0 109.122 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -54.58 -35.38 63.27 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.683 0.793 . . . . 10.0 111.504 176.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -61.92 -19.0 62.23 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.0 mt -77.54 140.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 119.443 1.02 . . . . 10.0 109.197 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -89.36 125.63 35.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.554 1.142 . . . . 10.0 108.467 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.38 14.39 48.01 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.818 0.723 . . . . 10.0 113.101 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -90.09 146.39 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.11 -51.72 5.05 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 109.256 -0.646 . . . . 10.0 109.256 170.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -171.9 174.98 4.0 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 107.583 -1.266 . . . . 10.0 107.583 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -172.28 59.94 0.27 Allowed Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.896 1.073 . . . . 10.0 113.896 -171.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.73 130.49 14.75 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.556 2.171 . . . . 10.0 111.248 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.4 HG13 ' HB1' ' A' ' 18' ' ' ALA . 4.7 p -103.49 139.52 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.853 0.861 . . . . 10.0 112.167 -178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.08 167.39 18.84 Favored 'General case' 0 C--N 1.343 0.319 0 O-C-N 121.566 -0.709 . . . . 10.0 111.514 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -127.71 51.19 1.96 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 168.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.95 -55.93 0.6 Allowed 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 122.805 0.442 . . . . 10.0 110.926 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.65 -13.17 20.44 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.39 0.676 . . . . 10.0 110.549 -174.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 69.95 50.17 0.47 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.201 1.8 . . . . 10.0 108.569 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.46 148.85 47.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.389 1.476 . . . . 10.0 110.592 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.15 134.91 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.942 1.297 . . . . 10.0 109.27 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.9 m -90.62 126.97 36.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 166.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.88 129.37 75.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 124.191 0.996 . . . . 10.0 108.897 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -107.14 117.49 34.2 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.81 169.65 22.86 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 125.168 1.387 . . . . 10.0 108.353 175.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.1 126.68 27.56 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.143 0.977 . . . . 10.0 110.362 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 78.6 1.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 124.291 3.327 . . . . 10.0 109.97 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -136.3 -56.65 0.75 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.158 0.983 . . . . 10.0 108.896 175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -115.47 -25.19 8.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.287 1.035 . . . . 10.0 111.56 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -116.83 146.48 42.86 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.046 1.338 . . . . 10.0 108.31 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.1 m -145.92 160.86 41.22 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.368 1.067 . . . . 10.0 109.128 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -53.29 -47.96 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.683 0.793 . . . . 10.0 110.913 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.9 m -62.89 -31.6 72.69 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.512 0.56 . . . . 10.0 112.512 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.49 -59.75 2.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.7 pp -55.61 -32.07 62.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.28 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -43.95 -58.87 2.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 118.744 -0.646 . . . . 10.0 109.339 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -60.49 -36.15 77.61 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 119.055 0.843 . . . . 10.0 110.496 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.38 96.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 123.236 0.614 . . . . 10.0 110.448 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG21 HD13 ' A' ' 68' ' ' LEU . 59.0 t -69.42 -51.63 40.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 C-N-CA 123.334 0.654 . . . . 10.0 109.336 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -48.32 -43.17 32.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.083 1.353 . . . . 10.0 109.544 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -49.48 -34.75 17.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.728 1.211 . . . . 10.0 113.046 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 19.3 mt -74.89 -25.32 58.86 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.78 0.832 . . . . 10.0 111.546 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.14 -53.53 0.79 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.023 -0.831 . . . . 10.0 111.023 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.33 158.44 26.45 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 122.534 -0.392 . . . . 10.0 110.141 174.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -105.61 171.57 7.26 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 122.949 0.5 . . . . 10.0 110.794 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 61' ' ' VAL . 6.4 tt -151.65 155.63 38.76 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.619 1.167 . . . . 10.0 107.95 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -151.89 166.89 30.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.36 1.864 . . . . 10.0 108.412 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.62 148.1 48.47 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.92 0.488 . . . . 10.0 111.478 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -125.47 -146.92 0.35 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.751 1.62 . . . . 10.0 109.228 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.6 95.98 2.08 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.335 -1.506 . . . . 10.0 109.335 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -57.64 153.82 12.62 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 117.89 0.845 . . . . 10.0 111.865 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 52.06 72.97 0.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.901 1.28 . . . . 10.0 113.27 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -149.69 113.06 4.96 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.79 -1.189 . . . . 10.0 107.79 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.5 t -80.03 -28.28 39.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 117.772 -1.109 . . . . 10.0 112.868 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -161.4 90.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.548 1.139 . . . . 10.0 109.887 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.97 -57.88 11.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.46 0.704 . . . . 10.0 112.148 -176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.43 93.43 1.83 Allowed Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.162 -0.799 . . . . 10.0 114.742 -160.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 126.104 1.762 . . . . 10.0 106.534 154.722 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.8 p -66.63 162.6 20.71 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.715 0.406 . . . . 10.0 110.241 170.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -92.08 132.54 36.5 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 102.705 -3.072 . . . . 10.0 102.705 162.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 117.04 31.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.26 147.73 38.54 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.131 2.172 . . . . 10.0 107.656 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -128.06 133.58 49.09 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 10.3 m-85 -129.66 156.39 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.09 1.356 . . . . 10.0 109.49 -175.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -100.03 138.61 36.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 103.914 -2.624 . . . . 10.0 103.914 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.03 147.87 15.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 168.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -127.72 127.74 44.2 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.98 -9.54 7.96 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.723 1.154 . . . . 10.0 113.314 166.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.7 ptp -82.63 45.08 0.94 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.689 1.244 . . . . 10.0 112.968 -166.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.1 p -83.01 59.1 4.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 120.54 -1.35 . . . . 10.0 108.339 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 t -156.1 -30.29 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.372 1.069 . . . . 10.0 112.45 -164.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 74.88 -55.73 0.64 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.849 1.26 . . . . 10.0 111.793 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.72 -35.21 68.29 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.557 -0.714 . . . . 10.0 110.545 173.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.5 m -54.32 -50.31 67.66 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.024 1.73 . . . . 10.0 111.493 167.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.77 -51.09 71.25 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -55.98 -35.64 66.98 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.834 0.349 . . . . 10.0 111.7 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -61.98 -34.47 76.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 120.963 -1.086 . . . . 10.0 111.305 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.448 HG23 HG12 ' A' ' 61' ' ' VAL . 2.8 mt -59.41 -51.41 72.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 172.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -52.55 -50.26 63.28 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -49.92 71.76 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.942 0.897 . . . . 10.0 110.111 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -60.32 -51.06 71.11 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 110.416 -0.216 . . . . 10.0 110.416 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD1' HG22 ' A' ' 21' ' ' ILE . 35.1 mt -57.77 -47.5 82.34 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.516 0.727 . . . . 10.0 110.053 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -53.27 -39.16 63.69 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.483 0.713 . . . . 10.0 110.843 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -68.07 -19.5 64.87 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.181 -0.914 . . . . 10.0 113.251 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -75.87 132.13 33.68 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-N 120.14 1.336 . . . . 10.0 109.582 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -74.28 106.66 6.02 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.283 1.433 . . . . 10.0 108.047 177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.54 -14.71 8.65 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.55 0.595 . . . . 10.0 113.727 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.3 137.8 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.247 -1.02 . . . . 10.0 108.247 172.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.5 -50.05 7.57 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -168.26 166.93 12.45 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -178.79 67.55 0.18 Allowed Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.366 1.067 . . . . 10.0 113.353 -173.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -73.11 125.84 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.926 1.751 . . . . 10.0 109.837 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.52 136.33 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 O-C-N 121.51 -0.744 . . . . 10.0 110.885 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.46 105.8 18.03 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 121.64 -0.662 . . . . 10.0 111.672 -173.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -74.82 66.73 1.55 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.598 0.759 . . . . 10.0 111.748 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.57 -60.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.054 1.341 . . . . 10.0 109.086 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.2 -9.86 54.08 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.982 0.513 . . . . 10.0 111.399 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 59.91 48.73 8.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.241 1.816 . . . . 10.0 109.359 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.84 149.09 51.72 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.035 1.734 . . . . 10.0 108.144 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.98 135.52 59.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 123.414 0.686 . . . . 10.0 109.462 168.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -102.5 92.82 4.83 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.927 2.091 . . . . 10.0 107.82 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.2 t -84.93 126.72 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 O-C-N 121.611 -0.681 . . . . 10.0 109.538 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -100.27 127.37 46.58 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.976 0.91 . . . . 10.0 110.925 168.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -156.57 -171.39 3.67 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.636 0.774 . . . . 10.0 109.437 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -119.63 135.93 24.43 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 107.175 -1.417 . . . . 10.0 107.175 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.12 52.46 3.48 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 124.437 3.425 . . . . 10.0 111.474 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.67 -19.15 0.12 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.741 1.216 . . . . 10.0 112.724 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -111.57 -62.22 1.59 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.0 174.57 6.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.731 1.212 . . . . 10.0 109.059 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.23 144.75 30.08 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.852 0.861 . . . . 10.0 109.613 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.2 p -56.75 -41.65 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.789 0.835 . . . . 10.0 111.399 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.8 m -64.5 -38.26 90.39 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.761 -0.587 . . . . 10.0 112.231 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.29 -59.13 4.39 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 108.273 -1.01 . . . . 10.0 108.273 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -54.24 -36.45 63.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.522 -0.752 . . . . 10.0 111.666 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.89 -58.79 3.93 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 118.764 0.711 . . . . 10.0 109.442 170.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -57.73 -34.51 69.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.941 0.401 . . . . 10.0 111.082 -177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.46 -46.38 73.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.268 0.627 . . . . 10.0 110.008 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.474 HG21 HD13 ' A' ' 68' ' ' LEU . 33.3 m -70.03 -45.1 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 110.507 -0.183 . . . . 10.0 110.507 176.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -47.75 -44.77 28.39 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.603 1.161 . . . . 10.0 109.593 174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.54 -33.47 6.47 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.822 1.249 . . . . 10.0 113.75 175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 HD13 ' OH ' ' A' ' 66' ' ' TYR . 14.4 mt -76.66 -25.17 53.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.695 0.798 . . . . 10.0 111.721 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.22 -52.7 0.82 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-N 118.763 0.71 . . . . 10.0 111.78 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.483 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -64.73 161.26 18.29 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.806 0.443 . . . . 10.0 110.872 177.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -104.21 158.02 16.73 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 122.58 0.352 . . . . 10.0 110.436 -174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 HG21 ' A' ' 61' ' ' VAL . 7.1 tt -142.06 154.06 44.67 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.386 1.474 . . . . 10.0 107.544 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 170.4 21.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.627 1.971 . . . . 10.0 108.41 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -63.67 150.88 43.33 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.209 0.604 . . . . 10.0 111.947 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -127.1 -51.73 1.42 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.174 1.389 . . . . 10.0 111.349 167.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.97 -143.3 7.4 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.64 -1.384 . . . . 10.0 109.64 -176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.26 155.23 15.43 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.964 0.906 . . . . 10.0 110.359 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 56.83 63.42 1.94 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.509 1.524 . . . . 10.0 113.051 168.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -154.88 112.31 3.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.574 1.549 . . . . 10.0 107.568 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.9 p -88.61 -73.4 0.5 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.149 1.78 . . . . 10.0 110.911 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.427 ' N ' HD12 ' A' ' 77' ' ' ILE . 3.5 mp 54.48 80.29 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.395 1.878 . . . . 10.0 110.562 -173.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.39 133.91 56.55 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 163.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -156.37 179.42 32.25 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 106.345 -2.702 . . . . 10.0 106.345 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.254 0 CA-C-O 115.857 -2.021 . . . . 10.0 105.688 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.9 p -70.96 173.91 6.85 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.936 -0.765 . . . . 10.0 108.936 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.16 -178.97 3.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.064 1.345 . . . . 10.0 107.801 169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -119.79 140.12 51.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.654 1.981 . . . . 10.0 106.355 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.94 147.26 38.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.633 -1.617 . . . . 10.0 106.633 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -138.26 131.07 29.61 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.366 -2.457 . . . . 10.0 104.366 -169.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -133.11 148.59 52.14 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.121 1.368 . . . . 10.0 109.989 -169.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -94.97 132.31 39.96 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.123 -2.547 . . . . 10.0 104.123 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -108.95 143.94 18.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -114.17 110.65 20.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.035 -0.728 . . . . 10.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.82 -57.71 0.57 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.209 0.909 . . . . 10.0 114.037 164.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.4 mtp 21.56 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 129.468 3.107 . . . . 10.0 115.343 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.98 -7.94 58.94 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.233 -0.894 . . . . 10.0 110.27 -166.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 p -148.4 155.39 41.17 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.171 0.988 . . . . 10.0 110.004 173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.83 -30.69 71.7 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.355 -0.841 . . . . 10.0 110.224 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.4 90.77 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.562 0.745 . . . . 10.0 110.778 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.3 m -58.54 -51.98 67.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.869 1.268 . . . . 10.0 109.683 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.74 -58.29 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.444 0.465 . . . . 10.0 111.117 172.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -55.8 -33.42 64.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.294 -0.879 . . . . 10.0 112.158 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -32.31 71.74 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.529 -0.732 . . . . 10.0 110.896 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -55.62 -56.57 11.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.874 -1.158 . . . . 10.0 107.874 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -58.07 -44.02 87.3 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 122.496 0.319 . . . . 10.0 110.197 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpp -53.46 -53.72 47.26 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 110.221 -0.288 . . . . 10.0 110.221 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 mmt-85 -60.35 -50.54 73.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.185 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.9 mt -57.57 -46.97 83.31 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.764 0.257 . . . . 10.0 111.283 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -55.85 -36.14 67.23 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.672 0.789 . . . . 10.0 111.139 175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -63.89 -23.84 67.51 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.73 -0.652 . . . . 10.0 111.112 176.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.3 mm -80.09 134.12 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 119.965 1.257 . . . . 10.0 108.911 176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 42.4 mm-40 -77.24 139.03 39.75 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.78 12.5 62.28 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.481 0.562 . . . . 10.0 113.027 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.0 t -93.46 137.48 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.162 0.985 . . . . 10.0 108.586 170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.1 -52.82 4.76 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -167.75 171.98 9.59 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.29 55.09 0.25 Allowed Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.614 1.166 . . . . 10.0 113.13 -169.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -59.56 121.93 10.66 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.076 1.85 . . . . 10.0 110.438 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 t -82.28 146.55 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.226 0.536 . . . . 10.0 109.83 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 39' ' ' ALA . 1.2 t-20 -101.5 141.72 33.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.137 0.975 . . . . 10.0 108.696 169.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -120.06 57.68 0.93 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.073 0.949 . . . . 10.0 109.571 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 37' ' ' ASN . . . -154.18 -49.95 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.973 0.509 . . . . 10.0 111.589 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.81 -26.22 31.95 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.888 1.275 . . . . 10.0 109.189 176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 81.58 49.91 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.188 2.195 . . . . 10.0 108.963 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.5 m -128.11 152.14 48.36 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.777 1.631 . . . . 10.0 110.338 -173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.57 138.72 53.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 163.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 m -110.5 102.57 11.16 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -94.69 123.08 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.172 0.989 . . . . 10.0 109.002 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -101.26 121.02 41.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 167.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -153.66 179.5 8.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.117 0.967 . . . . 10.0 109.211 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -117.28 117.8 36.28 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 118.291 -0.861 . . . . 10.0 109.482 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.64 70.43 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.084 2.523 . . . . 10.0 109.982 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.5 tptp -135.65 -55.63 0.78 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.296 1.039 . . . . 10.0 109.409 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -101.47 -16.72 16.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.575 1.15 . . . . 10.0 111.886 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.63 167.07 21.79 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.44 1.496 . . . . 10.0 107.555 176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.8 m -151.57 164.33 37.09 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 122.193 0.997 . . . . 10.0 109.295 171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.59 -45.19 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 114.299 -1.318 . . . . 10.0 110.894 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -59.9 -38.48 82.39 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.059 -0.401 . . . . 10.0 111.662 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -68.63 -53.59 21.61 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -62.8 -28.46 70.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.875 -1.057 . . . . 10.0 110.948 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.7 -60.34 3.49 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 170.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -52.34 -42.43 63.89 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.529 0.604 . . . . 10.0 109.956 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.45 94.42 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.54 1.136 . . . . 10.0 111.184 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG21 HD13 ' A' ' 68' ' ' LEU . 73.6 t -67.71 -48.97 74.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 122.93 0.492 . . . . 10.0 109.692 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -47.51 -45.17 26.21 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.458 1.503 . . . . 10.0 109.564 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -57.34 -26.08 60.4 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.464 1.105 . . . . 10.0 113.056 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.54 -18.66 56.76 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.529 0.604 . . . . 10.0 111.968 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.88 -57.18 0.72 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 110.92 -0.872 . . . . 10.0 110.92 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.62 164.0 2.93 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.944 0.898 . . . . 10.0 111.232 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.4 165.0 11.58 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -148.82 153.67 38.43 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.509 -1.293 . . . . 10.0 107.509 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -150.87 168.93 22.99 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 125.762 1.625 . . . . 10.0 108.73 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.23 149.31 42.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.714 0.806 . . . . 10.0 111.26 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -124.49 -51.55 1.73 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.825 1.65 . . . . 10.0 110.748 168.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.13 -164.29 32.42 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.046 -1.622 . . . . 10.0 109.046 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -165.53 40.14 0.06 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.198 0.523 . . . . 10.0 111.37 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -162.06 54.11 0.23 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.926 -0.484 . . . . 10.0 110.792 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 44.93 63.32 1.76 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.387 1.475 . . . . 10.0 111.796 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.2 t -111.42 40.18 2.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.244 1.018 . . . . 10.0 110.954 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 77' ' ' ILE . 3.5 mp -35.25 -62.23 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.35 1.86 . . . . 10.0 112.77 -172.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.7 153.33 23.59 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.902 0.881 . . . . 10.0 109.388 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.81 -138.39 9.5 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.762 -0.935 . . . . 10.0 110.762 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 N-CA-C 104.564 -2.384 . . . . 10.0 104.564 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.5 mtt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -158.59 161.81 37.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 104.257 -2.498 . . . . 10.0 104.257 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -132.6 147.18 52.34 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.519 -1.66 . . . . 10.0 106.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -99.83 132.86 44.92 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.853 2.061 . . . . 10.0 105.926 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.04 150.32 50.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.55 135.5 50.41 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.2 m-85 -123.97 145.95 48.82 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -93.07 134.27 35.38 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 104.762 -2.31 . . . . 10.0 104.762 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.24 145.78 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -122.21 120.51 34.38 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.157 0.583 . . . . 10.0 109.625 172.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.5 -13.62 7.34 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.508 1.528 . . . . 10.0 113.339 161.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.0 ptp -71.5 67.03 0.51 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.736 1.215 . . . . 10.0 111.509 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 m -84.91 -10.87 56.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.439 0.696 . . . . 10.0 109.991 -173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 p -110.93 141.6 44.14 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.42 1.488 . . . . 10.0 109.33 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.44 71.98 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.575 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -47.72 64.72 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.975 0.91 . . . . 10.0 111.399 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.9 m -54.35 -55.33 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.303 1.041 . . . . 10.0 109.576 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.58 -48.35 79.59 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.226 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.68 -36.76 72.38 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.022 -1.049 . . . . 10.0 111.303 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -38.78 92.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.058 -1.026 . . . . 10.0 110.764 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.5 mm -51.78 -58.3 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 170.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -53.32 -45.84 69.2 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.555 -0.535 . . . . 10.0 109.555 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -55.77 -50.14 71.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.301 0.64 . . . . 10.0 111.228 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.73 -52.37 65.41 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 117.966 0.348 . . . . 10.0 110.848 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.0 mt -60.09 -43.42 95.55 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.718 0.236 . . . . 10.0 110.826 -174.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -55.8 -37.12 68.19 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.38 0.672 . . . . 10.0 111.159 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -66.77 -12.71 59.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 118.693 -0.67 . . . . 10.0 112.781 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.2 mm -74.02 137.26 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 119.944 1.247 . . . . 10.0 108.84 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -76.18 132.39 39.93 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.766 0.826 . . . . 10.0 109.245 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.68 77.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.687 -0.565 . . . . 10.0 111.687 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.39 144.13 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.95 -53.94 4.17 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -165.88 173.61 10.37 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.62 57.18 0.16 Allowed Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.377 1.471 . . . . 10.0 113.434 -171.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.45 126.15 11.94 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 121.975 1.783 . . . . 10.0 110.562 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 80.4 t -71.5 135.42 27.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 121.809 -0.557 . . . . 10.0 110.286 174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -97.46 85.3 3.6 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -70.18 77.83 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.272 1.029 . . . . 10.0 110.658 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -167.62 -55.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.334 1.454 . . . . 10.0 109.152 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -86.14 -13.16 47.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.241 1.416 . . . . 10.0 110.622 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 63.21 48.26 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 123.503 1.62 . . . . 10.0 108.667 -175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 93.5 m -128.63 147.42 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.734 2.014 . . . . 10.0 106.947 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -125.46 132.76 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.297 1.039 . . . . 10.0 108.905 169.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -97.58 100.67 12.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.743 1.217 . . . . 10.0 107.976 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.0 t -94.41 129.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.503 0.721 . . . . 10.0 109.067 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -115.16 127.36 55.5 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.421 -0.955 . . . . 10.0 108.421 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -160.7 -179.32 7.51 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.126 0.97 . . . . 10.0 108.706 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -114.07 134.78 22.12 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 173.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.17 57.58 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.549 2.833 . . . . 10.0 109.881 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -144.64 7.3 1.27 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.561 0.744 . . . . 10.0 111.694 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.25 -67.22 0.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.081 1.752 . . . . 10.0 106.866 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.78 175.88 5.64 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.637 1.175 . . . . 10.0 110.021 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 p -144.39 144.53 31.46 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.004 1.322 . . . . 10.0 109.55 174.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.28 -48.44 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.973 0.909 . . . . 10.0 111.477 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.1 m -59.47 -37.15 77.45 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.65 -55.91 13.06 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.3 pp -60.17 -31.83 70.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.633 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -58.77 5.97 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.652 -0.87 . . . . 10.0 108.652 172.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 2.1 tt0 -60.53 -33.18 72.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.123 0.487 . . . . 10.0 110.755 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.86 92.47 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.553 0.741 . . . . 10.0 111.091 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 45.5 t -70.57 -45.82 72.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.415 -0.587 . . . . 10.0 109.415 171.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -52.09 -41.38 62.37 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 59' ' ' GLU . 13.8 mttp -55.54 -22.58 22.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.047 1.339 . . . . 10.0 113.973 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.4 mt -80.15 -23.25 41.23 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.637 1.108 . . . . 10.0 111.786 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.33 -55.18 0.77 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-N 119.045 0.839 . . . . 10.0 111.673 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.85 157.29 30.88 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.209 0.604 . . . . 10.0 110.969 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -99.72 162.67 12.87 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.247 0.619 . . . . 10.0 110.536 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.42 151.93 36.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.315 1.446 . . . . 10.0 107.412 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -146.39 161.23 40.81 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.014 1.726 . . . . 10.0 108.062 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.37 150.51 48.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.84 0.352 . . . . 10.0 110.454 171.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -131.08 -51.07 1.03 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.875 1.27 . . . . 10.0 109.741 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.53 129.37 5.27 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.691 -1.363 . . . . 10.0 109.691 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -84.44 -65.33 1.02 Allowed 'General case' 0 C--N 1.338 0.096 0 N-CA-C 108.375 -0.972 . . . . 10.0 108.375 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 177.16 -47.29 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 126.114 1.766 . . . . 10.0 106.336 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.91 -59.88 0.43 Allowed 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.139 1.776 . . . . 10.0 109.353 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 t -46.46 -55.8 6.9 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.74 2.416 . . . . 10.0 112.14 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.4 mp -131.45 -84.75 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.445 0.698 . . . . 10.0 109.338 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.93 -97.78 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -97.21 -33.4 5.99 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 120.957 -1.09 . . . . 10.0 111.821 173.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 117.109 -1.424 . . . . 10.0 110.184 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.0 p -73.56 172.03 12.1 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -133.2 151.3 51.95 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.681 -2.34 . . . . 10.0 104.681 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -117.77 108.86 15.89 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.836 -1.542 . . . . 10.0 106.836 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.58 157.86 18.61 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 127.525 2.33 . . . . 10.0 107.116 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -142.06 135.83 29.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-N 119.891 1.223 . . . . 10.0 108.572 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.6 m-85 -132.79 153.88 50.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.544 1.537 . . . . 10.0 110.478 -169.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.54 140.75 29.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.808 2.043 . . . . 10.0 105.876 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.39 124.72 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 120.486 1.494 . . . . 10.0 110.976 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -105.79 107.69 18.81 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 123.957 0.903 . . . . 10.0 109.428 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.7 -77.91 0.24 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.509 1.052 . . . . 10.0 112.411 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.489 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 15.3 mtp 33.56 64.53 0.32 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.512 1.925 . . . . 10.0 114.853 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 p -73.64 -26.52 60.81 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 119.037 -0.506 . . . . 10.0 111.336 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.7 p -150.75 164.64 35.69 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.847 0.749 . . . . 10.0 110.384 171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.64 62.95 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.665 -0.647 . . . . 10.0 111.397 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.04 -30.34 71.42 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 117.872 -1.061 . . . . 10.0 111.416 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 45.2 m -57.57 -58.39 8.53 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.682 1.128 . . . . 10.0 109.029 172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -43.72 -56.39 3.82 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 124.303 1.002 . . . . 10.0 110.345 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -64.24 -33.32 75.54 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.304 0.853 . . . . 10.0 113.304 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.61 -41.56 81.49 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.967 -1.083 . . . . 10.0 109.397 173.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.62 -53.22 47.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -53.35 -49.11 67.82 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.482 0.713 . . . . 10.0 109.883 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -57.56 9.58 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.262 1.025 . . . . 10.0 111.194 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -60.26 -45.32 93.69 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 118.062 0.392 . . . . 10.0 111.268 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.54 -47.17 87.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 118.309 0.504 . . . . 10.0 110.143 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -55.11 -36.82 66.12 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.885 0.474 . . . . 10.0 110.926 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -25.87 67.39 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.06 -0.971 . . . . 10.0 112.875 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mm -78.33 129.88 36.92 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 CA-C-N 119.368 0.986 . . . . 10.0 108.817 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -75.97 131.55 39.65 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.023 0.929 . . . . 10.0 108.52 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.55 40.03 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.555 0.598 . . . . 10.0 112.786 -175.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.8 t -77.75 134.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 117.863 0.832 . . . . 10.0 109.123 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.5 -51.36 4.99 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.191 0.996 . . . . 10.0 109.561 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -158.12 172.43 18.43 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.166 0.439 . . . . 10.0 110.067 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.65 56.91 0.28 Allowed Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.753 1.221 . . . . 10.0 113.028 -175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.09 118.79 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.275 1.983 . . . . 10.0 111.077 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.6 t -84.05 142.87 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 118.406 0.548 . . . . 10.0 109.904 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -113.32 111.96 22.9 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.012 0.824 . . . . 10.0 112.439 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -78.58 57.13 1.94 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.371 1.468 . . . . 10.0 110.933 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.16 -55.3 0.06 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.781 -0.574 . . . . 10.0 111.678 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.5 mt -87.58 3.32 48.03 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.015 0.526 . . . . 10.0 110.124 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 49.38 42.99 23.11 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 126.493 1.917 . . . . 10.0 109.991 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 63.5 m -132.87 147.94 52.3 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.85 1.66 . . . . 10.0 109.325 -173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.7 p -128.14 127.41 67.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 125.386 1.474 . . . . 10.0 108.403 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.4 m -89.04 113.46 24.58 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.56 125.73 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -102.42 128.54 48.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -154.21 -178.2 6.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.32 -0.993 . . . . 10.0 108.32 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -116.47 130.61 24.37 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.826 -0.805 . . . . 10.0 108.826 171.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.23 56.27 6.0 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.312 2.675 . . . . 10.0 110.113 -176.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -139.65 2.41 2.0 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.054 0.542 . . . . 10.0 112.206 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -137.09 -61.38 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.283 1.433 . . . . 10.0 107.966 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -107.13 176.43 5.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.81 1.244 . . . . 10.0 109.865 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 t -146.61 169.33 19.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.417 1.087 . . . . 10.0 108.762 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -58.34 -47.06 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.284 -1.326 . . . . 10.0 110.048 -176.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -55.3 -44.18 75.52 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.081 0.952 . . . . 10.0 112.369 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.75 -53.68 37.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.051 -1.463 . . . . 10.0 107.051 -170.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.97 -35.09 79.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.569 -1.196 . . . . 10.0 110.113 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -52.44 -53.22 48.16 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.483 -0.761 . . . . 10.0 109.122 174.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -51.03 -49.87 59.66 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.384 -0.599 . . . . 10.0 109.384 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.17 -34.08 73.09 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.49 1.116 . . . . 10.0 111.775 -175.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.62 -46.74 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.239 0.616 . . . . 10.0 109.913 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -52.06 -38.04 55.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.391 0.676 . . . . 10.0 109.389 174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -69.46 10.11 0.39 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.545 2.338 . . . . 10.0 114.298 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.4 mt -108.8 -19.53 13.38 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.981 1.312 . . . . 10.0 110.981 165.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.67 -52.18 0.79 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 124.253 0.93 . . . . 10.0 110.908 173.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -65.03 159.1 23.89 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.597 -0.355 . . . . 10.0 110.79 176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.65 162.31 13.01 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.522 0.729 . . . . 10.0 109.487 -175.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -149.45 150.72 32.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -154.29 162.03 41.42 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.895 1.678 . . . . 10.0 108.39 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -62.36 148.36 45.5 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 123.236 0.615 . . . . 10.0 111.726 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.24 -53.9 2.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.479 1.511 . . . . 10.0 111.005 171.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.55 -147.28 9.05 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 109.253 -1.539 . . . . 10.0 109.253 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -138.14 146.42 42.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.11 1.364 . . . . 10.0 108.019 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 68.19 123.25 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.675 1.99 . . . . 10.0 113.496 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -31.62 -61.1 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.6 1.96 . . . . 10.0 113.254 172.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.8 p 44.5 48.42 8.37 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.883 1.673 . . . . 10.0 112.198 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -45.73 105.87 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.991 1.316 . . . . 10.0 112.714 -174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.8 175.46 11.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.43 159.46 35.6 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.662 -0.975 . . . . 10.0 110.662 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 N-CA-C 105.028 -2.212 . . . . 10.0 105.028 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.3 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 107.044 -1.465 . . . . 10.0 107.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 m 66.77 172.14 0.25 Allowed 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.938 0.774 . . . . 10.0 108.961 -172.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -156.22 155.02 31.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.437 -2.06 . . . . 10.0 105.437 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 mtpp -102.22 135.62 43.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.562 0.745 . . . . 10.0 110.012 167.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.47 151.42 48.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.647 1.979 . . . . 10.0 107.892 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -129.83 125.48 35.79 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 104.941 -2.244 . . . . 10.0 104.941 -172.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' THR . 3.5 m-85 -120.33 153.86 35.86 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 123.701 0.8 . . . . 10.0 109.87 -178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -97.74 133.37 42.37 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 129.322 3.049 . . . . 10.0 105.691 -175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.47 124.68 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 120.163 1.347 . . . . 10.0 111.25 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.32 107.71 19.14 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.474 0.71 . . . . 10.0 109.83 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.74 -78.9 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.085 1.326 . . . . 10.0 112.012 168.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.1 mtp 30.71 57.56 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.819 2.447 . . . . 10.0 115.116 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -26.27 60.37 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.4 0.68 . . . . 10.0 111.595 -175.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.65 153.8 47.38 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.604 0.716 . . . . 10.0 112.488 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.34 -34.75 58.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.092 0.557 . . . . 10.0 110.621 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.44 -44.84 89.33 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.904 -0.497 . . . . 10.0 111.339 172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' SG ' ' NH2' ' A' ' 20' ' ' ARG . 19.0 m -57.22 -49.04 77.26 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 174.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.05 -57.07 11.63 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.383 0.427 . . . . 10.0 111.275 175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -55.45 -36.09 66.17 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.153 -0.967 . . . . 10.0 112.045 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NH2' ' SG ' ' A' ' 17' ' ' CYS . 1.7 mpp_? -58.86 -34.01 71.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.386 -0.821 . . . . 10.0 110.638 176.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.2 mm -54.52 -58.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.248 -1.019 . . . . 10.0 108.248 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.59 -45.33 81.45 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -174.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -55.51 -54.39 44.53 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.518 0.327 . . . . 10.0 110.85 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -60.68 -47.48 86.08 Favored 'General case' 0 C--O 1.226 -0.14 0 O-C-N 122.147 -0.346 . . . . 10.0 110.082 -177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.39 -45.45 94.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 120.927 -0.309 . . . . 10.0 110.744 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.47 -34.91 62.42 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.474 0.709 . . . . 10.0 111.271 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -62.26 -19.73 63.52 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.0 mt -70.04 141.09 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 119.091 0.86 . . . . 10.0 109.474 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -82.39 124.26 29.86 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.461 -0.94 . . . . 10.0 108.461 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 17.98 41.68 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.379 0.514 . . . . 10.0 113.271 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -89.75 143.78 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.114 -1.069 . . . . 10.0 108.114 168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.09 -51.51 4.61 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 122.99 0.516 . . . . 10.0 110.045 173.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -153.87 167.02 31.08 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.894 -0.78 . . . . 10.0 108.894 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.55 54.23 0.28 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.049 0.94 . . . . 10.0 113.506 178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.74 134.94 36.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.374 1.383 . . . . 10.0 110.967 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.5 p -107.47 144.5 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.509 1.123 . . . . 10.0 111.185 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.65 147.96 25.39 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.749 0.42 . . . . 10.0 111.096 177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -110.44 86.76 2.37 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 174.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -179.36 -61.33 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 126.092 1.757 . . . . 10.0 110.115 -170.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt -107.8 -10.05 15.65 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.05 1.34 . . . . 10.0 110.317 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.55 68.76 0.73 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.676 2.39 . . . . 10.0 107.653 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' PHE . 45.2 m -146.74 138.58 24.56 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 112.891 -1.959 . . . . 10.0 108.506 -170.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.56 130.28 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.7 p -95.88 92.45 6.52 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.977 -1.49 . . . . 10.0 106.977 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.9 t -88.41 124.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -104.1 118.76 37.42 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.52 -1.289 . . . . 10.0 107.52 175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -154.44 -179.34 7.86 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.983 -1.118 . . . . 10.0 107.983 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -117.55 137.82 24.54 Favored Pre-proline 0 N--CA 1.443 -0.797 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -80.33 54.47 5.23 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.484 2.789 . . . . 10.0 109.816 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -138.14 -7.71 1.57 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.114 0.966 . . . . 10.0 111.913 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -130.62 -61.95 0.93 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.988 1.315 . . . . 10.0 108.882 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.25 172.59 7.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.603 1.161 . . . . 10.0 109.625 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.9 m -151.84 161.62 42.36 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.441 1.097 . . . . 10.0 109.959 168.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.87 -44.1 99.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.525 1.53 . . . . 10.0 111.245 -172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 m -53.72 -45.55 70.52 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.013 0.925 . . . . 10.0 112.041 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.82 -53.76 12.28 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.08 -1.081 . . . . 10.0 108.08 -169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -55.74 -33.0 63.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.298 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.431 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -48.79 -53.05 20.75 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 172.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.57 -35.14 67.84 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.469 0.652 . . . . 10.0 111.705 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.74 -42.57 77.38 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.528 0.731 . . . . 10.0 109.715 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.8 t -66.42 -47.71 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.789 0.836 . . . . 10.0 109.506 174.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 4.8 t70 -50.25 -45.95 54.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.108 1.363 . . . . 10.0 110.134 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -51.62 -20.53 2.05 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.268 1.427 . . . . 10.0 114.272 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -89.9 -15.62 31.74 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.038 0.836 . . . . 10.0 112.39 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.22 -50.19 0.84 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.084 0.849 . . . . 10.0 111.23 170.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.44 161.37 17.26 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 122.612 -0.346 . . . . 10.0 110.359 172.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.35 168.3 9.49 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 10.0 109.883 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 tt -154.11 157.4 38.89 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -155.66 165.87 35.25 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.916 1.686 . . . . 10.0 107.914 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.99 150.28 48.34 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 122.586 0.355 . . . . 10.0 110.685 175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -120.37 -72.34 0.69 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.958 1.303 . . . . 10.0 109.721 170.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -139.93 172.4 23.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.887 -1.285 . . . . 10.0 109.887 -170.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -173.89 50.02 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.788 0.835 . . . . 10.0 109.389 -167.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -67.67 -58.18 5.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.078 -0.389 . . . . 10.0 110.703 -172.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.2 t70 170.21 -64.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.087 2.155 . . . . 10.0 107.077 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.1 t -137.65 -44.75 0.54 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.2 1.4 . . . . 10.0 112.677 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.5 171.85 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 63.72 58.23 1.3 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.719 1.207 . . . . 10.0 110.634 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -50.98 121.23 10.63 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.828 -0.909 . . . . 10.0 110.828 169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.8 ppt_? . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.716 -1.135 . . . . 10.0 111.156 174.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.9 mtt . . . . . 0 N--CA 1.476 0.85 0 N-CA-C 105.879 -1.897 . . . . 10.0 105.879 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 p 57.54 -166.38 0.14 Allowed 'General case' 0 CA--C 1.536 0.426 0 O-C-N 124.514 1.134 . . . . 10.0 110.292 -168.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -137.03 127.27 26.32 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 103.778 -2.675 . . . . 10.0 103.778 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mtmm -103.84 106.06 16.46 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 173.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.74 158.19 17.86 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.949 2.099 . . . . 10.0 107.871 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -138.88 128.68 24.92 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CE2' HD11 ' A' ' 57' ' ' LEU . 3.5 m-85 -130.64 151.4 51.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.502 1.521 . . . . 10.0 108.827 -176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -114.18 126.6 55.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.803 -2.295 . . . . 10.0 104.803 -168.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.64 145.45 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 C-N-CA 123.592 0.757 . . . . 10.0 109.065 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -122.66 127.89 49.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.279 0.632 . . . . 10.0 110.012 164.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.97 -14.84 4.89 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.997 1.761 . . . . 10.0 113.026 158.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.424 ' HE1' HG21 ' A' ' 36' ' ' VAL . 4.9 ptp -80.55 60.81 4.04 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 118.853 1.327 . . . . 10.0 112.042 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -87.98 52.27 2.42 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 125.462 1.505 . . . . 10.0 108.575 -174.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.9 t -144.99 -89.03 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.107 0.963 . . . . 10.0 109.058 -168.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 145.97 -56.21 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 129.133 2.973 . . . . 10.0 107.757 -177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.12 -42.69 86.33 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.113 0.483 . . . . 10.0 109.847 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.8 m -47.14 -40.45 15.62 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.175 1.39 . . . . 10.0 112.554 170.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.59 -52.11 23.7 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.125 0.57 . . . . 10.0 109.946 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -58.08 -33.19 68.8 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.411 -0.806 . . . . 10.0 112.058 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -58.49 -37.11 74.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.12 -0.988 . . . . 10.0 110.179 174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.545 HG23 HG22 ' A' ' 61' ' ' VAL . 1.4 mt -60.83 -52.88 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -50.04 -47.63 53.22 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.27 0.628 . . . . 10.0 109.807 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -63.06 -31.87 73.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.176 0.991 . . . . 10.0 113.161 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -51.74 14.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.499 0.591 . . . . 10.0 109.576 172.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD11 HG22 ' A' ' 21' ' ' ILE . 21.1 mt -53.24 -48.0 68.56 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.392 1.077 . . . . 10.0 109.611 -177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -54.29 -39.36 66.87 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.726 0.81 . . . . 10.0 112.328 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -64.46 -27.88 69.29 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.88 -0.581 . . . . 10.0 111.269 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.51 120.95 23.38 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 CA-C-O 122.42 1.105 . . . . 10.0 108.928 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -71.26 134.22 46.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.359 -1.292 . . . . 10.0 108.147 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.18 -11.74 58.63 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 119.608 -0.551 . . . . 10.0 113.036 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.6 t -86.73 132.05 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 107.744 -1.206 . . . . 10.0 107.744 171.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.54 -49.07 8.93 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.336 -0.616 . . . . 10.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -167.76 169.75 11.42 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.65 61.68 0.19 Allowed Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 113.337 0.866 . . . . 10.0 113.337 -167.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.41 126.63 13.09 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.094 1.863 . . . . 10.0 110.27 177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG21 ' HE1' ' A' ' 12' ' ' MET . 7.2 p -90.61 134.02 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.036 0.446 . . . . 10.0 111.437 176.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -92.6 101.87 14.3 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.074 0.95 . . . . 10.0 110.745 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -72.86 67.32 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.712 1.205 . . . . 10.0 110.805 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.91 -57.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.125 0.97 . . . . 10.0 110.178 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.3 mt -84.75 -13.18 52.04 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.75 0.42 . . . . 10.0 110.381 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 61.78 54.94 2.77 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.262 1.506 . . . . 10.0 107.272 -171.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 32.7 m -134.96 139.82 45.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.31 1.444 . . . . 10.0 108.281 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.8 p -113.77 139.39 39.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.952 0.901 . . . . 10.0 108.826 169.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -104.08 108.59 20.02 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.33 126.81 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.525 0.73 . . . . 10.0 109.147 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.89 117.84 35.5 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.571 1.149 . . . . 10.0 108.033 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -154.54 -179.78 8.3 Favored 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.128 0.422 . . . . 10.0 110.973 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -113.56 125.63 29.29 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.807 1.243 . . . . 10.0 108.59 177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.14 42.73 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.345 3.364 . . . . 10.0 112.305 -176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.86 -3.62 0.98 Allowed 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.273 1.429 . . . . 10.0 111.295 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.47 -57.8 1.06 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.8 0.84 . . . . 10.0 109.121 -169.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -106.86 168.63 9.05 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.347 1.059 . . . . 10.0 108.71 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.8 137.89 33.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.513 1.125 . . . . 10.0 108.906 -175.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 11.8 p -50.24 -48.23 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.327 0.651 . . . . 10.0 110.509 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -56.39 -39.8 73.56 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.757 1.021 . . . . 10.0 113.757 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.24 -54.9 14.46 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 122.264 1.03 . . . . 10.0 108.684 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.5 pp -62.64 -36.78 83.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.112 -0.949 . . . . 10.0 109.916 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -52.83 -53.49 47.84 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.369 -0.974 . . . . 10.0 108.369 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.96 -45.49 74.94 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.231 -0.655 . . . . 10.0 109.231 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.59 85.44 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.244 0.618 . . . . 10.0 110.688 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 21' ' ' ILE . 46.4 t -63.64 -46.35 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 O-C-N 122.275 -0.266 . . . . 10.0 110.357 176.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -50.23 -45.88 54.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.072 0.939 . . . . 10.0 109.535 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 tttt -67.29 -19.48 65.49 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.051 1.34 . . . . 10.0 112.703 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.99 -26.96 66.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.364 0.983 . . . . 10.0 110.829 169.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.61 -44.03 1.24 Allowed Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.508 0.595 . . . . 10.0 111.677 175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -179.07 2.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.503 0.721 . . . . 10.0 109.606 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -117.58 152.01 36.01 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.806 -0.559 . . . . 10.0 109.693 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.1 154.49 47.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.801 -1.926 . . . . 10.0 105.801 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 156.6 39.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.974 1.31 . . . . 10.0 108.035 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.98 146.62 54.48 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 10.0 110.538 177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -110.87 -54.81 2.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.513 1.125 . . . . 10.0 109.842 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.22 -150.75 20.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.332 -1.907 . . . . 10.0 108.332 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.14 152.49 38.54 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.409 1.484 . . . . 10.0 109.263 -176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -125.74 -49.18 1.63 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.8 0.84 . . . . 10.0 111.709 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.6 t0 6.28 78.45 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 128.102 2.561 . . . . 10.0 115.326 -166.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.7 t -155.68 -61.99 0.11 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 tt -87.66 168.12 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.285 0.634 . . . . 10.0 109.86 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -56.89 -57.14 13.81 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.183 1.393 . . . . 10.0 111.109 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.47 -169.29 34.19 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 108.144 -1.983 . . . . 10.0 108.144 -173.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 . . . . . 0 C--O 1.254 1.311 0 CA-C-O 115.87 -2.014 . . . . 10.0 105.578 -175.002 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 105.882 -1.896 . . . . 10.0 105.882 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.1 p -111.31 -108.68 0.35 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.717 1.144 . . . . 10.0 109.478 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -123.54 -179.2 4.25 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.012 -2.218 . . . . 10.0 105.012 166.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.41 144.57 50.79 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.53 -2.026 . . . . 10.0 105.53 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -139.13 138.15 36.76 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -113.05 126.76 55.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 104.313 -2.477 . . . . 10.0 104.313 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' CE1' HG23 ' A' ' 54' ' ' VAL . 2.1 m-85 -124.28 149.47 46.46 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.677 1.191 . . . . 10.0 108.583 174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -108.4 125.29 51.58 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.547 3.139 . . . . 10.0 105.728 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.12 140.56 41.01 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 O-C-N 124.002 0.813 . . . . 10.0 109.448 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -112.15 126.26 55.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.819 0.848 . . . . 10.0 109.052 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.35 2.11 24.67 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 124.953 1.263 . . . . 10.0 112.808 162.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptp -83.9 58.38 4.65 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.551 1.176 . . . . 10.0 110.538 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -71.91 -17.99 62.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.401 0.68 . . . . 10.0 110.01 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 131.78 46.82 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 124.17 0.988 . . . . 10.0 109.514 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.2 -37.95 37.67 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.152 -0.967 . . . . 10.0 110.729 171.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.21 -42.52 77.35 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.202 1.001 . . . . 10.0 112.341 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.0 m -62.36 -51.26 68.3 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.31 67.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.79 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -59.09 -35.1 72.82 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.409 -0.807 . . . . 10.0 111.381 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.239 -0.913 . . . . 10.0 110.967 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -53.94 -58.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -57.17 -46.39 82.83 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.832 -0.433 . . . . 10.0 109.832 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.43 -46.1 73.16 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.471 0.708 . . . . 10.0 111.139 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 64' ' ' LEU . 6.0 tpt180 -70.84 -46.95 61.79 Favored 'General case' 0 N--CA 1.458 -0.048 0 O-C-N 121.996 -0.44 . . . . 10.0 110.782 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -55.77 -41.35 73.89 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.192 0.451 . . . . 10.0 111.186 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -54.62 -34.97 62.9 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.599 0.76 . . . . 10.0 111.885 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.02 -22.51 65.89 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.826 0.45 . . . . 10.0 110.935 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.19 138.63 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 120.93 -1.106 . . . . 10.0 108.902 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -99.23 134.05 42.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -166.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.82 8.76 64.91 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.567 0.603 . . . . 10.0 113.341 -170.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.5 t -84.51 137.71 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.48 -49.12 6.69 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.238 1.015 . . . . 10.0 109.915 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -171.03 176.6 3.97 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 108.27 -1.011 . . . . 10.0 108.27 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.05 57.45 0.36 Allowed Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 114.339 1.237 . . . . 10.0 114.339 -172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -58.65 122.03 10.96 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.77 1.647 . . . . 10.0 111.371 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.13 137.93 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.193 0.997 . . . . 10.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -108.58 86.82 2.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.752 0.821 . . . . 10.0 109.51 -173.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -73.06 73.84 1.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.532 1.133 . . . . 10.0 111.09 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.54 -56.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.387 1.075 . . . . 10.0 109.33 172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 mt -78.18 -21.82 49.58 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.984 1.314 . . . . 10.0 110.337 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 71.15 55.6 0.22 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.253 1.821 . . . . 10.0 108.105 -172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.3 m -134.45 148.28 50.57 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.305 2.242 . . . . 10.0 108.391 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.33 139.19 46.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.407 -0.96 . . . . 10.0 108.407 163.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.6 m -106.85 98.86 8.47 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.766 -1.198 . . . . 10.0 107.766 176.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -94.98 127.22 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 10.0 109.571 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -100.5 125.06 46.79 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.348 -0.982 . . . . 10.0 108.348 164.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -152.21 172.85 15.75 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 106.39 -1.708 . . . . 10.0 106.39 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -105.8 124.34 36.43 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 118.361 -0.828 . . . . 10.0 109.778 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.21 56.29 5.4 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 124.195 3.263 . . . . 10.0 111.476 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.35 -0.69 0.42 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.669 1.588 . . . . 10.0 111.169 175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -129.21 -74.12 0.56 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.359 1.464 . . . . 10.0 107.386 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.92 163.88 16.14 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.648 1.179 . . . . 10.0 108.501 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.7 p -140.45 153.86 46.43 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.044 1.338 . . . . 10.0 109.247 171.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.2 p -53.17 -43.15 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.042 0.937 . . . . 10.0 110.75 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -64.17 -41.34 97.17 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.027 0.531 . . . . 10.0 111.778 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -63.89 -58.1 7.79 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.4 pp -60.09 -30.17 69.07 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.795 -0.638 . . . . 10.0 110.863 -175.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.59 -53.02 5.94 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 169.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.36 -39.13 82.27 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.958 -0.464 . . . . 10.0 110.588 -176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.67 75.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.664 0.786 . . . . 10.0 110.637 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 68' ' ' LEU . 16.0 m -66.73 -43.47 90.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.441 -0.504 . . . . 10.0 110.603 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.43 -43.96 62.16 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.437 0.695 . . . . 10.0 110.119 175.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -53.8 -20.98 6.49 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.127 1.158 . . . . 10.0 114.127 175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD13 ' OH ' ' A' ' 66' ' ' TYR . 17.1 mt -76.89 -26.37 54.11 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.466 1.03 . . . . 10.0 111.514 175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.19 -50.12 0.9 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.927 0.775 . . . . 10.0 111.79 173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.2 p90 -69.98 175.41 4.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.218 0.607 . . . . 10.0 110.544 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -123.85 149.44 45.76 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-O 120.995 0.426 . . . . 10.0 110.706 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 tt -130.21 153.11 48.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.951 2.5 . . . . 10.0 105.907 -173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -146.95 162.0 39.62 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.414 1.485 . . . . 10.0 107.664 172.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.18 149.61 49.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.97 0.414 . . . . 10.0 110.477 177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.22 -48.63 2.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.771 1.228 . . . . 10.0 109.775 165.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.32 137.5 2.41 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.224 -0.512 . . . . 10.0 112.431 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -77.68 62.23 2.53 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.707 1.203 . . . . 10.0 110.725 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.66 165.54 16.51 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.467 0.707 . . . . 10.0 109.707 165.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -142.17 96.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 164.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.5 m -171.89 66.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.015 2.126 . . . . 10.0 108.114 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.0 mt -67.06 134.32 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -144.65 162.7 36.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 107.584 -1.265 . . . . 10.0 107.584 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 70.96 -76.63 0.56 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 110.099 -1.2 . . . . 10.0 110.099 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 18.3 ttt-85 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 125.505 1.522 . . . . 10.0 113.316 171.141 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 ttm . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.8 p -159.29 175.03 13.89 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 105.51 -2.033 . . . . 10.0 105.51 -165.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -98.42 -168.09 1.6 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.091 1.314 . . . . 10.0 108.353 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -140.66 137.04 33.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.361 1.064 . . . . 10.0 108.186 168.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.8 141.85 51.17 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.034 1.733 . . . . 10.0 107.42 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -126.36 130.0 49.92 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.294 -2.113 . . . . 10.0 105.294 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.99 147.56 52.64 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.501 1.121 . . . . 10.0 108.802 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.23 139.94 30.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.181 -2.525 . . . . 10.0 104.181 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.12 143.17 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.13 0.972 . . . . 10.0 108.408 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -125.43 124.48 41.54 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.465 1.106 . . . . 10.0 108.49 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.91 -14.62 6.64 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 123.503 0.573 . . . . 10.0 113.433 164.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.589 ' HE1' HG11 ' A' ' 36' ' ' VAL . 3.8 ptp -74.46 81.2 1.93 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 122.412 1.101 . . . . 10.0 110.939 -177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 p -65.55 -25.35 67.39 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.324 0.649 . . . . 10.0 110.248 171.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -113.22 138.87 49.34 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.409 1.084 . . . . 10.0 112.649 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.36 -30.2 71.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.322 -0.862 . . . . 10.0 110.662 170.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.91 71.28 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.67 -0.644 . . . . 10.0 110.551 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 91.1 m -53.04 -49.97 65.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.032 0.933 . . . . 10.0 110.017 174.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.31 -49.17 67.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.88 0.371 . . . . 10.0 111.493 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.34 -34.57 78.0 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.18 -0.95 . . . . 10.0 111.215 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -38.89 86.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.308 -0.87 . . . . 10.0 110.074 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG12 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -57.22 -47.69 83.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 177.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HG2' HG23 ' A' ' 36' ' ' VAL . 58.5 mt-10 -55.2 -46.1 75.87 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.956 0.503 . . . . 10.0 109.704 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -60.48 -47.73 84.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.875 0.47 . . . . 10.0 111.624 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -59.08 -50.44 74.06 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 118.242 0.474 . . . . 10.0 110.722 175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.89 -44.32 91.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.679 0.392 . . . . 10.0 110.418 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -53.57 -36.31 61.76 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.5 0.72 . . . . 10.0 111.696 173.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 tttp -65.61 -20.13 66.19 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 118.595 -0.717 . . . . 10.0 112.453 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mm -72.55 141.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 119.476 1.035 . . . . 10.0 109.779 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -78.96 126.27 30.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.756 1.222 . . . . 10.0 109.375 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.31 25.53 54.44 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 123.668 0.651 . . . . 10.0 112.29 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.53 151.43 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.179 -1.045 . . . . 10.0 108.179 166.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.25 -59.4 1.7 Allowed 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 123.172 0.589 . . . . 10.0 110.039 170.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -152.16 170.82 19.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.19 58.9 0.36 Allowed Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.274 1.03 . . . . 10.0 112.68 175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -65.88 123.38 11.24 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.759 1.639 . . . . 10.0 110.032 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.589 HG11 ' HE1' ' A' ' 12' ' ' MET . 36.4 t -89.17 126.34 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 121.797 0.808 . . . . 10.0 110.187 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -90.85 85.79 6.11 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.443 1.097 . . . . 10.0 109.03 -171.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -71.33 69.81 0.57 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.303 1.441 . . . . 10.0 111.966 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.56 -54.58 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 125.649 1.58 . . . . 10.0 108.841 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.8 mt -82.96 -5.56 59.12 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.661 1.584 . . . . 10.0 110.424 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 56.65 46.33 20.44 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.439 1.496 . . . . 10.0 108.152 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.1 m -131.59 150.2 52.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.97 -1.492 . . . . 10.0 106.97 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 146.02 27.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 C-N-CA 124.318 1.047 . . . . 10.0 108.623 170.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.1 p -111.68 94.28 4.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.579 1.551 . . . . 10.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 44.4 t -88.73 126.55 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -103.38 121.4 42.71 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.709 -1.589 . . . . 10.0 106.709 171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -155.03 -179.23 7.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -121.15 129.16 25.4 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 118.238 -0.886 . . . . 10.0 108.92 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.62 55.48 5.65 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.878 3.052 . . . . 10.0 110.98 -172.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.12 18.65 0.87 Allowed 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 124.661 1.184 . . . . 10.0 108.41 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -146.14 -68.26 0.28 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 107.108 -1.442 . . . . 10.0 107.108 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -93.72 169.66 10.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.504 1.121 . . . . 10.0 109.076 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -139.79 152.56 46.66 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.325 1.05 . . . . 10.0 109.158 174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.08 -51.19 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 C-N-CA 123.143 0.577 . . . . 10.0 110.094 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -57.86 -29.97 65.44 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.157 0.799 . . . . 10.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.62 -60.28 2.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.35 -30.16 64.61 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.211 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -53.38 12.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.747 0.819 . . . . 10.0 111.34 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -56.54 -43.05 79.5 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.124 -0.695 . . . . 10.0 109.124 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.44 -39.87 92.58 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.54 0.736 . . . . 10.0 110.165 -169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 21' ' ' ILE . 34.5 m -73.35 -48.57 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 119.132 -0.461 . . . . 10.0 111.139 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -47.8 -41.01 22.59 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.136 0.425 . . . . 10.0 110.241 173.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -54.54 -28.94 49.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.461 1.105 . . . . 10.0 113.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.45 -19.34 53.34 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.284 0.634 . . . . 10.0 111.735 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.96 -55.56 0.73 Allowed Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.297 0.951 . . . . 10.0 111.085 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 17' ' ' CYS . 1.1 p90 -62.62 155.47 26.04 Favored 'General case' 0 C--N 1.335 -0.049 0 C-N-CA 122.744 0.418 . . . . 10.0 109.996 173.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.9 162.9 13.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.107 0.563 . . . . 10.0 110.096 -175.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 61' ' ' VAL . 6.2 tt -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.08 1.752 . . . . 10.0 106.609 -177.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -153.25 168.47 25.89 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.786 1.634 . . . . 10.0 108.795 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -68.46 150.58 47.93 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.121 0.568 . . . . 10.0 112.029 -174.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.49 -34.54 1.04 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 114.509 1.3 . . . . 10.0 114.509 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.76 175.1 47.14 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.367 -1.493 . . . . 10.0 109.367 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -156.6 45.75 0.42 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.438 0.637 . . . . 10.0 110.956 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -165.51 137.42 4.09 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.535 -1.283 . . . . 10.0 107.535 176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -144.88 85.0 1.74 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.361 1.464 . . . . 10.0 107.086 166.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.5 t -171.3 76.91 0.06 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.774 -0.579 . . . . 10.0 111.137 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp 49.65 54.05 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.83 1.252 . . . . 10.0 111.23 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -73.32 158.4 35.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.026 0.931 . . . . 10.0 110.649 165.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.98 45.84 11.3 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.988 0.755 . . . . 10.0 114.988 163.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.268 2.627 . . . . 10.0 109.021 176.297 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.9 mtt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 108.855 -0.795 . . . . 10.0 108.855 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.2 p -113.58 159.96 19.05 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -107.59 -165.64 1.07 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.8 1.24 . . . . 10.0 107.996 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -132.04 129.9 40.63 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.35 157.77 40.08 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.132 1.773 . . . . 10.0 107.46 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -141.21 133.35 27.89 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.979 -1.859 . . . . 10.0 105.979 -174.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -134.05 152.69 51.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.58 1.552 . . . . 10.0 109.575 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.15 146.04 24.59 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 106.089 -1.819 . . . . 10.0 106.089 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mp -120.88 132.53 70.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 120.721 1.601 . . . . 10.0 110.805 177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -108.45 109.16 20.36 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.627 1.171 . . . . 10.0 109.819 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.81 -75.52 0.31 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.118 0.866 . . . . 10.0 112.674 169.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 27.0 mtp 33.63 67.97 0.18 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.338 1.855 . . . . 10.0 115.3 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.5 p -77.66 -21.26 52.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.584 -0.697 . . . . 10.0 112.304 -176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.5 p -156.01 166.04 34.66 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 119.21 0.914 . . . . 10.0 109.925 171.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.91 -35.28 44.98 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.322 0.582 . . . . 10.0 111.595 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.27 -27.6 69.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.117 -0.944 . . . . 10.0 111.893 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.3 m -56.97 -60.45 3.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.56 1.073 . . . . 10.0 109.105 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.13 -54.92 9.4 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.671 -1.15 . . . . 10.0 109.813 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -65.07 -31.36 72.54 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.123 0.786 . . . . 10.0 113.123 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -60.41 -41.78 94.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.853 -1.154 . . . . 10.0 109.501 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.71 -49.12 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -53.19 -49.57 66.45 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.228 0.611 . . . . 10.0 109.562 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -55.32 -53.23 58.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.644 0.777 . . . . 10.0 111.142 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -56.22 -52.0 66.03 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.71 -47.27 86.3 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.03 0.932 . . . . 10.0 109.639 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -51.43 -39.74 57.94 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 10.0 111.347 172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -71.4 -19.2 62.29 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.391 -0.814 . . . . 10.0 112.78 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -76.89 127.0 38.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 120.193 1.361 . . . . 10.0 109.814 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -71.82 102.5 2.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.803 1.641 . . . . 10.0 108.927 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.51 -8.18 6.98 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.21 0.91 . . . . 10.0 112.333 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.9 t -85.48 133.37 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 118.086 0.943 . . . . 10.0 108.921 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.06 -58.88 2.32 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.454 1.102 . . . . 10.0 109.469 172.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -140.94 166.77 23.86 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.001 -0.74 . . . . 10.0 109.001 -177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.76 54.37 0.27 Allowed Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 114.013 1.116 . . . . 10.0 114.013 -176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.33 117.95 5.3 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.465 2.11 . . . . 10.0 111.943 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -81.29 132.01 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.58 -0.7 . . . . 10.0 110.752 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -104.66 83.92 2.1 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.144 0.978 . . . . 10.0 111.062 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.87 86.78 0.98 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.938 2.095 . . . . 10.0 108.88 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 176.07 -41.79 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 129.403 3.081 . . . . 10.0 109.693 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -111.92 -4.18 14.63 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 126.277 1.831 . . . . 10.0 110.065 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 46.64 23.84 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 125.963 1.705 . . . . 10.0 107.638 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.1 m -131.99 144.86 51.1 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 112.717 -2.038 . . . . 10.0 106.061 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 129.01 73.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 m -84.86 132.2 34.43 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 164.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.9 t -123.21 130.36 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.67 114.39 28.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -145.64 176.14 9.85 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 124.529 1.132 . . . . 10.0 108.658 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.92 121.69 40.12 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.68 0.792 . . . . 10.0 111.579 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.43 80.74 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.535 2.823 . . . . 10.0 109.055 176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -157.34 -59.34 0.09 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.783 0.833 . . . . 10.0 108.898 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -107.45 -30.92 8.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.042 1.337 . . . . 10.0 110.311 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.5 154.54 32.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.123 1.369 . . . . 10.0 107.751 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.77 156.42 42.33 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.732 0.813 . . . . 10.0 109.496 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -49.8 -44.21 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.718 1.207 . . . . 10.0 111.538 -177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 p -51.8 -50.3 61.04 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.079 1.751 . . . . 10.0 111.873 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.39 -49.12 23.89 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -167.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.23 -35.91 72.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.517 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.9 -53.01 21.37 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.482 -0.762 . . . . 10.0 111.315 172.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -52.97 -39.06 62.7 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.475 0.655 . . . . 10.0 110.613 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.85 72.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.63 0.772 . . . . 10.0 109.485 -174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 68' ' ' LEU . 44.3 t -74.54 -53.25 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.5 -44.24 35.75 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.257 0.623 . . . . 10.0 110.193 174.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.04 -29.09 27.71 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.5 mt -81.84 -17.35 47.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.681 0.673 . . . . 10.0 111.832 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 123.69 -54.26 0.73 Allowed Glycine 0 C--N 1.337 0.597 0 N-CA-C 110.347 -1.101 . . . . 10.0 110.347 171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -65.13 156.15 32.59 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 120.911 0.386 . . . . 10.0 110.5 174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -102.73 173.29 6.39 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.601 0.76 . . . . 10.0 111.658 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -152.74 155.91 38.12 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.079 -1.452 . . . . 10.0 107.079 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.9 mtpt -154.6 167.29 30.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.828 1.651 . . . . 10.0 108.029 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 148.9 50.69 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.091 0.557 . . . . 10.0 111.779 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -120.58 -53.86 2.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.421 1.488 . . . . 10.0 110.324 170.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.6 -169.3 39.14 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.502 -1.439 . . . . 10.0 109.502 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -161.74 37.54 0.13 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 122.547 1.165 . . . . 10.0 110.844 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.96 47.93 0.85 Allowed 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.453 177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.15 55.17 3.08 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.27 162.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.3 m -82.36 -65.04 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.15 -0.452 . . . . 10.0 112.124 -166.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 63.55 175.64 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.274 1.03 . . . . 10.0 111.733 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.42 -173.68 0.18 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.005 . . . . 10.0 111.637 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.67 -123.06 2.06 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.095 1.331 . . . . 10.0 112.137 -174.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 . . . . . 0 C--O 1.252 1.209 0 C-N-CA 126.926 2.09 . . . . 10.0 105.677 -176.058 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.221 -1.399 . . . . 10.0 107.221 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.7 p -139.24 165.07 28.15 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 105.419 -2.067 . . . . 10.0 105.419 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -118.5 178.54 4.42 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 106.775 -1.565 . . . . 10.0 106.775 171.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -119.81 128.02 53.31 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.352 -2.092 . . . . 10.0 105.352 170.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.27 152.78 46.97 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 124.589 1.155 . . . . 10.0 107.978 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -132.25 131.3 41.95 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 104.801 -2.296 . . . . 10.0 104.801 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' CD2' HD21 ' A' ' 68' ' ' LEU . 7.7 m-85 -130.66 150.6 51.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.62 1.568 . . . . 10.0 110.145 -175.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -97.68 125.81 42.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.101 3.36 . . . . 10.0 103.178 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 43' ' ' VAL . 3.5 mp -111.55 143.6 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -116.15 116.34 27.65 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.32 0.648 . . . . 10.0 109.376 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.97 -70.01 0.5 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.012 0.815 . . . . 10.0 113.142 161.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.3 mtp 40.48 63.94 1.03 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.615 1.566 . . . . 10.0 114.171 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 p -73.08 -19.96 61.06 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.729 -0.607 . . . . 10.0 112.362 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.8 p -155.47 166.05 34.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.989 0.813 . . . . 10.0 109.967 165.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.82 -33.82 51.04 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 122.048 -0.408 . . . . 10.0 111.656 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.05 -28.08 69.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.936 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.6 m -57.0 -59.37 5.16 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.264 0.938 . . . . 10.0 108.833 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.62 -53.4 24.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.934 0.894 . . . . 10.0 110.281 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -53.97 -40.93 67.32 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.022 0.439 . . . . 10.0 112.018 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.06 -40.53 89.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.334 -0.854 . . . . 10.0 110.272 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' HG21 ' A' ' 36' ' ' VAL . 2.7 mt -54.54 -50.01 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 175.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.9 mt-10 -56.74 -47.76 79.31 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.95 -49.43 76.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.427 0.691 . . . . 10.0 111.64 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -50.66 72.75 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 122.146 -0.346 . . . . 10.0 110.087 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.27 -39.63 91.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.01 -33.92 53.96 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.673 0.619 . . . . 10.0 112.673 172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 tptm -62.1 -25.32 67.64 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.888 -0.507 . . . . 10.0 111.929 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.1 mt -64.16 144.52 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-O 121.654 0.74 . . . . 10.0 110.103 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -87.45 123.85 32.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.08 30.76 36.95 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.619 0.628 . . . . 10.0 112.163 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -95.37 150.31 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 167.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -101.5 -59.52 1.68 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.169 0.588 . . . . 10.0 109.423 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -151.65 170.12 20.49 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.83 57.29 0.26 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.645 1.178 . . . . 10.0 113.261 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.36 127.18 14.53 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.745 1.63 . . . . 10.0 110.187 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HB ' ' A' ' 21' ' ' ILE . 45.9 t -87.66 136.48 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.565 0.62 . . . . 10.0 110.456 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -99.98 98.46 9.21 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.274 0.63 . . . . 10.0 111.164 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -74.48 65.37 1.25 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.965 1.306 . . . . 10.0 111.75 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.11 0.05 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.61 0.764 . . . . 10.0 110.32 175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.4 mt -84.69 -16.31 42.28 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.598 0.759 . . . . 10.0 110.374 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 71.0 45.47 0.51 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.099 1.76 . . . . 10.0 108.977 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.6 m -132.19 148.28 52.46 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.12 1.768 . . . . 10.0 109.279 -173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 9' ' ' ILE . 6.4 p -122.93 136.81 58.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 N-CA-C 108.168 -1.049 . . . . 10.0 108.168 165.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.92 104.85 16.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 170.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 64.6 t -93.97 128.89 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.699 -0.852 . . . . 10.0 108.699 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -105.25 116.22 31.58 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.232 -1.396 . . . . 10.0 107.232 171.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.71 175.11 11.16 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.39 0.676 . . . . 10.0 110.229 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -104.72 118.21 56.96 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.216 -0.897 . . . . 10.0 109.512 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.65 51.97 3.51 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 123.202 2.601 . . . . 10.0 111.223 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -153.58 17.36 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.478 1.511 . . . . 10.0 109.668 175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -145.24 -59.62 0.35 Allowed 'General case' 0 C--N 1.339 0.136 0 C-N-CA 125.681 1.592 . . . . 10.0 107.668 -174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -114.05 169.73 8.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.848 1.259 . . . . 10.0 108.974 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 151.61 44.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.248 1.019 . . . . 10.0 108.881 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -52.49 -43.47 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 123.69 0.796 . . . . 10.0 111.099 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.1 m -59.43 -46.1 89.68 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.527 0.731 . . . . 10.0 112.551 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -63.02 -54.46 37.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.45 -35.86 72.79 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.343 -0.844 . . . . 10.0 110.865 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.98 -60.74 2.25 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -29.69 70.86 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 120.843 0.354 . . . . 10.0 111.505 -173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.12 -40.48 94.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.89 0.876 . . . . 10.0 110.258 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.0 t -78.5 -40.71 24.76 Favored 'Isoleucine or valine' 0 C--N 1.342 0.248 0 C-N-CA 123.245 0.618 . . . . 10.0 109.869 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.88 -41.25 61.75 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.631 0.772 . . . . 10.0 109.415 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -47.74 -29.84 3.42 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.469 0.914 . . . . 10.0 113.469 174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 34.6 mt -75.52 -31.83 60.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.06 0.944 . . . . 10.0 111.956 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.37 -59.53 0.57 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 118.764 0.711 . . . . 10.0 111.849 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.83 160.99 21.97 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.814 0.446 . . . . 10.0 110.372 177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -107.96 160.48 15.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.762 0.825 . . . . 10.0 110.537 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 HD21 ' CD2' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -143.11 145.21 32.64 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 105.984 -1.858 . . . . 10.0 105.984 -170.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -153.19 170.73 19.83 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.197 1.399 . . . . 10.0 108.022 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.96 146.36 54.46 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.972 0.509 . . . . 10.0 111.926 -177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 -51.66 2.0 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.072 1.349 . . . . 10.0 111.286 170.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -171.61 86.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.832 0 CA-C-N 118.381 0.537 . . . . 10.0 112.935 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.0 51.91 1.2 Allowed 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.783 -0.833 . . . . 10.0 112.143 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -175.7 66.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.41 0.684 . . . . 10.0 110.866 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.1 t0 30.55 64.73 0.16 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.109 2.164 . . . . 10.0 113.934 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.2 p -126.42 61.58 1.3 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.79 0.836 . . . . 10.0 109.336 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mt -63.88 134.08 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.74 93.59 0.11 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.68 -77.64 0.02 OUTLIER Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.561 -0.577 . . . . 10.0 114.035 -177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 116.293 -1.813 . . . . 10.0 109.421 -167.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 116.259 -1.829 . . . . 10.0 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.0 p -98.34 -122.86 0.14 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.604 1.093 . . . . 10.0 108.297 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -122.83 141.16 52.16 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.584 -1.635 . . . . 10.0 106.584 165.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -90.9 147.96 22.79 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.003 1.721 . . . . 10.0 107.829 173.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.98 131.52 9.6 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -117.16 133.66 55.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.071 -1.825 . . . . 10.0 106.071 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HG21 ' A' ' 45' ' ' VAL . 3.7 m-85 -128.35 152.19 48.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.397 1.061 . . . . 10.0 109.58 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -101.13 131.26 47.16 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.586 1.954 . . . . 10.0 105.741 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mt -119.82 122.22 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 123.888 0.743 . . . . 10.0 112.444 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -106.73 122.11 45.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.349 1.06 . . . . 10.0 110.388 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.33 11.92 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.66 1.124 . . . . 10.0 114.003 166.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.629 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 4.7 ptm -77.55 65.67 3.12 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.505 1.152 . . . . 10.0 110.407 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -80.36 25.33 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.33 -1.481 . . . . 10.0 110.684 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 m -143.46 139.74 30.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 123.981 0.912 . . . . 10.0 108.822 -174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.22 -42.8 82.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.322 -0.861 . . . . 10.0 110.12 173.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.86 -39.13 90.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.709 0.804 . . . . 10.0 111.867 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 17.7 m -56.01 -55.93 26.86 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.019 -1.104 . . . . 10.0 108.019 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.629 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -54.77 -51.74 64.78 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.977 0.798 . . . . 10.0 110.493 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.05 -39.7 59.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.565 0.746 . . . . 10.0 111.974 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -40.67 82.34 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.549 -0.719 . . . . 10.0 110.405 175.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.428 HG23 HG22 ' A' ' 61' ' ' VAL . 2.9 mt -61.03 -48.22 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -53.13 -48.37 67.94 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.854 -0.424 . . . . 10.0 109.854 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -54.4 42.39 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.83 0.852 . . . . 10.0 110.998 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -59.54 -46.7 88.1 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.103 -0.373 . . . . 10.0 111.238 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 35.1 mt -60.21 -46.13 90.81 Favored 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 117.976 0.353 . . . . 10.0 110.218 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -55.85 -35.58 66.58 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 123.676 0.79 . . . . 10.0 111.084 174.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.8 ttmm -65.9 -16.53 63.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 118.53 -0.748 . . . . 10.0 112.906 177.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.59 142.86 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 119.519 1.054 . . . . 10.0 108.864 174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -83.81 131.58 34.88 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.661 0.784 . . . . 10.0 109.5 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.13 25.53 57.32 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.56 0.6 . . . . 10.0 112.171 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.49 141.95 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 124.085 0.954 . . . . 10.0 108.477 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.79 -58.64 2.12 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.87 132.34 1.78 Allowed 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 118.392 0.542 . . . . 10.0 110.216 178.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.58 56.06 6.64 Favored Pre-proline 0 N--CA 1.451 -0.422 0 C-N-CA 125.563 1.545 . . . . 10.0 112.817 -168.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.8 124.74 7.66 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.536 2.157 . . . . 10.0 110.489 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 18' ' ' ALA . 2.4 p -85.75 147.83 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.516 0.726 . . . . 10.0 110.613 176.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 40' ' ' LEU . 16.5 t30 -113.56 111.81 22.5 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.454 0.702 . . . . 10.0 112.108 -175.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -77.05 64.52 2.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.204 1.401 . . . . 10.0 110.61 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.19 -50.59 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.916 0.886 . . . . 10.0 111.655 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 9.4 mt -94.32 5.15 52.66 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.693 0.797 . . . . 10.0 110.045 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 48.85 39.7 14.8 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.725 2.01 . . . . 10.0 111.111 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 49.6 m -131.56 150.65 52.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.773 1.629 . . . . 10.0 108.792 -172.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.5 140.75 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.279 1.031 . . . . 10.0 109.87 166.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 m -106.89 92.03 3.92 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.847 2.059 . . . . 10.0 107.222 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG21 ' CE2' ' A' ' 7' ' ' PHE . 52.8 t -85.76 128.54 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -111.54 125.87 54.38 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.571 -1.27 . . . . 10.0 107.571 165.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -158.49 175.39 13.74 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 124.543 1.137 . . . . 10.0 109.092 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -108.2 126.31 29.96 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.464 -0.779 . . . . 10.0 110.629 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.51 52.85 3.76 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 124.211 3.274 . . . . 10.0 112.102 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -156.26 23.71 0.36 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.428 -0.795 . . . . 10.0 109.969 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -141.24 -63.93 0.45 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.851 -1.537 . . . . 10.0 106.851 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.38 176.88 4.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.32 1.448 . . . . 10.0 109.372 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 p -141.43 147.11 37.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.905 1.282 . . . . 10.0 110.109 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.448 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -48.66 -46.72 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.043 0.937 . . . . 10.0 110.992 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 t -63.42 -32.83 74.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.777 0.658 . . . . 10.0 112.777 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -69.94 -53.94 15.58 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.86 -32.69 72.1 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.606 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -53.5 -55.15 27.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.353 -0.98 . . . . 10.0 108.353 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -58.96 -41.76 88.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.212 0.605 . . . . 10.0 110.388 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.88 -38.8 83.23 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.641 1.176 . . . . 10.0 111.908 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG22 HG23 ' A' ' 21' ' ' ILE . 80.2 t -71.59 -47.01 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 118.327 0.512 . . . . 10.0 109.752 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.37 -41.29 60.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.778 0.431 . . . . 10.0 109.89 177.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -52.32 -28.2 18.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.334 1.054 . . . . 10.0 113.788 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.6 mt -76.22 -23.48 54.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.922 0.783 . . . . 10.0 111.917 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.24 -54.57 0.78 Allowed Glycine 0 CA--C 1.527 0.833 0 CA-C-N 118.926 0.785 . . . . 10.0 111.721 173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.77 33.34 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.432 -0.452 . . . . 10.0 110.342 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -101.43 159.54 15.19 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.139 0.576 . . . . 10.0 109.878 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -143.99 151.57 39.9 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -148.67 159.88 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.393 1.477 . . . . 10.0 109.228 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.5 tt -64.36 147.36 52.75 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 123.094 0.557 . . . . 10.0 110.61 175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -125.8 -54.0 1.54 Allowed 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.733 1.213 . . . . 10.0 110.484 175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.94 -125.37 1.34 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.754 -0.736 . . . . 10.0 113.046 175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 66.12 -27.02 0.11 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 128.284 2.634 . . . . 10.0 116.289 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.64 81.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.772 0.829 . . . . 10.0 111.503 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -168.11 118.09 0.78 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 128.581 2.752 . . . . 10.0 105.593 -170.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.2 m -120.05 44.26 2.47 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.697 1.199 . . . . 10.0 111.04 168.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.5 tt -131.21 75.79 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.505 1.122 . . . . 10.0 108.522 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -38.66 -57.93 1.12 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.95 1.7 . . . . 10.0 112.121 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 45.32 -126.09 7.38 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.096 0.855 . . . . 10.0 112.347 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.246 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 mtt . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.439 -0.791 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 p 58.01 -179.86 0.06 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.885 0.874 . . . . 10.0 111.816 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -135.2 175.14 9.86 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 164.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -111.7 133.41 53.95 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.34 1.456 . . . . 10.0 107.285 173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.4 150.01 47.35 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -124.84 132.42 53.33 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.6 m-85 -127.42 144.07 51.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 123.474 0.71 . . . . 10.0 109.616 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -99.13 128.99 45.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 mt -116.28 138.92 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 109.101 -0.703 . . . . 10.0 109.101 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -122.37 124.96 44.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.071 0.463 . . . . 10.0 110.385 168.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.33 1.52 6.13 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.657 2.075 . . . . 10.0 112.974 163.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptp -85.29 72.47 10.71 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 119.27 1.535 . . . . 10.0 110.625 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 p -68.88 -24.18 64.29 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.444 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.6 p -115.49 146.33 41.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.541 1.136 . . . . 10.0 111.091 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.72 69.13 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.189 -0.945 . . . . 10.0 111.058 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.64 -47.69 79.18 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.03 0.532 . . . . 10.0 110.575 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.2 m -56.71 -46.62 81.16 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.343 1.057 . . . . 10.0 110.016 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.27 -54.54 45.64 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.824 -0.171 . . . . 10.0 111.383 175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 -35.82 67.24 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.049 -1.032 . . . . 10.0 111.151 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.8 mtt-85 -60.97 -34.79 75.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.147 0.979 . . . . 10.0 110.969 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.4 mm -52.99 -61.93 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -55.45 -45.7 76.84 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 117.573 0.169 . . . . 10.0 110.784 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 -48.53 61.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.014 0.526 . . . . 10.0 110.593 177.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -69.28 -47.77 63.61 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-O 119.063 -0.494 . . . . 10.0 112.008 176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.2 -47.02 79.18 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.16 0.891 . . . . 10.0 110.879 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -54.01 -37.03 63.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.189 0.996 . . . . 10.0 111.374 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 tptp -64.54 -27.54 69.03 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.197 -0.906 . . . . 10.0 112.188 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.1 mt -74.7 137.13 23.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.839 0.828 . . . . 10.0 109.203 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -83.33 114.58 21.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.583 1.153 . . . . 10.0 107.947 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.84 -9.28 9.82 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.842 0.734 . . . . 10.0 113.655 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.6 t -86.05 136.26 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 172.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.23 -51.17 5.29 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -159.21 166.15 32.03 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.033 -0.728 . . . . 10.0 109.033 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.81 58.25 0.31 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.894 0.877 . . . . 10.0 112.934 -166.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.78 117.47 4.3 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.02 1.813 . . . . 10.0 110.197 176.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.26 146.05 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.16 0.584 . . . . 10.0 110.529 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -110.2 126.01 53.66 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.766 0.426 . . . . 10.0 110.935 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -101.9 65.57 1.0 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.669 1.188 . . . . 10.0 109.84 -175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.33 -53.85 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.114 0.966 . . . . 10.0 110.354 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 23.3 mt -83.64 -19.01 36.16 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.446 0.698 . . . . 10.0 110.664 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.22 58.92 0.54 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 124.096 1.903 . . . . 10.0 108.142 -172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.0 m -144.4 150.75 38.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.55 -1.205 . . . . 10.0 108.324 -175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.56 139.95 45.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 170.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 11.2 m -105.87 105.11 15.0 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 172.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.9 t -97.41 127.95 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.021 -0.733 . . . . 10.0 109.021 -177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.17 110.82 23.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 165.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -138.56 178.43 7.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.094 1.358 . . . . 10.0 107.846 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.04 123.25 31.22 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.264 -0.874 . . . . 10.0 109.141 178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.28 56.22 5.71 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.617 2.878 . . . . 10.0 110.53 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -147.91 2.42 0.69 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.124 1.769 . . . . 10.0 109.163 174.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 50' ' ' LYS . 78.9 mm-40 -140.9 -56.38 0.5 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.982 0.913 . . . . 10.0 109.293 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -112.29 166.24 11.45 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.744 1.218 . . . . 10.0 108.552 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.22 149.26 42.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.533 1.133 . . . . 10.0 109.28 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG23 ' CE1' ' A' ' 7' ' ' PHE . 10.4 p -53.11 -41.13 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.389 1.076 . . . . 10.0 111.222 177.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -43.94 81.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.455 1.502 . . . . 10.0 112.193 175.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -68.17 -56.54 8.39 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.7 pp -56.54 -32.68 65.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.891 -1.05 . . . . 10.0 111.589 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -58.28 4.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.57 -37.7 76.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.017 0.437 . . . . 10.0 110.269 -176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.64 -44.82 95.32 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.248 1.019 . . . . 10.0 111.768 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 68' ' ' LEU . 19.1 m -73.6 -43.93 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 118.599 0.636 . . . . 10.0 110.779 174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' OD1' ' NZ ' ' A' ' 67' ' ' LYS . 5.2 t0 -51.61 -39.9 58.87 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.289 0.635 . . . . 10.0 109.871 177.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.81 -39.7 1.84 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.121 1.369 . . . . 10.0 113.068 172.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.09 -19.84 46.49 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.474 1.109 . . . . 10.0 112.009 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.87 -56.11 0.75 Allowed Glycine 0 CA--C 1.526 0.754 0 CA-C-N 118.953 0.797 . . . . 10.0 111.629 170.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -59.5 163.83 3.86 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.553 0.741 . . . . 10.0 110.987 176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' NZ ' ' OD1' ' A' ' 62' ' ' ASP . 5.6 mptp? -112.71 156.7 22.34 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.062 0.458 . . . . 10.0 110.065 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 61' ' ' VAL . 8.1 tt -138.98 152.08 47.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 126.73 2.012 . . . . 10.0 105.882 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.67 158.75 44.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.502 1.521 . . . . 10.0 107.543 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.63 148.3 49.52 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.221 0.209 . . . . 10.0 110.526 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -129.34 -133.26 0.22 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.539 1.535 . . . . 10.0 109.433 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -95.03 -148.18 23.82 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.792 0.724 . . . . 10.0 112.118 -170.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 71.99 -123.72 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.881 1.672 . . . . 10.0 109.27 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? 40.83 65.99 0.71 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.806 1.642 . . . . 10.0 111.631 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 39.08 54.17 2.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.823 2.049 . . . . 10.0 112.509 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 t -131.44 -56.35 1.02 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.113 . . . . 10.0 109.981 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.8 mt 68.38 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.123 1.369 . . . . 10.0 109.122 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -148.22 171.67 15.57 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.571 1.548 . . . . 10.0 108.423 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -106.53 -66.55 0.65 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.26 0.457 . . . . 10.0 113.832 -163.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 . . . . . 0 C--O 1.249 1.074 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -175.714 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 mtt . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.5 p 63.59 153.35 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.087 1.355 . . . . 10.0 110.867 -160.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -161.36 163.97 30.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.614 1.165 . . . . 10.0 107.869 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -96.4 121.18 37.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.552 1.941 . . . . 10.0 108.29 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -120.54 142.86 48.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.635 -1.617 . . . . 10.0 106.635 176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 27.2 tt0 -127.49 136.4 51.71 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 105.987 -1.857 . . . . 10.0 105.987 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CE1' HG23 ' A' ' 54' ' ' VAL . 6.4 m-85 -132.89 146.7 52.03 Favored 'General case' 0 N--CA 1.437 -1.084 0 O-C-N 124.928 1.392 . . . . 10.0 109.865 -176.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 130.03 46.49 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.484 2.713 . . . . 10.0 104.384 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.72 143.95 24.46 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -116.8 121.7 42.29 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.316 0.646 . . . . 10.0 109.683 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.54 -66.75 0.5 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.408 1.48 . . . . 10.0 111.047 161.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.6 mtp 25.14 64.22 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.975 2.51 . . . . 10.0 113.716 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -73.45 -20.79 60.62 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.872 0.869 . . . . 10.0 111.072 -172.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.28 149.32 32.63 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 123.98 0.912 . . . . 10.0 109.205 -177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.89 -35.7 64.38 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.606 -0.684 . . . . 10.0 110.455 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.68 -42.07 61.9 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.835 0.854 . . . . 10.0 111.974 172.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.65 -48.4 81.17 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 123.577 0.751 . . . . 10.0 109.403 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.75 -53.09 62.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.063 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.77 -30.0 65.28 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.372 -0.83 . . . . 10.0 111.84 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -63.63 -33.43 75.6 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.378 1.471 . . . . 10.0 111.226 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 25' ' ' LEU . 8.5 mm -53.23 -57.7 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 107.821 -1.177 . . . . 10.0 107.821 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -58.95 -45.48 90.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.734 0.413 . . . . 10.0 110.919 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -42.47 90.45 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.691 0.796 . . . . 10.0 111.149 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HE ' HD21 ' A' ' 64' ' ' LEU . 0.5 OUTLIER -71.48 -50.48 31.13 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.797 -0.621 . . . . 10.0 110.869 173.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 21' ' ' ILE . 41.6 mt -51.7 -47.39 63.94 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.786 0.721 . . . . 10.0 111.991 -177.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -54.29 -34.09 60.12 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.613 0.765 . . . . 10.0 112.095 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -65.49 -19.34 65.89 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 118.955 -0.545 . . . . 10.0 112.232 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.7 mt -83.87 127.67 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 119.273 0.942 . . . . 10.0 108.774 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -66.35 122.43 17.5 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.553 1.141 . . . . 10.0 108.815 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.38 -17.86 23.5 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 123.65 0.643 . . . . 10.0 112.713 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.18 128.2 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.677 1.238 . . . . 10.0 108.998 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.65 -50.68 6.34 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.569 0.748 . . . . 10.0 109.972 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -147.01 166.52 26.57 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -164.54 57.13 0.52 Allowed Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 114.401 1.26 . . . . 10.0 114.401 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -61.15 122.45 11.18 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.556 1.504 . . . . 10.0 111.688 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -92.28 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.087 0.955 . . . . 10.0 111.294 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -126.45 125.5 42.24 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.407 0.683 . . . . 10.0 111.721 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -95.0 63.56 2.7 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.603 1.161 . . . . 10.0 110.115 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -154.53 -51.53 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.839 0.456 . . . . 10.0 110.89 174.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.72 -20.55 30.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.635 0.774 . . . . 10.0 110.497 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 70.54 52.65 0.32 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.735 1.614 . . . . 10.0 108.594 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 64.1 m -136.87 149.79 47.88 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.73 2.012 . . . . 10.0 110.321 -175.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.87 142.62 38.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.101 1.36 . . . . 10.0 108.732 163.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.6 m -101.08 120.48 40.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.428 -1.693 . . . . 10.0 106.428 163.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.09 133.24 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 10.0 108.288 171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -109.8 113.55 26.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.35 -1.352 . . . . 10.0 107.35 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.1 177.03 11.25 Favored 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.591 0.757 . . . . 10.0 109.173 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -115.32 127.47 26.78 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.463 1.505 . . . . 10.0 110.541 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 72.54 3.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.429 2.753 . . . . 10.0 109.886 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.25 -58.92 0.46 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.575 1.15 . . . . 10.0 108.442 174.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -104.02 -18.46 14.56 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.13 0.572 . . . . 10.0 111.788 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -130.0 153.28 48.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.192 1.397 . . . . 10.0 107.286 171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.48 153.41 44.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.517 1.127 . . . . 10.0 108.394 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.404 HG23 ' CE1' ' A' ' 7' ' ' PHE . 7.1 p -48.35 -45.15 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.861 0.864 . . . . 10.0 111.457 176.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.4 t -58.89 -39.33 81.11 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.789 0.436 . . . . 10.0 111.826 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.95 -55.18 7.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 107.008 -1.479 . . . . 10.0 107.008 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -56.54 -35.14 67.76 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.748 -1.114 . . . . 10.0 111.143 174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.01 -54.23 21.52 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.52 -42.64 83.23 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.063 0.392 . . . . 10.0 110.219 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.64 96.71 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.363 1.065 . . . . 10.0 111.589 -175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 68' ' ' LEU . 19.2 m -72.44 -42.97 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 118.404 0.547 . . . . 10.0 110.776 175.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -52.73 -39.15 61.85 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.197 -0.298 . . . . 10.0 110.197 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.44 -27.6 2.75 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.97 1.308 . . . . 10.0 113.489 173.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.548 HD13 ' OH ' ' A' ' 66' ' ' TYR . 12.0 mt -79.48 -24.81 42.08 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.193 0.997 . . . . 10.0 112.386 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.24 -48.67 0.96 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-N 119.1 0.864 . . . . 10.0 112.242 173.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -65.34 168.8 6.56 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.124 -0.633 . . . . 10.0 110.413 175.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.2 155.5 25.99 Favored 'General case' 0 CA--C 1.523 -0.067 0 C-N-CA 122.508 0.323 . . . . 10.0 110.362 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 61' ' ' VAL . 2.8 tt -138.56 150.79 46.7 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 127.275 2.23 . . . . 10.0 105.859 -174.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -151.44 166.08 32.19 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.551 1.54 . . . . 10.0 108.445 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' C ' HD23 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -65.69 148.5 51.65 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.481 0.712 . . . . 10.0 111.775 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -132.23 -52.84 0.96 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.137 1.375 . . . . 10.0 111.06 173.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 86.22 105.8 0.76 Allowed Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.337 0.97 . . . . 10.0 114.196 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 75' ' ' ASP . 26.1 tt0 -97.38 -66.35 0.91 Allowed 'General case' 0 C--N 1.342 0.271 0 C-N-CA 125.211 1.404 . . . . 10.0 110.799 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 44.42 48.52 8.22 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.685 1.594 . . . . 10.0 113.757 -175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.429 ' H ' ' HG2' ' A' ' 73' ' ' GLU . 0.4 OUTLIER -179.9 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.785 1.634 . . . . 10.0 109.091 -179.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 t -167.62 -48.84 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.273 1.029 . . . . 10.0 111.362 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 77' ' ' ILE . 3.1 mp 25.83 67.57 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.611 2.364 . . . . 10.0 112.815 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.34 125.56 8.0 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 157.98 -82.35 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.625 0.648 . . . . 10.0 113.567 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.933 0 CA-C-O 117.584 -1.198 . . . . 10.0 109.307 -164.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.7 p -154.24 -176.21 5.77 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 105.391 -2.078 . . . . 10.0 105.391 -170.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -77.39 175.95 9.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 167.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.25 135.53 40.99 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 128.304 2.642 . . . . 10.0 103.981 168.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.34 152.24 45.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -125.27 131.43 53.09 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.045 -2.205 . . . . 10.0 105.045 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.8 m-85 -126.02 155.34 41.62 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.39 -0.967 . . . . 10.0 108.39 174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -109.61 132.78 53.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.956 -1.868 . . . . 10.0 105.956 -173.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -114.12 128.36 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.094 0.861 . . . . 10.0 110.678 -169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -107.14 110.83 23.01 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.201 1.0 . . . . 10.0 108.616 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.04 -76.41 0.28 Allowed Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.858 0.742 . . . . 10.0 112.641 170.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.576 ' CE ' ' HB2' ' A' ' 18' ' ' ALA . 23.8 mtp 30.0 70.23 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.67 1.988 . . . . 10.0 114.95 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -73.71 -30.9 63.12 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.891 -0.506 . . . . 10.0 111.139 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.6 p -152.17 166.35 31.96 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.214 0.606 . . . . 10.0 109.745 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.27 -33.5 58.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.817 -0.552 . . . . 10.0 111.4 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.26 -28.41 69.71 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 118.256 -0.878 . . . . 10.0 111.744 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.7 m -58.85 -58.75 7.24 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.776 1.171 . . . . 10.0 109.243 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' CE ' ' A' ' 12' ' ' MET . . . -45.53 -55.23 6.48 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 124.202 0.938 . . . . 10.0 110.058 175.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -60.68 -38.83 86.23 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.654 0.613 . . . . 10.0 112.654 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -59.3 -38.89 81.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.07 0.948 . . . . 10.0 109.782 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 61' ' ' VAL . 1.8 mt -55.48 -56.38 12.19 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.285 -1.006 . . . . 10.0 108.285 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -54.46 -41.95 70.08 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.814 0.846 . . . . 10.0 110.417 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.81 -55.0 22.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.111 0.965 . . . . 10.0 111.35 173.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -62.77 -49.39 75.2 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 118.584 0.629 . . . . 10.0 110.677 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 21' ' ' ILE . 23.1 mt -51.29 -52.78 41.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 124.145 0.978 . . . . 10.0 110.446 -176.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -52.0 -38.48 56.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.874 0.87 . . . . 10.0 111.464 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -72.01 -19.19 61.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.293 -0.861 . . . . 10.0 112.532 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.4 mt -74.96 131.24 35.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 119.945 1.248 . . . . 10.0 109.113 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -66.11 111.02 3.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 114.724 -1.126 . . . . 10.0 109.673 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.72 -8.41 19.53 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.754 0.693 . . . . 10.0 113.731 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.3 t -78.94 139.27 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.506 1.153 . . . . 10.0 109.092 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.59 -57.9 2.04 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.353 0.661 . . . . 10.0 109.981 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -143.17 165.69 26.72 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -175.11 59.53 0.21 Allowed Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.69 1.196 . . . . 10.0 112.112 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.44 125.94 13.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 121.988 1.792 . . . . 10.0 110.744 176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -90.74 133.83 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.381 1.072 . . . . 10.0 109.09 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 40' ' ' LEU . 1.2 p30 -84.08 172.58 11.85 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 119.913 1.233 . . . . 10.0 110.481 176.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -135.57 53.55 1.96 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 172.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -151.14 -40.52 0.12 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.018 0.747 . . . . 10.0 113.018 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' HD21 ' A' ' 37' ' ' ASN . 0.4 OUTLIER -122.19 9.18 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 124.203 1.001 . . . . 10.0 109.908 178.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 53.92 46.57 25.37 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.237 1.815 . . . . 10.0 108.619 171.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 92.6 m -129.88 144.6 51.4 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.852 1.661 . . . . 10.0 108.192 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.7 p -120.75 132.92 69.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 124.895 1.278 . . . . 10.0 108.144 168.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -98.51 99.8 10.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.782 -1.192 . . . . 10.0 107.782 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG21 ' CE2' ' A' ' 7' ' ' PHE . 56.3 t -92.01 129.91 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 123.498 0.719 . . . . 10.0 109.373 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -108.92 125.68 52.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.066 1.346 . . . . 10.0 108.933 168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -155.62 173.9 16.05 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 176.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.57 129.87 29.26 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.89 46.62 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.079 3.186 . . . . 10.0 110.765 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -156.02 6.2 0.2 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.205 1.002 . . . . 10.0 111.779 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -132.75 -73.99 0.5 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.721 1.209 . . . . 10.0 107.796 -178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.19 175.14 10.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.737 -0.838 . . . . 10.0 108.737 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.5 p -148.91 143.14 26.02 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.276 1.031 . . . . 10.0 109.856 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 15.0 p -53.85 -47.56 63.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.492 0.717 . . . . 10.0 110.914 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m -56.69 -41.53 77.51 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.205 -0.934 . . . . 10.0 113.188 178.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -66.37 -55.56 15.28 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.528 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -60.1 -39.32 85.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.066 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -51.74 -58.08 7.42 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.774 -0.824 . . . . 10.0 108.774 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -53.86 -44.5 70.43 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.986 -0.376 . . . . 10.0 109.986 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.0 -37.54 80.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.063 1.345 . . . . 10.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 21' ' ' ILE . 70.0 t -69.38 -50.8 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.492 -0.559 . . . . 10.0 109.492 172.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -44.17 27.42 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.802 0.841 . . . . 10.0 109.775 177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -55.6 -26.61 44.85 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.792 1.237 . . . . 10.0 113.09 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.4 mt -81.72 -10.54 59.34 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 118.267 -0.873 . . . . 10.0 113.183 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 125.34 -55.33 0.73 Allowed Glycine 0 C--N 1.341 0.86 0 C-N-CA 124.378 0.99 . . . . 10.0 111.41 169.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.02 158.13 31.75 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 122.915 0.486 . . . . 10.0 110.279 174.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.62 161.86 13.39 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.803 0.841 . . . . 10.0 109.782 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.1 tt -150.58 155.9 40.33 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -159.39 154.43 24.99 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.531 1.932 . . . . 10.0 107.697 -171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.71 150.67 48.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.537 0.335 . . . . 10.0 111.105 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -132.11 -52.21 0.96 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.2 1.0 . . . . 10.0 111.282 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.26 147.73 18.5 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.3 -73.03 0.31 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.289 1.435 . . . . 10.0 108.168 -173.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 61.25 60.74 1.69 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.273 1.029 . . . . 10.0 109.583 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.2 t0 50.42 52.07 15.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.196 1.398 . . . . 10.0 111.655 171.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.8 m -62.48 -58.6 7.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.541 0.571 . . . . 10.0 112.541 -167.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.8 mt 38.65 69.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.169 1.788 . . . . 10.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -132.92 168.08 19.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.038 0.935 . . . . 10.0 109.749 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.57 83.97 0.11 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 107.307 -2.317 . . . . 10.0 107.307 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.625 -1.655 . . . . 10.0 109.038 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ttt . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 105.004 -2.221 . . . . 10.0 105.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 t -69.31 171.89 7.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.87 1.214 . . . . 10.0 108.571 159.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 pm0 -86.88 -165.94 1.43 Allowed 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 128.408 2.683 . . . . 10.0 107.728 174.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -140.12 132.15 27.87 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.138 1.775 . . . . 10.0 106.69 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.81 150.04 39.8 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.551 1.94 . . . . 10.0 107.252 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -132.49 130.69 40.78 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 -171.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.34 149.21 52.4 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.069 1.347 . . . . 10.0 108.718 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 134.33 50.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.368 -2.456 . . . . 10.0 104.368 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.63 147.09 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.799 -1.185 . . . . 10.0 107.799 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -123.18 108.2 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.844 1.258 . . . . 10.0 107.606 173.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 10.51 4.79 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.857 1.694 . . . . 10.0 114.938 163.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.8 ptp -84.86 80.67 9.19 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 120.203 2.002 . . . . 10.0 110.201 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 p -68.46 -27.28 66.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.533 -0.729 . . . . 10.0 110.348 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 p -115.05 144.04 44.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.323 1.049 . . . . 10.0 111.906 -174.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.12 -33.12 70.49 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.013 -1.054 . . . . 10.0 110.377 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.95 -42.68 72.63 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.958 0.903 . . . . 10.0 111.589 175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 77.3 m -63.3 -47.4 82.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.932 1.293 . . . . 10.0 109.22 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.94 -48.65 77.8 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.415 -0.357 . . . . 10.0 111.276 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.18 -35.53 67.35 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.953 -1.092 . . . . 10.0 112.499 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -59.84 -35.8 75.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.335 -0.853 . . . . 10.0 110.535 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.3 mm -53.52 -57.51 5.03 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -57.83 -46.42 84.77 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 -170.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -59.79 -51.1 71.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.093 -0.503 . . . . 10.0 111.209 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -61.22 -46.16 91.57 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 119.985 -0.686 . . . . 10.0 111.135 179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.8 -46.82 84.1 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 118.291 0.496 . . . . 10.0 110.852 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -54.18 -37.19 64.22 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.898 0.479 . . . . 10.0 111.516 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -26.42 68.67 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 119.136 -0.459 . . . . 10.0 111.249 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.1 mt -74.38 126.16 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 122.699 1.238 . . . . 10.0 109.395 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -59.12 122.09 12.93 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.709 2.004 . . . . 10.0 110.004 175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.28 0.31 54.04 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 124.357 0.98 . . . . 10.0 114.14 174.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.0 t -83.24 135.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.68 -55.35 3.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.517 0.727 . . . . 10.0 109.941 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -145.98 166.36 26.27 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.396 -0.964 . . . . 10.0 108.396 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.92 55.82 0.61 Allowed Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 113.441 0.904 . . . . 10.0 113.441 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -61.26 121.03 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.282 1.988 . . . . 10.0 111.543 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.45 128.82 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.383 0.673 . . . . 10.0 111.558 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -95.95 83.7 3.72 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.985 0.914 . . . . 10.0 108.867 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -73.08 72.58 1.17 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.314 1.046 . . . . 10.0 111.376 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -159.8 -54.45 0.06 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 125.07 1.348 . . . . 10.0 109.074 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.88 -25.07 48.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.451 1.1 . . . . 10.0 110.466 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 77.41 51.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.05 1.74 . . . . 10.0 108.201 -172.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.4 m -134.48 141.94 46.91 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.349 1.46 . . . . 10.0 107.948 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.88 140.27 36.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 124.428 1.091 . . . . 10.0 108.398 168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.5 m -104.87 118.29 36.16 Favored 'General case' 0 C--O 1.228 -0.071 0 N-CA-C 106.647 -1.612 . . . . 10.0 106.647 170.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.7 t -109.23 127.08 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 124.076 0.951 . . . . 10.0 109.24 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -102.93 105.52 15.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 173.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -147.4 159.94 43.12 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.667 0.787 . . . . 10.0 109.333 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.97 122.02 59.41 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 114.676 -1.147 . . . . 10.0 110.176 -177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -78.08 58.58 6.63 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.447 2.764 . . . . 10.0 110.29 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -136.95 -16.83 1.44 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.487 1.515 . . . . 10.0 111.076 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -125.16 -69.55 0.79 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.923 1.289 . . . . 10.0 108.793 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.6 173.17 12.19 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.706 0.802 . . . . 10.0 108.861 174.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 58.1 m -154.19 165.83 35.03 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.872 1.269 . . . . 10.0 108.949 169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.7 p -61.28 -43.12 95.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 114.483 -1.235 . . . . 10.0 110.565 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.7 m -54.27 -45.05 72.34 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.793 1.237 . . . . 10.0 112.322 176.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.24 -54.75 8.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 -169.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.21 -33.74 63.32 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.605 -0.725 . . . . 10.0 111.276 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.95 -59.79 3.31 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 170.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -56.62 -40.18 74.93 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 120.886 0.374 . . . . 10.0 110.09 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.62 96.96 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.027 0.931 . . . . 10.0 110.768 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.3 t -70.78 -49.75 48.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.289 -0.263 . . . . 10.0 110.289 174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -50.07 -43.12 51.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.435 1.094 . . . . 10.0 110.0 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -55.32 -25.18 32.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.779 1.232 . . . . 10.0 113.123 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.7 mt -79.48 -19.75 49.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.259 0.624 . . . . 10.0 112.162 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 126.5 -56.45 0.72 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.951 -0.86 . . . . 10.0 110.951 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -64.14 160.37 18.47 Favored 'General case' 0 CA--C 1.527 0.068 0 N-CA-C 109.719 -0.474 . . . . 10.0 109.719 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -115.76 166.68 11.68 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.384 0.674 . . . . 10.0 110.22 -172.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -145.31 153.57 41.41 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.95 1.3 . . . . 10.0 107.572 -173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -150.28 160.11 43.95 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.293 1.837 . . . . 10.0 107.653 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.02 150.17 48.56 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 122.753 0.421 . . . . 10.0 110.664 176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -128.14 -49.69 1.32 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.486 1.115 . . . . 10.0 112.606 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.69 -179.33 41.94 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.551 -1.42 . . . . 10.0 109.551 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.74 42.98 0.18 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 117.084 0.442 . . . . 10.0 111.674 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -164.86 73.92 0.23 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 122.522 1.153 . . . . 10.0 111.281 169.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.23 74.82 0.34 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.795 1.638 . . . . 10.0 107.925 165.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.0 t -161.63 -75.31 0.05 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.295 1.438 . . . . 10.0 109.486 168.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.13 -39.3 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 123.64 0.776 . . . . 10.0 111.064 -178.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.42 -47.38 49.58 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -48.68 120.97 7.29 Favored Glycine 0 CA--C 1.532 1.15 0 N-CA-C 111.024 -0.83 . . . . 10.0 111.024 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 127.006 2.122 . . . . 10.0 105.648 -178.291 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.318 -0.993 . . . . 10.0 108.318 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.5 p -124.5 172.32 9.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.478 1.511 . . . . 10.0 107.134 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -134.94 151.58 50.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 106.001 -1.851 . . . . 10.0 106.001 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -92.39 121.79 34.21 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.396 1.079 . . . . 10.0 109.524 175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.38 145.83 47.5 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.544 1.538 . . . . 10.0 108.213 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -123.08 131.7 53.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 -173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 6.8 m-85 -131.06 146.72 52.47 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.993 1.317 . . . . 10.0 109.89 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 136.81 32.91 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 103.917 -2.623 . . . . 10.0 103.917 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -109.66 144.59 17.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.816 0.735 . . . . 10.0 109.075 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.82 105.74 13.37 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.1 0.56 . . . . 10.0 109.622 170.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.4 -73.6 0.25 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.879 1.228 . . . . 10.0 113.507 166.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.4 mtp 22.78 70.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.135 2.574 . . . . 10.0 115.485 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 74.8 p -72.73 -32.09 65.45 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.758 -0.589 . . . . 10.0 110.704 -175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 30.4 p -149.81 165.92 31.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.033 0.533 . . . . 10.0 110.57 177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.88 31.82 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.881 -0.512 . . . . 10.0 111.468 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.566 ' HB1' HH21 ' A' ' 20' ' ' ARG . . . -68.18 -23.53 64.86 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.69 -0.631 . . . . 10.0 112.3 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.84 -54.09 21.72 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.109 -0.7 . . . . 10.0 109.109 167.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.24 -48.74 73.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.972 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -47.83 -45.53 29.96 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.435 0.694 . . . . 10.0 111.123 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.566 HH21 ' HB1' ' A' ' 16' ' ' ALA . 1.5 mtm180 -63.23 -36.43 83.63 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.524 -0.751 . . . . 10.0 111.457 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 20.4 mm -53.34 -58.47 3.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.272 0 N-CA-C 108.147 -1.057 . . . . 10.0 108.147 171.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -57.33 -45.78 83.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 -175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -56.75 -50.34 72.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.275 0.63 . . . . 10.0 111.591 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -65.18 -49.32 70.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.86 -43.99 86.3 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 123.185 0.303 . . . . 10.0 110.281 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -50.05 -34.48 21.7 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.213 1.005 . . . . 10.0 112.247 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -66.83 -22.83 65.99 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.702 -0.666 . . . . 10.0 112.159 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.0 mt -70.48 134.08 30.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 119.384 0.993 . . . . 10.0 110.645 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -60.52 115.44 3.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.849 1.659 . . . . 10.0 109.26 174.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 1.25 60.11 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.378 0.513 . . . . 10.0 113.133 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -68.48 131.74 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 118.626 1.213 . . . . 10.0 108.4 170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.39 -46.43 11.72 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 121.937 -0.477 . . . . 10.0 110.0 167.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -170.31 170.56 7.11 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 -178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.77 60.69 0.51 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 113.426 0.898 . . . . 10.0 113.426 -170.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.98 131.94 26.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.864 1.709 . . . . 10.0 111.012 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.08 150.65 6.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.112 0.965 . . . . 10.0 111.341 174.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -115.69 108.47 16.42 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.707 0.803 . . . . 10.0 112.069 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -77.34 64.02 2.64 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.323 1.049 . . . . 10.0 111.512 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.62 -53.59 0.07 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 123.092 0.557 . . . . 10.0 110.917 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.2 mt -82.54 -18.74 40.41 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.976 0.511 . . . . 10.0 110.62 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 69.26 46.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.53 1.532 . . . . 10.0 108.625 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.4 m -124.24 145.95 49.05 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.296 1.838 . . . . 10.0 109.215 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -116.96 141.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 123.449 0.7 . . . . 10.0 109.824 161.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -105.34 110.69 23.13 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.438 1.895 . . . . 10.0 107.315 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 65.8 t -104.35 133.07 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 C-N-CA 123.543 0.737 . . . . 10.0 109.976 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -99.26 113.62 26.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 123.758 0.661 . . . . 10.0 110.034 158.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -139.85 -178.04 5.25 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.924 -1.509 . . . . 10.0 106.924 167.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -119.06 128.69 25.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 124.699 1.199 . . . . 10.0 111.403 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.54 71.44 5.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.872 3.048 . . . . 10.0 109.03 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.74 -55.68 0.14 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.596 0.758 . . . . 10.0 109.418 -173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -110.24 -16.49 13.74 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.467 1.107 . . . . 10.0 112.011 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.69 168.58 18.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.066 1.346 . . . . 10.0 108.341 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.9 p -142.54 161.45 38.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.924 1.289 . . . . 10.0 109.593 177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.5 p -51.73 -47.08 39.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 123.227 0.611 . . . . 10.0 110.183 168.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.6 m -59.14 -45.39 91.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.636 0.775 . . . . 10.0 112.302 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.43 -58.81 6.7 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 121.39 0.614 . . . . 10.0 109.426 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.2 pp -60.56 -31.31 70.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.182 -0.463 . . . . 10.0 111.155 -175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.88 -50.77 14.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 170.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -62.32 -36.42 82.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.788 0.435 . . . . 10.0 111.172 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.75 -44.32 96.86 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.323 0.649 . . . . 10.0 109.817 177.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.28 -47.42 81.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -53.46 -40.44 65.26 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.902 0.481 . . . . 10.0 110.418 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -50.82 -23.77 3.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.142 1.377 . . . . 10.0 113.574 175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 20.9 mt -87.5 -26.99 22.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.985 0.914 . . . . 10.0 111.727 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.6 -55.22 0.77 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 123.998 0.809 . . . . 10.0 111.463 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 158.79 18.61 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.551 -0.382 . . . . 10.0 110.586 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 171.53 7.3 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 122.636 0.374 . . . . 10.0 110.848 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tt -148.48 155.28 40.97 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.709 1.604 . . . . 10.0 107.339 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -148.92 163.56 37.09 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.137 1.375 . . . . 10.0 108.516 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 tt -65.28 149.57 49.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 122.68 0.392 . . . . 10.0 110.27 173.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -126.97 -38.95 1.98 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 113.486 0.921 . . . . 10.0 113.486 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 149.35 113.77 0.69 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.94 -0.647 . . . . 10.0 111.564 173.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.39 67.55 2.62 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.168 0.987 . . . . 10.0 109.439 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -55.48 -45.77 76.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.591 0.756 . . . . 10.0 111.894 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 21.34 79.29 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 128.108 2.563 . . . . 10.0 114.784 -173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.8 t -157.28 63.39 0.49 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.4 pt 43.95 45.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.634 1.574 . . . . 10.0 112.57 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -143.51 157.65 44.27 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.524 1.13 . . . . 10.0 107.987 -175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 177.78 107.59 0.22 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.415 -2.274 . . . . 10.0 107.415 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.239 -1.839 . . . . 10.0 107.319 -167.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 p -102.05 166.65 10.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.747 -1.575 . . . . 10.0 106.747 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -116.17 -164.5 0.97 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 172.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -128.86 138.69 52.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.138 -1.801 . . . . 10.0 106.138 167.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.24 137.64 23.39 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -120.19 130.52 54.6 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 104.98 -2.23 . . . . 10.0 104.98 -172.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 54' ' ' VAL . 3.4 m-85 -125.93 161.55 27.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.276 0.985 . . . . 10.0 109.608 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.7 124.72 40.45 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 128.57 2.748 . . . . 10.0 106.953 -164.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.01 125.39 72.14 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.11 0 O-C-N 124.033 0.833 . . . . 10.0 110.918 -162.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -111.06 128.98 56.04 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.801 0.841 . . . . 10.0 110.386 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.14 -22.27 14.24 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.935 1.731 . . . . 10.0 113.184 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -75.04 62.16 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.524 1.13 . . . . 10.0 113.179 -171.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -102.64 -3.34 26.78 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.777 -0.577 . . . . 10.0 111.907 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 p -94.63 5.04 53.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.792 1.237 . . . . 10.0 113.643 -173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 70.43 -60.37 0.5 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.096 1.759 . . . . 10.0 111.976 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.83 -42.54 58.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.481 0.712 . . . . 10.0 110.379 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.8 m -42.56 -55.5 3.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.088 1.355 . . . . 10.0 112.116 170.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.96 -46.78 87.79 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -57.79 -38.44 75.48 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.573 0.701 . . . . 10.0 111.149 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -34.82 75.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.743 -1.223 . . . . 10.0 111.083 178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.685 HG22 HD11 ' A' ' 25' ' ' LEU . 15.6 mm -53.0 -58.14 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 107.595 -1.261 . . . . 10.0 107.595 175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.99 -42.38 80.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.029 0.931 . . . . 10.0 110.47 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.17 -43.72 67.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.247 0.619 . . . . 10.0 111.509 173.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HD3' HD11 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -72.01 -47.42 52.04 Favored 'General case' 0 C--O 1.225 -0.185 0 O-C-N 121.805 -0.56 . . . . 10.0 111.521 176.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.685 HD11 HG22 ' A' ' 21' ' ' ILE . 18.8 mt -53.88 -44.05 70.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.859 0.3 . . . . 10.0 110.312 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -54.67 -38.87 67.48 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.739 0.815 . . . . 10.0 112.096 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -67.88 -20.74 65.15 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.843 -0.599 . . . . 10.0 112.181 176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.1 mt -80.07 135.05 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 119.553 1.07 . . . . 10.0 109.537 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -80.93 118.89 22.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.048 1.339 . . . . 10.0 107.888 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.53 9.23 33.7 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 123.384 0.516 . . . . 10.0 114.113 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -92.16 136.58 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.48 -59.11 1.78 Allowed 'General case' 0 C--N 1.342 0.267 0 C-N-CA 122.837 0.455 . . . . 10.0 109.892 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -134.53 162.53 32.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.245 -1.02 . . . . 10.0 108.245 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -174.43 58.63 0.21 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.915 1.286 . . . . 10.0 111.864 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.35 135.29 33.55 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 121.855 1.703 . . . . 10.0 110.695 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.5 t -91.9 144.17 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.484 1.114 . . . . 10.0 110.985 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.53 85.32 2.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.623 0.769 . . . . 10.0 112.658 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.88 83.7 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.781 2.032 . . . . 10.0 109.887 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 174.11 -49.49 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.253 2.621 . . . . 10.0 109.487 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.21 -12.01 14.51 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.616 1.166 . . . . 10.0 110.474 -176.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.95 52.37 2.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.41 1.484 . . . . 10.0 109.997 173.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.03 159.55 41.93 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 113.002 -1.908 . . . . 10.0 107.757 178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 p -128.92 133.34 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 169.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.2 p -96.76 90.28 5.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.007 1.723 . . . . 10.0 107.305 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.3 t -88.64 123.97 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 123.188 0.595 . . . . 10.0 109.652 -174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -104.83 107.17 17.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.371 -1.714 . . . . 10.0 106.371 167.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -137.95 -179.19 5.62 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.454 1.102 . . . . 10.0 108.498 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -114.93 116.17 42.93 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.164 -0.922 . . . . 10.0 109.826 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -71.96 73.25 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.417 2.745 . . . . 10.0 109.697 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -148.96 -51.65 0.16 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.56 1.144 . . . . 10.0 109.186 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.12 -13.41 14.37 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.049 0.94 . . . . 10.0 111.968 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.74 167.29 22.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.757 1.223 . . . . 10.0 108.179 174.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.2 t -143.02 159.4 42.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.005 1.722 . . . . 10.0 108.137 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 7' ' ' PHE . 9.4 p -47.6 -40.68 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 114.388 -1.278 . . . . 10.0 109.874 165.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.9 m -64.12 -41.17 97.34 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.794 0.438 . . . . 10.0 111.705 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -69.11 -59.11 3.25 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -53.36 -32.61 50.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.706 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.32 -56.18 6.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.4 0.545 . . . . 10.0 110.606 171.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.03 -30.58 69.26 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.773 0.32 . . . . 10.0 110.897 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.78 -48.72 68.17 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.485 -0.561 . . . . 10.0 109.485 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.45 -43.52 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 119.445 -0.312 . . . . 10.0 110.999 175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.22 -47.62 17.89 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.176 0.513 . . . . 10.0 110.03 173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.39 -21.37 59.81 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.548 0.944 . . . . 10.0 113.548 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.522 HD11 ' HD3' ' A' ' 24' ' ' ARG . 10.5 mt -81.82 -24.62 35.77 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.401 0.68 . . . . 10.0 111.692 173.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.31 -54.04 0.78 Allowed Glycine 0 CA--C 1.528 0.865 0 CA-C-N 119.015 0.825 . . . . 10.0 112.031 172.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CE1' HD13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -63.3 164.64 8.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.174 0.59 . . . . 10.0 110.633 175.452 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -113.98 166.03 12.01 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.49 0.662 . . . . 10.0 110.996 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tt -142.4 163.59 32.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.96 2.104 . . . . 10.0 106.121 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -163.64 163.74 24.25 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.676 1.591 . . . . 10.0 108.52 175.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.31 150.4 48.27 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.844 0.458 . . . . 10.0 111.128 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -128.7 -56.16 1.21 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.813 1.645 . . . . 10.0 110.607 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.79 -112.55 0.48 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-N 118.958 0.799 . . . . 10.0 114.371 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 63.81 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.447 1.899 . . . . 10.0 110.86 -162.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -156.19 -51.76 0.08 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.663 -172.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 37.07 78.29 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.035 2.134 . . . . 10.0 111.378 177.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m 49.88 51.84 15.8 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.787 1.635 . . . . 10.0 111.864 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . 0.28 6.5 tt 42.96 43.83 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.857 2.063 . . . . 10.0 112.415 -177.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 69.49 132.38 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.033 1.733 . . . . 10.0 111.988 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.35 -170.46 37.13 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 110.057 -1.217 . . . . 10.0 110.057 176.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.593 1.557 . . . . 10.0 110.491 -174.456 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.4 mtt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -86.41 146.49 26.42 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.646 -0.501 . . . . 10.0 109.646 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -102.59 -173.49 2.34 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -131.56 124.85 30.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.243 2.217 . . . . 10.0 105.676 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.7 145.68 51.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.66 1.184 . . . . 10.0 108.171 -172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.79 127.72 48.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 105.936 -1.876 . . . . 10.0 105.936 -166.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CZ ' HG23 ' A' ' 54' ' ' VAL . 5.9 m-85 -125.85 141.41 52.0 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 123.388 0.43 . . . . 10.0 110.087 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -95.39 129.89 42.38 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.435 -2.431 . . . . 10.0 104.435 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -118.88 138.92 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -118.08 129.77 55.75 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.401 0.438 . . . . 10.0 110.19 167.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.39 -7.74 7.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 126.379 1.942 . . . . 10.0 112.646 162.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.2 ptp -73.85 80.0 1.62 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.923 1.344 . . . . 10.0 109.917 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.88 -3.28 58.88 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.042 1.337 . . . . 10.0 110.506 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.4 p -138.9 152.25 47.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.5 1.12 . . . . 10.0 109.692 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.35 69.83 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.638 -0.663 . . . . 10.0 110.9 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.88 -49.71 74.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.756 -0.59 . . . . 10.0 110.415 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.3 m -52.47 -55.43 21.98 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.73 1.212 . . . . 10.0 109.748 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.53 -56.55 14.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.436 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -57.82 -31.37 66.54 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.256 -0.903 . . . . 10.0 111.589 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -34.29 75.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.435 -0.791 . . . . 10.0 110.958 176.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.6 -59.11 2.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -57.88 -43.4 86.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.036 0.535 . . . . 10.0 110.158 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -55.4 -52.01 64.96 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 122.816 0.447 . . . . 10.0 111.447 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 mmt85 -61.41 -49.94 74.83 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 120.229 -0.588 . . . . 10.0 110.954 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.08 -44.23 78.78 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 118.177 0.444 . . . . 10.0 111.419 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -53.71 -36.85 62.68 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 123.312 0.645 . . . . 10.0 111.13 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -74.98 -8.56 56.86 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.522 -0.752 . . . . 10.0 112.835 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mm -94.44 133.24 36.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-N 119.476 1.034 . . . . 10.0 108.477 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -79.06 141.66 37.19 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.203 1.001 . . . . 10.0 108.812 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.69 -3.14 60.8 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.435 0.54 . . . . 10.0 113.357 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.52 135.59 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 174.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.44 -54.75 3.67 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.767 0.827 . . . . 10.0 109.751 176.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -147.1 168.22 22.16 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.8 58.31 0.52 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.815 0.846 . . . . 10.0 112.795 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -63.17 124.41 13.85 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.748 1.632 . . . . 10.0 110.46 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.51 133.5 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.952 0.901 . . . . 10.0 109.68 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -99.15 90.41 4.58 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.415 0.626 . . . . 10.0 109.573 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -73.39 66.63 0.96 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.93 1.292 . . . . 10.0 110.684 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.89 -54.44 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.975 1.31 . . . . 10.0 109.665 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.6 mt -86.58 -12.97 47.14 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.428 0.691 . . . . 10.0 110.792 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 66.55 53.84 0.92 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.804 1.764 . . . . 10.0 108.271 -174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.9 m -138.19 146.65 42.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.08 -1.418 . . . . 10.0 108.184 -174.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -117.42 141.15 37.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 108.244 -1.021 . . . . 10.0 108.244 168.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.1 m -106.5 101.92 11.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t -92.53 124.86 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.847 -0.798 . . . . 10.0 108.847 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -99.31 114.32 27.11 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 107.254 -1.387 . . . . 10.0 107.254 168.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -141.62 171.99 13.3 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.637 0.775 . . . . 10.0 109.655 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.43 118.66 57.15 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 118.29 -0.862 . . . . 10.0 108.913 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.76 56.73 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.213 2.609 . . . . 10.0 110.528 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -150.19 11.71 0.72 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.72 1.208 . . . . 10.0 110.324 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -148.46 -65.91 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.958 1.703 . . . . 10.0 107.474 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.96 163.2 14.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.817 0.847 . . . . 10.0 109.166 175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.06 138.47 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.533 1.533 . . . . 10.0 108.82 -177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 10.9 p -50.96 -45.21 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.537 0.735 . . . . 10.0 110.872 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 m -60.98 -36.43 79.42 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.405 0.891 . . . . 10.0 113.405 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -68.43 -52.99 26.63 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.966 -1.124 . . . . 10.0 107.966 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -32.81 73.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.284 -0.871 . . . . 10.0 110.741 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -58.73 5.63 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 107.922 -1.14 . . . . 10.0 107.922 170.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -55.57 -43.48 75.95 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.118 0.567 . . . . 10.0 110.383 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.86 82.63 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.088 1.355 . . . . 10.0 112.01 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.7 t -73.46 -45.88 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.488 0.715 . . . . 10.0 109.834 174.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -51.24 -44.47 61.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.291 1.037 . . . . 10.0 108.922 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -58.28 -9.09 1.34 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.424 1.489 . . . . 10.0 114.748 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.9 mt -94.13 -20.42 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.848 1.204 . . . . 10.0 111.803 174.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.73 -54.63 0.78 Allowed Glycine 0 C--N 1.341 0.84 0 CA-C-N 119.448 1.022 . . . . 10.0 112.336 172.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -65.0 170.24 4.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.664 0.785 . . . . 10.0 110.515 174.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 157.03 25.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.9 tt -134.88 154.59 51.6 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.777 2.031 . . . . 10.0 107.305 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -153.34 173.4 15.66 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.835 2.054 . . . . 10.0 108.286 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.68 151.03 39.3 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.084 0.954 . . . . 10.0 111.21 177.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.0 tmtp? -141.41 32.42 1.69 Allowed 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 125.04 1.336 . . . . 10.0 112.498 -176.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.4 -162.94 48.17 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.981 -2.047 . . . . 10.0 107.981 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -151.75 103.76 2.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.462 -0.78 . . . . 10.0 109.861 -170.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 117.84 103.81 0.0 OUTLIER 'General case' 0 C--N 1.343 0.29 0 C-N-CA 128.142 2.577 . . . . 10.0 111.472 163.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -65.61 71.17 0.05 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 127.531 2.333 . . . . 10.0 109.911 172.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -164.26 53.8 0.14 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.224 1.41 . . . . 10.0 109.239 177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.9 mt 77.48 117.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.502 1.921 . . . . 10.0 110.458 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.72 -68.36 0.61 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.066 1.347 . . . . 10.0 107.569 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.37 136.77 3.4 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.638 -1.785 . . . . 10.0 108.638 -171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 116.429 -1.748 . . . . 10.0 110.183 -166.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.45 159.01 25.25 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.546 1.538 . . . . 10.0 109.763 175.033 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -128.61 -179.96 5.35 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 173.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -127.89 130.85 49.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.36 1.864 . . . . 10.0 107.207 176.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 137.82 46.73 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.066 -1.827 . . . . 10.0 106.066 -172.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -128.14 135.65 50.05 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 107.121 -1.437 . . . . 10.0 107.121 -169.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -132.77 147.89 52.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 124.624 1.202 . . . . 10.0 109.56 -171.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -104.04 134.15 47.79 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.1 mp -123.65 122.19 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.764 0.711 . . . . 10.0 111.727 -174.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -105.19 122.56 46.17 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.395 1.078 . . . . 10.0 110.174 178.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.0 -8.46 7.17 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.974 1.274 . . . . 10.0 114.248 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -69.68 84.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.582 1.153 . . . . 10.0 111.266 178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.2 p -76.14 -20.97 57.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 118.592 -0.718 . . . . 10.0 111.011 -179.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.8 p -132.12 159.47 38.83 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.986 0.898 . . . . 10.0 112.549 179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.96 -29.71 69.81 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.086 177.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.91 96.89 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.603 -0.686 . . . . 10.0 110.867 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.7 m -52.45 -51.69 57.99 Favored 'General case' 0 C--N 1.34 0.18 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 171.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.58 -56.29 23.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.092 -0.504 . . . . 10.0 111.182 -179.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.74 -36.07 57.16 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.847 -1.158 . . . . 10.0 112.012 178.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -62.31 -31.85 72.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.4 -0.813 . . . . 10.0 111.668 177.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.4 mm -52.83 -58.58 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -55.66 -48.1 75.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.915 -0.402 . . . . 10.0 109.915 -176.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.97 -51.98 65.79 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.639 0.775 . . . . 10.0 111.091 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 64' ' ' LEU . 12.1 mmt-85 -63.28 -47.56 81.85 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 121.98 -0.45 . . . . 10.0 110.669 178.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -56.92 -45.26 82.81 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.152 -0.619 . . . . 10.0 111.341 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -55.66 -34.33 64.9 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.059 0.944 . . . . 10.0 111.977 175.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.07 -30.07 65.93 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 122.149 -0.344 . . . . 10.0 110.236 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.0 mt -77.14 126.46 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.507 1.146 . . . . 10.0 109.795 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -64.12 134.63 55.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.459 1.904 . . . . 10.0 109.934 175.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.65 -7.58 65.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.719 0.676 . . . . 10.0 112.768 175.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 68.0 t -78.42 135.0 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 CA-C-N 118.206 1.003 . . . . 10.0 108.616 174.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.81 -57.74 2.83 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.199 0.6 . . . . 10.0 109.39 176.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -142.95 167.25 22.5 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.593 -0.891 . . . . 10.0 108.593 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.35 55.12 0.34 Allowed Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 124.138 0.975 . . . . 10.0 112.618 179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.16 131.5 30.7 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.744 1.629 . . . . 10.0 111.247 176.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.3 p -98.42 158.13 3.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 124.052 0.941 . . . . 10.0 110.74 173.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 40' ' ' LEU . 16.5 t30 -130.91 107.22 8.95 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.144 0.497 . . . . 10.0 112.051 -179.198 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -75.49 61.53 1.29 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.547 1.539 . . . . 10.0 110.907 178.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.59 -51.46 0.06 Allowed 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.798 0.839 . . . . 10.0 110.952 174.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' H ' ' ND2' ' A' ' 37' ' ' ASN . 12.7 mt -90.39 1.28 56.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.022 0.929 . . . . 10.0 110.398 174.371 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 44.67 50.51 8.48 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.176 1.79 . . . . 10.0 110.296 -177.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.7 m -129.62 148.61 51.53 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.45 2.3 . . . . 10.0 108.699 -174.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.6 138.65 52.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 125.03 1.332 . . . . 10.0 108.861 166.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -110.63 103.69 12.3 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.33 126.94 46.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 123.826 0.851 . . . . 10.0 110.281 -176.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -104.55 112.04 24.96 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.948 -1.131 . . . . 10.0 107.948 172.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -147.51 179.35 7.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.436 1.094 . . . . 10.0 108.299 177.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -115.82 133.29 22.86 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 107.259 -1.385 . . . . 10.0 107.259 171.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.35 61.52 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.921 2.414 . . . . 10.0 108.969 -179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -150.4 17.32 0.83 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.517 0.727 . . . . 10.0 111.258 -178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -145.31 -67.82 0.3 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.572 1.949 . . . . 10.0 106.547 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.03 -179.21 3.93 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.479 1.511 . . . . 10.0 109.605 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.55 148.66 33.42 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.255 1.022 . . . . 10.0 108.842 176.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -48.61 -44.87 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 123.794 0.838 . . . . 10.0 111.891 175.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.1 t -62.5 -39.31 93.09 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.714 -0.616 . . . . 10.0 111.987 -179.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.27 -53.91 21.26 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.109 -0.701 . . . . 10.0 109.109 -178.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LYS . 3.5 pp -56.33 -32.57 64.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.297 -0.41 . . . . 10.0 110.997 177.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -51.38 -60.58 2.98 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.632 -1.247 . . . . 10.0 107.632 173.029 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -56.56 -40.38 75.07 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 123.113 0.565 . . . . 10.0 110.108 -174.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.68 -41.61 97.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.685 0.794 . . . . 10.0 111.368 -178.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.3 t -72.26 -44.79 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 122.766 0.427 . . . . 10.0 110.069 173.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -49.09 -41.7 36.5 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.268 1.427 . . . . 10.0 109.446 175.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -52.28 -28.95 20.86 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.894 1.678 . . . . 10.0 113.307 177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 24' ' ' ARG . 31.7 mt -76.96 -21.32 54.95 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.627 0.771 . . . . 10.0 111.486 178.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.14 -60.82 0.67 Allowed Glycine 0 C--N 1.34 0.754 0 C-N-CA 124.163 0.887 . . . . 10.0 111.006 170.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -59.43 164.39 3.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.327 1.051 . . . . 10.0 111.104 176.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -106.64 154.45 20.91 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.151 0.58 . . . . 10.0 110.373 -175.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 tt -139.47 149.42 43.97 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.166 1.786 . . . . 10.0 106.224 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -150.67 164.49 35.98 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.54 1.536 . . . . 10.0 108.414 172.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.3 tt -65.46 145.66 55.85 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.19 0.596 . . . . 10.0 111.309 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -112.33 -57.5 2.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.502 1.521 . . . . 10.0 109.888 173.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -166.71 179.49 40.54 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 109.239 -1.545 . . . . 10.0 109.239 -177.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -135.18 108.3 7.69 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.091 0.956 . . . . 10.0 109.186 -179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 82.67 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 126.244 1.818 . . . . 10.0 112.753 171.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -126.6 80.52 1.94 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.525 1.13 . . . . 10.0 110.377 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.8 t -75.07 -39.15 61.01 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 122.056 -0.402 . . . . 10.0 111.909 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.2 pp -73.26 -44.29 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 112.343 0.497 . . . . 10.0 112.343 -171.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -174.87 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 125.065 1.346 . . . . 10.0 108.68 178.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.84 -74.29 2.49 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 110.354 -1.098 . . . . 10.0 110.354 -177.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.227 0 CA-C-O 116.838 -1.553 . . . . 10.0 109.213 -179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tpt . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 68.48 150.22 0.07 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.874 2.069 . . . . 10.0 111.485 -173.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -157.5 156.1 31.47 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 106.981 -1.489 . . . . 10.0 106.981 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -96.64 115.6 27.7 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.372 1.469 . . . . 10.0 107.513 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.01 150.82 23.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.766 2.026 . . . . 10.0 106.775 178.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -127.19 132.41 50.48 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 104.864 -2.273 . . . . 10.0 104.864 -172.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -129.76 162.51 28.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.852 1.261 . . . . 10.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.9 127.92 50.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.143 2.177 . . . . 10.0 106.094 -175.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mt -116.38 138.22 47.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 123.84 0.856 . . . . 10.0 109.841 -169.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -132.2 130.5 41.1 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.145 0.578 . . . . 10.0 110.918 175.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 136.02 -56.56 0.69 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.462 1.506 . . . . 10.0 110.523 173.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.6 ptp -24.39 91.31 0.01 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 128.061 2.545 . . . . 10.0 114.888 -177.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.0 p -74.83 -41.3 60.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.872 -1.058 . . . . 10.0 109.422 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -122.74 158.01 31.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.569 0.747 . . . . 10.0 111.667 -175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.3 -30.18 59.67 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.71 -0.619 . . . . 10.0 111.399 174.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.97 80.04 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 118.218 -0.896 . . . . 10.0 111.717 175.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.6 m -58.51 -53.34 59.4 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 119.212 0.914 . . . . 10.0 108.793 173.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.98 -53.09 61.97 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.731 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -49.93 -38.88 38.22 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.044 -1.035 . . . . 10.0 111.79 177.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.18 -29.44 70.37 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.518 -0.739 . . . . 10.0 112.351 178.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.2 mm -52.68 -59.36 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 170.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -56.81 -46.65 81.48 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.561 0.344 . . . . 10.0 110.469 -173.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -52.26 -56.65 13.37 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 123.815 0.846 . . . . 10.0 110.853 175.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -62.96 -45.33 92.95 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 119.282 -0.389 . . . . 10.0 111.4 -177.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.07 -46.19 90.4 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.019 0.372 . . . . 10.0 110.885 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -56.32 -35.67 67.84 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 121.974 -0.454 . . . . 10.0 110.93 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -63.6 -19.57 64.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.222 -0.894 . . . . 10.0 113.268 175.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.8 mm -84.31 132.69 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 119.593 1.088 . . . . 10.0 108.364 173.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -71.69 143.94 49.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.985 0.914 . . . . 10.0 109.646 177.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.2 -12.29 70.11 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 121.941 -0.474 . . . . 10.0 112.304 -179.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.7 t -77.35 121.39 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 118.328 1.064 . . . . 10.0 109.066 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.69 -43.02 14.73 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.191 0.996 . . . . 10.0 110.222 177.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -164.25 169.85 17.03 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 176.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -169.06 55.84 0.28 Allowed Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.747 1.017 . . . . 10.0 113.747 -175.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.02 124.08 12.94 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.756 1.637 . . . . 10.0 110.584 175.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.99 149.2 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.49 0.716 . . . . 10.0 111.363 175.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -121.61 109.15 14.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.556 0.742 . . . . 10.0 112.56 -172.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.58 64.87 3.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.78 1.232 . . . . 10.0 110.963 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.92 -38.0 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.118 0.784 . . . . 10.0 113.118 174.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.56 -13.51 21.59 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.136 0.974 . . . . 10.0 110.186 174.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 61.21 51.5 4.31 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.802 1.641 . . . . 10.0 109.332 -175.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.1 m -139.24 150.68 45.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.616 -178.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -122.25 140.77 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.88 1.272 . . . . 10.0 107.617 167.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 13.6 p -105.39 103.53 13.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 173.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.55 124.92 54.4 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.584 -0.895 . . . . 10.0 108.584 -175.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -97.82 122.41 40.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.23 -0.656 . . . . 10.0 109.23 168.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -150.32 179.03 8.46 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.809 1.244 . . . . 10.0 107.958 173.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -113.15 128.03 26.12 Favored Pre-proline 0 N--CA 1.447 -0.611 0 C-N-CA 123.855 0.862 . . . . 10.0 109.68 174.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -76.02 68.09 6.62 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.496 2.797 . . . . 10.0 109.617 -178.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -149.85 -52.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.527 1.131 . . . . 10.0 109.723 -175.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -111.27 6.9 20.87 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.591 0.757 . . . . 10.0 112.643 177.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.86 159.4 43.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.083 -1.451 . . . . 10.0 107.083 171.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.2 p -137.05 153.65 50.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 172.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.62 -45.25 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 115.587 -0.733 . . . . 10.0 110.205 -179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.5 m -55.88 -42.41 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.022 0.929 . . . . 10.0 113.176 177.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -64.47 -55.46 20.63 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 122.351 1.072 . . . . 10.0 108.268 -175.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.65 -33.74 74.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.897 -1.047 . . . . 10.0 111.027 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -56.39 20.72 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.409 -0.96 . . . . 10.0 108.409 172.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.97 -40.52 76.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.236 0.541 . . . . 10.0 110.049 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.73 93.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.46 1.104 . . . . 10.0 111.755 -178.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 68' ' ' LEU . 20.4 m -70.31 -43.65 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 118.563 0.62 . . . . 10.0 110.912 174.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -49.3 -42.41 41.23 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.313 0.645 . . . . 10.0 109.795 175.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -52.99 -22.86 6.19 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.938 1.088 . . . . 10.0 113.938 177.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.475 HD13 ' OH ' ' A' ' 66' ' ' TYR . 16.9 mt -80.2 -23.81 40.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.038 0.935 . . . . 10.0 111.837 178.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.47 -54.2 0.78 Allowed Glycine 0 CA--C 1.528 0.885 0 CA-C-N 118.964 0.802 . . . . 10.0 112.012 173.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' OH ' HD13 ' A' ' 64' ' ' LEU . 1.4 p90 -65.04 170.75 4.11 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.989 0.516 . . . . 10.0 110.335 174.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -118.93 162.09 19.09 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-O 121.115 0.483 . . . . 10.0 111.314 -178.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 61' ' ' VAL . 7.0 tt -143.93 152.73 41.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.012 -1.847 . . . . 10.0 106.012 -174.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -150.53 161.13 43.15 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.1 1.36 . . . . 10.0 108.224 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.02 149.34 37.15 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.424 0.29 . . . . 10.0 110.622 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -125.25 -49.07 1.7 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.469 1.108 . . . . 10.0 111.443 171.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.63 -141.57 7.03 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 109.25 -1.54 . . . . 10.0 109.25 -179.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -156.3 162.76 40.07 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.219 1.408 . . . . 10.0 109.066 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 59.48 90.59 0.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.896 1.678 . . . . 10.0 113.824 178.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -95.99 90.07 5.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 165.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.9 t -155.87 74.09 0.85 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.067 168.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.9 tt 43.28 57.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.661 1.584 . . . . 10.0 111.517 177.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -64.25 -60.49 3.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.827 -175.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 174.16 -76.8 0.08 OUTLIER Glycine 0 CA--C 1.53 1.017 0 C-N-CA 120.129 -1.034 . . . . 10.0 115.297 177.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 116.724 -1.608 . . . . 10.0 109.79 -155.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 108.308 -0.997 . . . . 10.0 108.308 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.1 p -77.69 174.28 11.13 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.598 0.759 . . . . 10.0 109.218 176.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -129.49 156.92 43.35 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.673 1.989 . . . . 10.0 105.66 177.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -107.6 116.52 32.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.361 1.464 . . . . 10.0 108.398 178.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.99 156.46 20.46 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.254 1.822 . . . . 10.0 108.363 -177.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -135.8 132.39 36.65 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 -169.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -133.95 146.97 50.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.814 1.246 . . . . 10.0 110.376 -175.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.33 138.42 31.45 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 128.75 2.82 . . . . 10.0 103.908 178.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 43' ' ' VAL . 2.8 mp -122.65 147.78 26.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 119.712 1.142 . . . . 10.0 109.889 167.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -124.28 122.8 38.73 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.911 0.884 . . . . 10.0 109.458 165.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.14 1.56 5.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.11 1.814 . . . . 10.0 113.849 160.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 15.9 ptp -77.9 81.29 4.32 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.427 1.613 . . . . 10.0 110.425 177.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 p -68.74 -30.42 69.05 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.33 -0.856 . . . . 10.0 109.899 176.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.15 143.61 45.64 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.284 1.033 . . . . 10.0 111.625 -176.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.07 -26.93 63.14 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.041 -1.037 . . . . 10.0 110.712 171.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -67.03 -19.55 65.71 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.031 0.932 . . . . 10.0 112.672 176.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.2 m -80.43 -50.0 10.69 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.509 1.124 . . . . 10.0 109.1 169.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -48.6 -57.43 6.22 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.304 0.642 . . . . 10.0 110.8 176.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -59.64 -30.11 68.49 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.345 -0.847 . . . . 10.0 112.548 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.28 -41.06 98.16 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.263 -0.898 . . . . 10.0 110.207 174.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.506 ' CG2' HG22 ' A' ' 61' ' ' VAL . 0.4 OUTLIER -61.22 -47.39 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 176.025 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -51.21 -49.53 60.86 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.26 -0.644 . . . . 10.0 109.26 178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -56.13 25.73 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.104 0.962 . . . . 10.0 111.966 178.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -59.11 -47.48 85.13 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 118.591 0.632 . . . . 10.0 111.22 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.04 -47.22 86.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.962 0.505 . . . . 10.0 109.852 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -52.93 -36.99 60.41 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 122.886 0.474 . . . . 10.0 111.398 173.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.83 -14.89 63.32 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.529 0.937 . . . . 10.0 113.529 178.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.7 mm -72.93 140.01 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 119.785 1.175 . . . . 10.0 108.959 177.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -86.01 124.05 32.02 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.158 0.983 . . . . 10.0 108.413 -177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.39 22.07 32.98 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.981 0.8 . . . . 10.0 112.813 -176.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.11 155.62 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 168.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -106.13 -56.39 2.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.722 0.809 . . . . 10.0 110.162 171.327 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -150.78 167.85 26.2 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.145 -0.687 . . . . 10.0 109.145 -178.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.21 54.14 0.34 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 123.89 0.876 . . . . 10.0 113.32 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -67.53 128.02 17.45 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.858 1.706 . . . . 10.0 110.907 176.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.5 t -85.27 128.55 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 121.354 0.597 . . . . 10.0 110.374 178.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.5 85.73 6.22 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.67 0.788 . . . . 10.0 109.341 -177.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -70.89 71.71 0.54 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.048 1.339 . . . . 10.0 111.778 -178.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.82 -57.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.216 1.406 . . . . 10.0 109.158 171.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.53 -24.51 56.77 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 10.0 110.465 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 69.58 52.05 0.45 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.022 1.729 . . . . 10.0 108.452 -168.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.5 m -124.76 149.02 47.77 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 127.417 2.287 . . . . 10.0 107.573 178.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 9' ' ' ILE . 7.1 p -123.07 138.25 53.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.653 -1.239 . . . . 10.0 107.653 163.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.0 m -105.61 112.85 26.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 173.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.28 124.26 58.64 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -93.5 119.89 33.12 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 172.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -154.66 -176.91 6.14 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 118.317 0.508 . . . . 10.0 109.999 179.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.59 128.61 19.13 Favored Pre-proline 0 N--CA 1.443 -0.795 0 C-N-CA 124.924 1.29 . . . . 10.0 109.149 173.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.82 78.19 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.381 2.721 . . . . 10.0 109.94 -175.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 -57.86 0.85 Allowed 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.794 0.837 . . . . 10.0 110.015 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.35 -34.21 5.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.776 1.23 . . . . 10.0 110.331 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.67 145.91 25.85 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.03 1.332 . . . . 10.0 107.865 173.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.6 p -129.35 159.95 34.59 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.142 1.377 . . . . 10.0 109.097 169.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -53.56 -46.88 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.387 -0.824 . . . . 10.0 110.253 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -56.98 -48.35 78.61 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.321 -0.862 . . . . 10.0 112.969 177.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.42 -53.26 59.69 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.183 0.992 . . . . 10.0 108.818 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -63.62 -36.48 83.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.185 -0.916 . . . . 10.0 110.387 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -55.23 -55.03 35.92 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.039 -1.097 . . . . 10.0 108.039 175.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -58.53 -41.28 85.17 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 110.283 -0.265 . . . . 10.0 110.283 -178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.56 84.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.947 0.899 . . . . 10.0 111.81 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 21' ' ' ILE . 93.9 t -66.53 -48.49 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 O-C-N 121.775 -0.578 . . . . 10.0 110.012 171.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.76 -39.5 58.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.898 0.479 . . . . 10.0 109.898 178.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -52.25 -32.74 38.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.399 1.08 . . . . 10.0 112.847 176.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 40.8 mt -74.61 -23.55 58.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.492 0.587 . . . . 10.0 111.779 177.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.19 -58.88 0.69 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.226 0.917 . . . . 10.0 111.078 172.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.85 154.44 22.06 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.874 0.47 . . . . 10.0 110.313 175.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -111.55 155.81 22.71 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 120.629 0.252 . . . . 10.0 111.278 -170.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.6 tt -136.11 150.85 49.27 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.283 1.833 . . . . 10.0 107.281 -168.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -150.38 172.62 15.12 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 126.203 1.801 . . . . 10.0 108.484 177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -76.36 150.82 36.79 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.76 0.824 . . . . 10.0 111.933 -176.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 tptt -132.76 21.12 4.21 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.761 1.224 . . . . 10.0 113.964 179.58 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.96 80.97 1.14 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 109.745 -1.342 . . . . 10.0 109.745 174.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -73.47 64.32 0.85 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.618 1.167 . . . . 10.0 111.451 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -130.77 31.97 4.43 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.628 1.571 . . . . 10.0 110.312 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 t70 72.63 78.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.075 1.75 . . . . 10.0 112.77 174.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.5 m 64.24 70.31 0.5 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.857 1.263 . . . . 10.0 110.203 179.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt 38.41 -144.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.649 1.58 . . . . 10.0 111.373 -163.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -164.14 136.32 4.83 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 103.826 -2.657 . . . . 10.0 103.826 165.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.21 -119.5 1.3 Allowed Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.32 0.964 . . . . 10.0 111.895 178.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.256 0 CA-C-O 116.055 -1.926 . . . . 10.0 106.298 -172.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.5 p -62.56 128.72 37.32 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 120.979 1.718 . . . . 10.0 108.772 175.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -149.31 168.74 22.52 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.085 1.754 . . . . 10.0 106.508 -170.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -116.03 117.45 30.14 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.444 1.498 . . . . 10.0 108.684 -173.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.76 167.69 9.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.576 1.55 . . . . 10.0 107.531 176.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -142.26 135.62 28.99 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.319 -1.734 . . . . 10.0 106.319 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 57' ' ' LEU . 8.2 m-85 -134.81 151.04 50.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.144 1.378 . . . . 10.0 109.977 -177.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.94 141.25 29.03 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 128.621 2.769 . . . . 10.0 106.022 176.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 43' ' ' VAL . 2.2 mp -127.03 134.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-N 120.169 1.35 . . . . 10.0 110.613 173.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -122.62 131.89 54.03 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.061 0.545 . . . . 10.0 110.741 173.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.85 0.92 Allowed Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.552 1.072 . . . . 10.0 111.242 169.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.4 ptp -27.52 91.18 0.01 OUTLIER 'General case' 0 C--N 1.342 0.259 0 C-N-CA 127.78 2.432 . . . . 10.0 114.682 -177.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -22.12 60.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.338 1.055 . . . . 10.0 110.554 -178.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 16' ' ' ALA . 28.7 p -150.61 163.08 39.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 118.12 0.418 . . . . 10.0 110.18 176.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.09 -27.99 49.13 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.956 0.502 . . . . 10.0 111.68 176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.42 -37.05 82.07 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.346 -0.835 . . . . 10.0 110.935 176.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.7 m -56.33 -53.02 62.24 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.172 0.896 . . . . 10.0 109.29 173.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.93 -53.86 43.26 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.999 179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -34.73 75.26 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.787 -1.196 . . . . 10.0 111.846 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -41.42 92.99 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.096 0.958 . . . . 10.0 109.713 175.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.78 -50.71 76.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 176.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -51.95 -48.52 64.25 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.081 0.4 . . . . 10.0 110.776 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -50.86 -58.4 6.07 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.283 1.033 . . . . 10.0 110.745 175.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -61.53 -45.29 94.83 Favored 'General case' 0 C--O 1.226 -0.169 0 O-C-N 121.778 -0.576 . . . . 10.0 111.914 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 22.4 mt -55.66 -51.94 65.55 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.815 0.846 . . . . 10.0 109.592 179.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -55.78 -36.85 67.82 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.211 0.604 . . . . 10.0 111.643 175.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -62.41 -26.32 68.42 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 119.082 -0.485 . . . . 10.0 111.357 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.1 mm -74.63 132.66 33.0 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-N 119.192 0.906 . . . . 10.0 108.958 178.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -78.83 132.13 36.74 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.19 -0.914 . . . . 10.0 108.956 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.27 20.67 54.4 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.338 0.494 . . . . 10.0 112.666 -174.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.9 t -101.81 137.34 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 107.394 -1.336 . . . . 10.0 107.394 164.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.09 -49.15 5.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.579 0.752 . . . . 10.0 110.089 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.34 167.65 29.27 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -170.62 65.14 0.46 Allowed Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 171.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -67.93 130.6 22.05 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.302 1.335 . . . . 10.0 110.23 175.061 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.71 140.48 23.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 124.025 0.93 . . . . 10.0 110.887 175.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -88.16 177.38 6.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.901 -0.499 . . . . 10.0 111.09 177.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -136.25 50.09 2.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.815 -1.18 . . . . 10.0 107.815 171.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.77 -41.14 0.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.059 0.762 . . . . 10.0 113.059 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.95 -3.43 13.37 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.109 0.963 . . . . 10.0 110.559 177.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 62.22 52.57 3.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.305 1.842 . . . . 10.0 109.307 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.6 m -133.22 144.08 49.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.63 1.572 . . . . 10.0 110.362 -174.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.489 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -123.29 133.7 68.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 C-N-CA 125.194 1.398 . . . . 10.0 109.135 169.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.1 p -103.93 88.96 3.16 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.472 1.509 . . . . 10.0 107.95 -178.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -79.21 125.25 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 -176.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -99.68 115.23 28.98 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.397 -1.335 . . . . 10.0 107.397 171.19 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -157.63 175.4 13.97 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.563 -0.532 . . . . 10.0 109.563 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.57 125.34 27.2 Favored Pre-proline 0 N--CA 1.449 -0.519 0 C-N-CA 125.384 1.474 . . . . 10.0 109.536 176.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.35 78.07 1.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.345 2.697 . . . . 10.0 109.234 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -136.98 -51.77 0.67 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.763 0.825 . . . . 10.0 109.555 174.004 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -112.84 -42.74 3.53 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.863 0.865 . . . . 10.0 110.746 -178.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -90.71 165.15 13.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.66 -0.867 . . . . 10.0 108.66 169.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -157.02 167.18 31.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.386 1.475 . . . . 10.0 109.41 168.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 7.4 p -62.23 -46.29 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.187 0.995 . . . . 10.0 110.312 -175.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -54.17 -43.8 70.94 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.383 0.673 . . . . 10.0 112.42 174.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.16 -53.0 34.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.866 -1.161 . . . . 10.0 107.866 -171.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.1 pp -62.15 -34.66 76.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.307 -0.86 . . . . 10.0 110.838 177.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 62' ' ' ASP . 1.3 tmtt? -51.42 -50.22 60.12 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 172.374 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -57.15 -42.43 81.03 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.0 97.62 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.006 0.922 . . . . 10.0 111.411 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.724 HG21 HD13 ' A' ' 68' ' ' LEU . 94.5 t -57.21 -56.83 12.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 172.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 58' ' ' LYS . 0.4 OUTLIER -52.97 -41.23 64.36 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.281 0.563 . . . . 10.0 109.855 -178.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -55.78 -31.58 62.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.67 1.188 . . . . 10.0 112.505 177.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -77.77 -42.82 32.76 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.411 0.551 . . . . 10.0 110.346 175.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.71 -48.2 0.76 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 112.348 -0.301 . . . . 10.0 112.348 171.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.26 159.67 14.56 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 122.362 -0.493 . . . . 10.0 110.263 176.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 157.33 16.28 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.826 0.85 . . . . 10.0 108.955 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.724 HD13 HG21 ' A' ' 61' ' ' VAL . 6.1 tt -142.22 154.77 45.05 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 176.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -154.29 168.04 27.91 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 126.292 1.837 . . . . 10.0 108.227 177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.48 151.71 46.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.898 0.879 . . . . 10.0 112.341 -177.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -138.21 -149.18 0.29 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.793 1.637 . . . . 10.0 110.687 174.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -88.83 86.8 1.46 Allowed Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.256 -1.138 . . . . 10.0 110.256 -169.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -50.08 137.09 18.03 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 122.233 -0.569 . . . . 10.0 111.528 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 62.44 106.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.712 2.005 . . . . 10.0 114.894 -170.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -96.18 93.52 6.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 166.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 t -129.9 -52.42 1.14 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.083 -0.962 . . . . 10.0 111.694 171.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 pt -147.28 51.69 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.933 0.893 . . . . 10.0 109.842 -176.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -75.03 161.62 29.29 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.931 -0.396 . . . . 10.0 109.931 176.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.41 59.87 0.68 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.15 0.881 . . . . 10.0 112.394 -165.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 . . . . . 0 C--O 1.249 1.079 0 C-N-CA 125.725 1.61 . . . . 10.0 110.978 -167.64 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 107.692 -1.225 . . . . 10.0 107.692 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p 52.55 -169.62 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.604 0.761 . . . . 10.0 112.332 -167.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -140.68 175.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 161.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -120.89 132.8 55.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.517 1.527 . . . . 10.0 107.726 172.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.73 159.43 42.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.039 1.336 . . . . 10.0 108.265 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -143.46 136.05 27.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -177.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -132.56 142.98 49.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.448 1.099 . . . . 10.0 110.18 -175.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -96.24 128.42 43.14 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.278 -2.119 . . . . 10.0 105.278 -177.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.33 140.24 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.273 -0.64 . . . . 10.0 109.273 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.93 117.3 25.23 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 177.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.39 -5.3 7.18 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.584 0.611 . . . . 10.0 114.044 165.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.57 74.93 1.99 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.528 1.164 . . . . 10.0 110.668 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p -69.93 -26.35 64.1 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 121.531 -0.731 . . . . 10.0 110.288 178.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.5 p -125.07 140.1 53.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.912 0.885 . . . . 10.0 111.216 -173.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.18 -25.38 46.62 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.612 -0.68 . . . . 10.0 112.381 -179.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.48 -47.19 79.77 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.472 0.709 . . . . 10.0 110.856 171.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.5 m -56.82 -50.97 70.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.735 0.814 . . . . 10.0 109.233 179.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.32 -54.47 43.2 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.245 -0.889 . . . . 10.0 111.069 176.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -54.93 -36.17 64.96 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.166 -0.958 . . . . 10.0 112.05 176.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -32.92 72.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 118.54 -0.743 . . . . 10.0 110.643 178.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.0 mm -55.27 -60.72 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.262 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 175.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -59.2 -42.81 91.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.41 0.684 . . . . 10.0 109.825 -169.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -56.02 -53.01 62.13 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.037 -0.529 . . . . 10.0 111.379 172.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -46.77 88.39 Favored 'General case' 0 C--O 1.226 -0.175 0 CA-C-N 118.785 0.72 . . . . 10.0 111.071 -179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.82 -51.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 123.098 0.249 . . . . 10.0 110.524 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -53.59 -41.63 66.78 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.252 -0.28 . . . . 10.0 110.586 173.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -64.8 -11.93 42.28 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.059 0.763 . . . . 10.0 113.059 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.0 mt -77.29 -9.92 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 119.642 1.11 . . . . 10.0 112.655 170.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 53.04 35.38 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 127.05 2.14 . . . . 10.0 111.058 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.92 25.5 0.36 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 123.39 0.519 . . . . 10.0 112.067 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.8 t -120.23 138.03 52.11 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 171.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.47 -52.85 3.8 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 122.781 0.433 . . . . 10.0 110.354 -175.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 46' ' ' GLU . 77.1 m-20 -136.52 154.4 50.73 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.791 -1.188 . . . . 10.0 107.791 -178.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.02 54.28 0.2 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 124.667 1.187 . . . . 10.0 112.098 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.95 116.37 3.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.741 1.627 . . . . 10.0 110.421 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.1 t -73.08 129.95 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 O-C-N 121.903 -0.498 . . . . 10.0 110.14 177.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -98.52 86.64 3.63 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.836 0.854 . . . . 10.0 109.035 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.49 70.27 1.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.93 1.292 . . . . 10.0 111.177 -177.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.66 -55.5 0.05 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.637 1.175 . . . . 10.0 109.17 173.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -76.49 -18.89 58.51 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.712 1.205 . . . . 10.0 109.836 174.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 69.18 53.44 0.46 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.585 1.954 . . . . 10.0 107.99 -175.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 53.2 m -142.61 154.24 44.21 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.896 -1.047 . . . . 10.0 108.91 -173.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -126.61 131.92 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 124.422 1.089 . . . . 10.0 108.277 172.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 p -93.76 99.51 11.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.628 -1.619 . . . . 10.0 106.628 171.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 92.2 t -92.23 131.99 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 118.502 0.592 . . . . 10.0 109.558 -178.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 33' ' ' ASN . 26.1 mt-10 -120.16 105.59 11.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.084 -1.08 . . . . 10.0 108.084 174.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -126.56 176.34 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.015 1.326 . . . . 10.0 108.981 177.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.79 122.53 44.27 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-O 118.267 -0.873 . . . . 10.0 109.564 171.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.78 58.7 6.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.491 2.794 . . . . 10.0 111.384 -171.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -155.47 11.26 0.32 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.153 0.981 . . . . 10.0 110.742 174.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -133.71 -62.42 0.77 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.941 -1.133 . . . . 10.0 107.941 -171.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -110.04 175.4 5.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.677 1.591 . . . . 10.0 108.341 173.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -140.73 164.84 29.12 Favored 'General case' 0 N--CA 1.439 -0.989 0 C-N-CA 124.526 1.131 . . . . 10.0 108.837 170.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.1 p -56.93 -41.93 77.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.383 -0.826 . . . . 10.0 109.847 169.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.86 -42.23 93.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.915 1.286 . . . . 10.0 112.627 179.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -64.09 -56.97 11.15 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.528 -0.916 . . . . 10.0 108.528 178.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -61.33 -31.13 70.98 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.336 -0.847 . . . . 10.0 111.471 -173.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.5 tptp -50.68 -58.22 6.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.571 0.701 . . . . 10.0 111.641 177.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -57.7 -33.25 68.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.916 179.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.46 -39.86 74.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.494 0.718 . . . . 10.0 111.378 -176.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 68' ' ' LEU . 15.7 m -73.85 -45.31 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 118.117 0.417 . . . . 10.0 109.973 176.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.28 -43.7 64.58 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 117.827 0.285 . . . . 10.0 110.243 174.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -51.72 -30.61 23.01 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 173.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.542 HD13 ' OH ' ' A' ' 66' ' ' TYR . 15.6 mt -75.12 -18.82 60.16 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.138 0.881 . . . . 10.0 112.01 178.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.98 -48.58 0.94 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-N 118.936 0.789 . . . . 10.0 111.28 171.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.542 ' OH ' HD13 ' A' ' 64' ' ' LEU . 2.1 p90 -65.42 172.05 3.53 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.69 0.396 . . . . 10.0 110.141 170.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -121.77 163.9 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.433 0.693 . . . . 10.0 110.434 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD13 HG21 ' A' ' 61' ' ' VAL . 3.5 tt -138.61 158.75 43.66 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.217 1.807 . . . . 10.0 106.514 -174.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -151.16 167.28 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 127.133 2.173 . . . . 10.0 107.461 173.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 tt -74.21 150.06 40.54 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.202 0.601 . . . . 10.0 110.88 176.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.3 tmtp? -139.58 25.09 2.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.662 1.585 . . . . 10.0 111.292 177.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.78 -122.82 14.42 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 109.438 -1.465 . . . . 10.0 109.438 -176.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.19 152.13 29.01 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.471 1.908 . . . . 10.0 108.839 -171.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -73.14 -50.71 21.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 10.0 110.227 178.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.7 t0 17.59 59.51 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.286 2.234 . . . . 10.0 114.64 -162.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.6 t 62.36 27.89 16.61 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.868 1.433 . . . . 10.0 114.868 173.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.9 mt -1.99 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 127.919 2.488 . . . . 10.0 114.407 -179.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.61 -64.33 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.074 1.349 . . . . 10.0 107.818 177.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.88 -174.76 42.85 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 108.311 -1.916 . . . . 10.0 108.311 -179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.8 ttt-85 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 116.06 -1.924 . . . . 10.0 109.522 -174.281 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.7 p -144.61 165.51 27.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -129.43 140.02 51.45 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 129.023 2.929 . . . . 10.0 103.539 177.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -105.44 133.14 50.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.54 -1.652 . . . . 10.0 106.54 175.126 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.4 149.39 52.56 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -127.25 131.88 50.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.084 -1.821 . . . . 10.0 106.084 -175.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -129.32 146.47 51.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.888 1.275 . . . . 10.0 109.501 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.92 136.63 35.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 103.416 -2.809 . . . . 10.0 103.416 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.48 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -115.84 151.16 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -128.9 110.56 12.22 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.165 0.986 . . . . 10.0 108.955 175.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.13 -72.11 0.27 Allowed Glycine 0 CA--C 1.53 0.997 0 C-N-CA 126.698 2.094 . . . . 10.0 111.017 170.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.54 ' SD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER 29.57 78.13 0.03 OUTLIER 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.128 2.571 . . . . 10.0 114.142 174.784 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -49.4 7.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 113.431 -1.713 . . . . 10.0 110.671 -168.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.5 p -141.62 163.9 31.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 175.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.58 -31.12 34.6 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 111.94 0.348 . . . . 10.0 111.94 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -37.02 83.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.576 -0.726 . . . . 10.0 111.572 176.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 78.1 m -57.68 -56.04 27.1 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.009 -0.737 . . . . 10.0 109.009 174.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HB2' ' SD ' ' A' ' 12' ' ' MET . . . -49.82 -56.09 11.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.933 0.893 . . . . 10.0 110.689 176.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -55.27 -39.48 69.86 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.503 -0.748 . . . . 10.0 111.467 178.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -57.91 -40.77 81.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 120.976 -1.077 . . . . 10.0 110.176 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -52.23 61.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 175.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -54.38 -45.33 72.83 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 117.977 0.353 . . . . 10.0 110.861 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -56.09 23.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.073 0.949 . . . . 10.0 110.55 176.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -51.08 70.83 Favored 'General case' 0 N--CA 1.461 0.096 0 O-C-N 122.223 -0.298 . . . . 10.0 110.956 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.615 HD13 ' HB1' ' A' ' 34' ' ' ALA . 20.7 mt -52.53 -52.95 52.28 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.701 0.8 . . . . 10.0 109.194 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -53.35 -37.86 62.75 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 124.066 0.946 . . . . 10.0 112.034 176.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -36.14 75.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.659 -0.686 . . . . 10.0 110.399 176.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.3 mt -53.57 133.57 16.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.628 1.204 . . . . 10.0 110.612 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.75 99.51 12.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.156 -1.424 . . . . 10.0 107.156 -169.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.79 7.96 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.919 1.247 . . . . 10.0 113.348 -178.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.02 155.89 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.456 -0.942 . . . . 10.0 108.456 163.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -99.76 -53.46 3.17 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.296 0.638 . . . . 10.0 110.483 169.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -154.6 168.26 27.35 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.615 ' HB1' HD13 ' A' ' 25' ' ' LEU . . . -171.89 62.66 0.34 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.7 1.0 . . . . 10.0 113.7 172.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.49 130.17 16.84 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.718 1.612 . . . . 10.0 110.881 174.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 18' ' ' ALA . 10.3 p -99.91 141.02 17.77 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 C-N-CA 123.888 0.875 . . . . 10.0 111.081 176.914 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -79.9 171.32 15.27 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.643 -0.661 . . . . 10.0 111.166 176.087 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -132.03 58.69 1.73 Allowed 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 106.849 -1.537 . . . . 10.0 106.849 166.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.33 -63.71 0.31 Allowed 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.462 0.705 . . . . 10.0 110.527 178.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.94 -13.69 33.01 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.608 0.363 . . . . 10.0 110.316 -176.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 70.38 56.8 0.27 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.173 1.789 . . . . 10.0 108.211 -177.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.5 m -140.62 143.02 34.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.207 -1.361 . . . . 10.0 109.144 -173.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG12 HD11 ' A' ' 9' ' ' ILE . 7.3 p -120.82 139.66 47.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.162 1.385 . . . . 10.0 108.934 172.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.0 m -106.89 100.84 10.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.308 -1.368 . . . . 10.0 107.308 176.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.5 t -92.56 126.92 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.57 -0.9 . . . . 10.0 108.57 -176.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -102.41 125.07 49.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.598 -1.26 . . . . 10.0 107.598 170.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -155.58 -168.55 2.85 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -127.39 137.36 30.52 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 118.993 0.815 . . . . 10.0 110.052 166.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.13 73.73 4.3 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.337 2.691 . . . . 10.0 108.691 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.74 -58.45 0.17 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.967 0.907 . . . . 10.0 108.592 176.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -87.84 -41.64 13.1 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.465 0.706 . . . . 10.0 109.156 -176.43 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.75 161.31 21.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.938 1.695 . . . . 10.0 108.43 -177.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.5 m -144.09 160.87 40.16 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.24 1.016 . . . . 10.0 109.448 176.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -58.82 -46.95 90.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.616 0.766 . . . . 10.0 110.59 178.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 m -58.83 -35.59 73.16 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.558 -0.714 . . . . 10.0 112.811 176.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -67.46 -60.87 2.22 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -177.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.23 -34.11 59.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.755 -0.657 . . . . 10.0 111.127 177.501 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.93 -52.12 35.77 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.735 -0.469 . . . . 10.0 109.735 174.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -59.75 -42.12 92.49 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.89 -0.411 . . . . 10.0 109.89 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.78 97.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.668 1.187 . . . . 10.0 111.185 -175.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -77.07 -45.88 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 117.928 0.331 . . . . 10.0 111.004 176.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.01 -38.24 62.17 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.746 -0.464 . . . . 10.0 109.746 176.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -35.18 11.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.964 0.905 . . . . 10.0 113.168 172.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.3 mt -73.04 -30.26 63.6 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.267 0.627 . . . . 10.0 111.418 178.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.73 -59.02 0.64 Allowed Glycine 0 CA--C 1.527 0.785 0 C-N-CA 123.707 0.67 . . . . 10.0 111.462 173.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.02 159.24 17.52 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 122.799 0.44 . . . . 10.0 110.823 178.32 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -105.03 159.36 15.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 122.823 0.449 . . . . 10.0 110.917 -173.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.1 tt -144.91 150.3 36.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.14 1.776 . . . . 10.0 106.486 -172.433 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 168.16 23.87 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.422 1.489 . . . . 10.0 109.213 -179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 tt -67.93 150.17 48.86 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.416 0.686 . . . . 10.0 112.358 -172.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -134.88 15.06 3.6 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.285 1.434 . . . . 10.0 113.643 -179.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.06 111.0 1.41 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -75.78 60.76 1.34 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.727 1.211 . . . . 10.0 111.448 -176.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -161.39 85.46 0.65 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.61 0.719 . . . . 10.0 109.238 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -75.5 43.09 0.23 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.674 1.989 . . . . 10.0 110.715 178.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -172.61 91.56 0.11 Allowed 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -171.003 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 6.1 tt -161.67 -53.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.024 0.93 . . . . 10.0 110.456 178.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 55.01 58.26 4.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.313 1.045 . . . . 10.0 111.226 176.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.19 -162.65 29.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.399 0.523 . . . . 10.0 112.953 -176.04 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.243 -2.132 . . . . 10.0 105.243 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.5 mtt . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.7 p -80.42 -179.29 7.08 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 124.526 1.141 . . . . 10.0 109.05 171.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.67 152.23 38.48 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 104.78 -2.304 . . . . 10.0 104.78 161.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -113.0 130.14 56.24 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.478 -2.045 . . . . 10.0 105.478 172.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.06 140.01 48.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.138 1.775 . . . . 10.0 106.33 -176.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -128.53 132.85 48.31 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.279 -2.119 . . . . 10.0 105.279 -170.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.08 146.73 52.47 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.592 1.183 . . . . 10.0 110.596 -174.657 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -94.67 132.82 39.0 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.311 2.644 . . . . 10.0 105.063 -178.175 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.601 HD11 HG12 ' A' ' 43' ' ' VAL . 3.3 mp -121.16 140.98 43.61 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 119.825 1.193 . . . . 10.0 110.266 175.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -117.81 111.15 18.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.415 1.486 . . . . 10.0 108.875 178.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.41 -69.74 0.32 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.803 2.144 . . . . 10.0 112.854 166.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.4 ' O ' ' HB ' ' A' ' 13' ' ' THR . 17.7 mmt 40.59 -90.99 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 129.931 3.292 . . . . 10.0 113.277 -177.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 12' ' ' MET . 1.8 m 78.23 -47.09 0.45 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.485 1.514 . . . . 10.0 109.404 170.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.4 p -125.14 148.48 48.55 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 124.153 0.981 . . . . 10.0 111.268 176.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -33.51 68.87 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.41 -0.806 . . . . 10.0 111.048 177.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.89 -42.64 65.51 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.315 0.646 . . . . 10.0 110.959 175.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.23 -45.17 92.86 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.109 0.563 . . . . 10.0 110.633 -178.607 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.69 -52.87 63.66 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.304 0.241 . . . . 10.0 110.819 172.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -52.14 -37.46 54.45 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.555 -0.716 . . . . 10.0 111.654 175.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.29 -35.36 77.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.211 -0.931 . . . . 10.0 110.991 177.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.2 mm -55.8 -59.54 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 172.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' A' ' 36' ' ' VAL . 40.3 mt-10 -54.46 -45.76 73.18 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.324 0.65 . . . . 10.0 109.814 -173.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -54.69 -54.78 37.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.177 0.991 . . . . 10.0 111.136 174.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -61.09 -47.5 86.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 118.399 0.545 . . . . 10.0 110.289 -177.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -59.76 -46.39 89.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.744 -0.17 . . . . 10.0 110.629 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -55.25 -37.55 67.37 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.144 0.578 . . . . 10.0 111.292 173.681 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 ttmm -69.0 -18.62 64.08 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.597 -0.716 . . . . 10.0 112.268 178.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.72 133.2 29.93 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-N 119.53 1.059 . . . . 10.0 108.178 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.88 134.4 35.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.0 -3.37 51.95 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.529 -0.595 . . . . 10.0 113.402 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.7 t -86.79 138.1 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 118.309 1.055 . . . . 10.0 108.379 173.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -95.77 -50.41 4.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.345 0.658 . . . . 10.0 110.415 -179.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -146.74 163.74 34.98 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -168.16 58.71 0.4 Allowed Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.538 0.94 . . . . 10.0 113.538 174.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.84 132.89 27.75 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 121.809 1.673 . . . . 10.0 111.099 174.311 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 HG23 ' HG2' ' A' ' 22' ' ' GLU . 59.5 t -97.15 139.28 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 C-N-CA 124.98 1.312 . . . . 10.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.42 HD21 ' HB ' ' A' ' 42' ' ' THR . 0.5 OUTLIER -101.35 100.85 11.39 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.617 0.722 . . . . 10.0 111.394 176.321 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -72.16 70.57 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.652 0.781 . . . . 10.0 110.04 175.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.83 -60.61 0.06 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.242 1.417 . . . . 10.0 109.317 -179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 -15.23 31.02 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.142 0.577 . . . . 10.0 110.764 -177.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 66.16 61.32 0.61 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 124.099 1.904 . . . . 10.0 108.19 -175.13 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.471 ' HA ' HD12 ' A' ' 9' ' ' ILE . 2.0 m -145.43 150.08 35.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.07 -1.423 . . . . 10.0 108.91 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.601 HG12 HD11 ' A' ' 9' ' ' ILE . 14.8 p -124.21 138.97 52.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 124.402 1.081 . . . . 10.0 108.939 172.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.5 m -107.53 99.19 8.71 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.575 -1.268 . . . . 10.0 107.575 177.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.1 t -87.62 127.81 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -100.88 130.11 46.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 167.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -153.92 -169.16 3.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 117.959 0.345 . . . . 10.0 110.151 177.022 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.78 130.16 24.99 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.812 1.245 . . . . 10.0 107.775 176.585 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.53 51.66 3.63 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.453 2.769 . . . . 10.0 111.49 -176.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -159.33 6.97 0.1 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.759 0.824 . . . . 10.0 111.939 -179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -135.72 -61.45 0.72 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 -169.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.12 178.26 4.65 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.126 -1.064 . . . . 10.0 108.126 168.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.65 140.18 22.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.892 0.877 . . . . 10.0 109.449 177.267 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.7 p -44.67 -45.66 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.848 1.259 . . . . 10.0 111.922 178.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.2 m -52.49 -49.59 64.43 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.475 1.11 . . . . 10.0 113.287 179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.89 -50.69 54.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.495 -0.928 . . . . 10.0 108.495 -171.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.1 pp -60.95 -34.06 74.14 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.267 -0.879 . . . . 10.0 111.353 177.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -55.0 -57.99 9.46 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.6 -1.259 . . . . 10.0 107.6 172.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -58.05 -43.46 86.87 Favored 'General case' 0 C--O 1.223 -0.313 0 O-C-N 123.094 0.246 . . . . 10.0 110.543 -177.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.79 91.55 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.49 1.116 . . . . 10.0 110.556 -178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.86 -49.57 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 175.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -50.25 -44.09 53.42 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 122.094 0.95 . . . . 10.0 110.036 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -57.94 -23.16 52.37 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.559 1.144 . . . . 10.0 113.128 -179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.01 -32.74 74.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.532 0.605 . . . . 10.0 111.348 173.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.61 -42.68 1.24 Allowed Glycine 0 CA--C 1.529 0.93 0 CA-C-N 118.485 0.584 . . . . 10.0 111.845 177.528 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -76.32 177.85 6.97 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.69 0.796 . . . . 10.0 109.329 175.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -121.79 154.81 36.48 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 118.232 0.469 . . . . 10.0 109.784 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.5 tt -134.11 154.85 50.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.239 1.816 . . . . 10.0 106.875 -174.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -149.72 170.43 18.73 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.942 1.697 . . . . 10.0 108.543 174.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tt -67.15 150.68 48.8 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.304 0.642 . . . . 10.0 111.192 175.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -124.01 -54.19 1.72 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.97 1.308 . . . . 10.0 111.407 171.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.83 -166.01 33.69 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -174.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -155.57 54.58 0.61 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.684 0.754 . . . . 10.0 111.252 -175.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -158.0 133.21 8.74 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.659 -0.65 . . . . 10.0 110.625 -176.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -44.29 -66.07 0.43 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.606 1.562 . . . . 10.0 111.414 171.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -177.87 87.5 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.493 1.917 . . . . 10.0 106.972 173.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.5 78.05 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.839 -0.801 . . . . 10.0 108.839 -173.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -147.25 -175.22 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.207 2.203 . . . . 10.0 106.256 168.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -160.07 163.26 33.7 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 177.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.325 0 C-N-CA 126.877 2.071 . . . . 10.0 110.186 -177.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 106.32 -1.733 . . . . 10.0 106.32 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.3 p -122.14 133.39 54.75 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.25 -2.5 . . . . 10.0 104.25 161.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -152.47 174.39 13.94 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -113.61 112.41 23.47 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.361 1.864 . . . . 10.0 107.757 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.16 150.09 21.84 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.667 1.987 . . . . 10.0 107.808 172.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.492 ' OE2' HD11 ' A' ' 77' ' ' ILE . 14.5 tt0 -130.25 131.86 45.69 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 -172.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -133.31 151.03 51.86 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.257 1.423 . . . . 10.0 110.56 -174.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -97.74 138.52 34.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 127.955 2.502 . . . . 10.0 106.1 -177.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.41 121.56 64.99 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-N 120.94 1.7 . . . . 10.0 111.278 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -99.5 115.74 30.02 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.883 0.873 . . . . 10.0 109.283 177.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.95 -70.7 0.51 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.336 1.446 . . . . 10.0 111.69 170.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 66.71 -61.17 0.32 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.366 2.266 . . . . 10.0 114.291 -178.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 78.2 -57.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 126.157 1.783 . . . . 10.0 110.597 175.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.6 p -162.46 168.81 21.41 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.37 0.668 . . . . 10.0 110.809 178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.29 -39.66 83.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.192 -0.458 . . . . 10.0 110.721 178.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.23 92.94 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.662 -0.649 . . . . 10.0 110.664 179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.5 m -60.87 -55.12 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.578 1.151 . . . . 10.0 110.344 173.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -44.44 -55.38 5.09 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.052 0.453 . . . . 10.0 111.815 173.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.26 -35.17 73.23 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.761 -1.212 . . . . 10.0 112.012 175.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.14 -41.35 78.96 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.871 -1.143 . . . . 10.0 110.343 174.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.2 mt -54.6 -52.01 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 176.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -53.82 -48.04 70.29 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.453 0.701 . . . . 10.0 109.558 -177.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -55.93 26.03 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.49 0.716 . . . . 10.0 110.756 176.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -58.97 -45.96 89.26 Favored 'General case' 0 C--O 1.225 -0.194 0 O-C-N 121.92 -0.488 . . . . 10.0 111.177 -178.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.2 mt -58.81 -51.07 71.57 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.641 -0.503 . . . . 10.0 109.641 178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -53.94 -37.22 63.63 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 123.351 0.66 . . . . 10.0 111.57 175.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -64.48 -19.56 65.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.738 -0.649 . . . . 10.0 112.077 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.3 mm -80.93 124.89 39.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-O 122.894 1.33 . . . . 10.0 109.495 176.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -68.08 121.52 16.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.891 -1.504 . . . . 10.0 108.306 -174.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 112.89 -23.05 15.16 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.012 0.815 . . . . 10.0 111.855 -173.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.12 132.76 32.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 118.493 1.147 . . . . 10.0 108.968 176.68 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.18 -51.59 4.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.737 1.215 . . . . 10.0 110.202 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -146.21 168.17 21.68 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 174.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -167.39 54.43 0.28 Allowed Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.51 0.93 . . . . 10.0 113.51 179.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.66 123.79 11.17 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 121.564 1.509 . . . . 10.0 111.06 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -95.24 143.31 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.752 0.705 . . . . 10.0 111.474 175.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -110.08 106.99 16.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.826 0.85 . . . . 10.0 111.628 -173.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.25 59.54 1.02 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 10.0 110.919 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -164.11 -33.98 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.511 0.93 . . . . 10.0 113.511 -178.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.6 mt -115.2 4.5 14.55 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.862 0.865 . . . . 10.0 109.996 173.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 53.65 44.57 29.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.252 1.421 . . . . 10.0 109.267 178.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.7 m -132.07 143.33 49.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.736 1.214 . . . . 10.0 108.822 -174.312 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.69 140.04 46.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 125.021 1.328 . . . . 10.0 107.91 169.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -104.55 106.18 16.58 Favored 'General case' 0 N--CA 1.46 0.071 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.8 t -94.32 118.11 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -89.15 120.17 30.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 171.089 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -155.42 176.78 12.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 175.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -108.71 119.62 48.64 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.838 1.255 . . . . 10.0 109.077 174.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.98 60.65 7.4 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.561 2.174 . . . . 10.0 110.286 -178.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.6 tttt -145.94 -1.85 0.75 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.874 1.27 . . . . 10.0 111.441 178.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -134.28 -67.11 0.59 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.786 1.634 . . . . 10.0 107.466 -175.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.24 166.97 11.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.725 1.21 . . . . 10.0 108.637 174.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.9 p -141.54 155.49 45.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.287 1.435 . . . . 10.0 109.641 170.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.64 -47.44 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.557 1.143 . . . . 10.0 111.549 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 t -61.57 -43.08 99.52 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.092 -0.38 . . . . 10.0 111.118 -175.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.59 -56.5 11.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 -177.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 58' ' ' LYS . 2.6 pp -59.64 -26.88 65.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.497 -178.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -47.53 -56.15 7.69 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.659 -0.497 . . . . 10.0 109.659 170.093 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -53.78 -37.07 63.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.584 0.707 . . . . 10.0 110.7 -178.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.3 77.48 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.566 0.747 . . . . 10.0 111.345 -174.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.7 m -79.12 -44.45 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 117.903 0.32 . . . . 10.0 110.812 173.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.63 -46.33 19.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.372 1.469 . . . . 10.0 109.41 174.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -46.81 -36.0 6.89 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.593 1.557 . . . . 10.0 113.023 175.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.8 mt -72.67 -25.22 61.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.313 0.645 . . . . 10.0 111.638 -178.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.33 -55.51 0.76 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.014 -0.834 . . . . 10.0 111.014 174.528 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -65.27 156.04 33.25 Favored 'General case' 0 C--O 1.231 0.126 0 O-C-N 122.539 -0.389 . . . . 10.0 110.137 174.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -107.99 167.06 10.26 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.202 0.601 . . . . 10.0 111.04 -175.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.1 tt -146.5 154.88 42.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.063 -1.458 . . . . 10.0 107.063 -173.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -155.26 167.32 30.75 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.703 1.601 . . . . 10.0 108.773 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tt -63.1 147.06 51.87 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.284 0.634 . . . . 10.0 111.305 177.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -125.63 -45.46 1.77 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.335 1.454 . . . . 10.0 111.968 175.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.55 -174.1 43.62 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.966 -1.253 . . . . 10.0 109.966 -176.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -140.08 47.59 1.81 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 10.0 109.762 -177.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -162.59 160.83 26.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.925 1.29 . . . . 10.0 108.281 170.349 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.67 -24.71 26.93 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.924 2.09 . . . . 10.0 111.933 173.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.7 p -76.52 -69.2 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.621 0.768 . . . . 10.0 111.22 -168.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' OE2' ' A' ' 6' ' ' GLU . 48.9 mt 72.02 111.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 126.708 2.003 . . . . 10.0 109.547 -168.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -145.74 136.22 24.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.357 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.01 -126.46 1.52 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 -172.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 116.018 -1.944 . . . . 10.0 105.962 -175.812 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 t 169.15 179.48 0.04 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 128.423 2.689 . . . . 10.0 104.863 -175.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.27 -165.77 1.25 Allowed 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.451 1.9 . . . . 10.0 108.242 173.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -140.04 139.62 36.0 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.014 2.126 . . . . 10.0 106.563 176.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.99 153.39 44.41 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.83 1.652 . . . . 10.0 109.174 173.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -125.76 124.94 42.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 103.766 -2.679 . . . . 10.0 103.766 -174.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 57' ' ' LEU . 5.7 m-85 -124.31 152.93 42.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.845 0.858 . . . . 10.0 109.568 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.68 127.01 53.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 -171.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.26 150.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.809 0.731 . . . . 10.0 110.145 -173.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -136.89 115.27 11.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.782 1.233 . . . . 10.0 108.494 -178.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.74 5.89 15.25 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 115.511 0.964 . . . . 10.0 115.511 166.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptm -73.61 90.19 1.77 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.742 1.271 . . . . 10.0 110.283 177.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.2 p -66.1 -33.79 76.58 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.969 0.908 . . . . 10.0 110.509 -176.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.5 p -140.76 164.85 29.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.435 0.636 . . . . 10.0 112.294 179.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.78 -31.89 50.5 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.942 -0.474 . . . . 10.0 111.846 178.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.17 83.28 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.609 -0.682 . . . . 10.0 111.378 177.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.9 m -53.54 -52.69 58.89 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.639 -0.874 . . . . 10.0 108.639 172.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.52 65.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.242 -0.89 . . . . 10.0 110.476 -178.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -35.59 78.33 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.017 -1.052 . . . . 10.0 111.745 -177.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -61.14 -37.47 82.95 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.366 -0.834 . . . . 10.0 110.732 176.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 61' ' ' VAL . 1.5 mt -55.93 -48.38 78.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 176.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -54.82 -44.38 73.8 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.804 0.842 . . . . 10.0 110.211 -176.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -52.84 -54.89 27.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.24 0.616 . . . . 10.0 110.653 174.032 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -58.81 -50.38 74.17 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.958 -0.297 . . . . 10.0 111.103 179.194 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.31 -51.25 62.98 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.07 0.948 . . . . 10.0 110.237 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -55.04 -39.31 69.03 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.279 0.632 . . . . 10.0 111.118 175.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -64.45 -19.05 65.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.976 -1.012 . . . . 10.0 113.654 176.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.1 mm -79.74 130.83 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 120.307 1.412 . . . . 10.0 109.773 179.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -74.41 117.11 15.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.906 1.283 . . . . 10.0 108.477 -176.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.52 -0.04 37.16 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.286 0.946 . . . . 10.0 112.944 -178.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.4 t -89.1 132.46 33.81 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 CA-C-N 118.046 0.923 . . . . 10.0 108.612 170.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.52 -50.11 7.52 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.425 0.69 . . . . 10.0 109.392 175.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -169.23 174.8 5.95 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 108.3 -1.0 . . . . 10.0 108.3 177.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -176.96 61.88 0.19 Allowed Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 124.655 1.182 . . . . 10.0 112.783 -170.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.01 129.36 17.2 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 121.982 1.788 . . . . 10.0 110.108 176.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.8 p -101.01 142.85 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.745 0.702 . . . . 10.0 112.198 -179.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -106.75 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.428 0.691 . . . . 10.0 111.773 -171.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.83 64.33 1.26 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.456 1.102 . . . . 10.0 110.948 177.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.23 -51.18 0.07 Allowed 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.62 0.768 . . . . 10.0 111.068 174.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 mt -92.76 -7.62 46.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.876 0.47 . . . . 10.0 110.775 -179.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 51.32 51.75 16.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.523 1.529 . . . . 10.0 109.32 -167.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.8 m -124.59 143.17 50.85 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.538 1.535 . . . . 10.0 108.776 175.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.71 135.34 61.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 C-N-CA 124.049 0.94 . . . . 10.0 108.649 165.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.74 98.26 8.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.242 1.817 . . . . 10.0 108.032 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 7' ' ' PHE . 42.4 t -97.32 124.93 50.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 C-N-CA 123.468 0.707 . . . . 10.0 110.077 -174.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -101.31 113.54 26.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 169.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -155.11 156.79 36.43 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 124.575 1.15 . . . . 10.0 109.547 177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.96 124.22 42.52 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 124.395 1.059 . . . . 10.0 110.741 -178.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.26 78.08 1.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 124.273 3.315 . . . . 10.0 109.925 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.6 tttp -147.27 -54.4 0.22 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.67 0.788 . . . . 10.0 109.277 179.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -106.19 -52.95 2.71 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.386 1.074 . . . . 10.0 108.902 176.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.7 152.25 24.83 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 172.508 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -146.17 159.1 43.77 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.808 1.643 . . . . 10.0 108.873 172.143 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 14.4 p -53.64 -50.24 51.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 C-N-CA 122.85 0.46 . . . . 10.0 110.441 -179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 m -56.64 -40.93 76.29 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.683 0.793 . . . . 10.0 112.879 178.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.37 -55.26 16.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.656 -0.868 . . . . 10.0 108.656 -174.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 7' ' ' PHE . 4.0 pp -61.94 -35.37 78.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.884 177.196 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.69 -56.54 9.78 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 173.741 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -57.42 -39.27 75.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.002 -0.37 . . . . 10.0 110.002 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.36 -36.82 81.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.904 0.881 . . . . 10.0 111.976 179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 21' ' ' ILE . 94.7 t -72.04 -49.74 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 N-CA-C 109.468 -0.567 . . . . 10.0 109.468 174.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.18 -37.87 48.98 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.728 0.24 . . . . 10.0 110.863 174.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -50.62 -28.98 9.84 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.183 1.393 . . . . 10.0 113.213 175.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 49.3 mt -87.24 -19.31 28.52 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.308 1.043 . . . . 10.0 112.222 178.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.58 -56.7 0.74 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-N 119.023 0.829 . . . . 10.0 111.338 170.44 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.46 154.17 36.62 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.742 0.417 . . . . 10.0 110.418 175.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -99.02 163.43 12.58 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.214 1.006 . . . . 10.0 110.275 -176.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 61' ' ' VAL . 8.4 tt -148.8 159.26 44.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 126.624 1.97 . . . . 10.0 106.148 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -157.81 164.26 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.375 1.87 . . . . 10.0 107.953 176.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.69 147.72 52.88 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.746 0.307 . . . . 10.0 111.158 178.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.7 tttp -119.64 -49.31 2.35 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.319 1.447 . . . . 10.0 110.43 174.222 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.72 -174.59 40.78 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -139.99 143.44 36.48 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 10.0 110.182 177.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 53.83 80.13 0.12 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.666 2.386 . . . . 10.0 114.569 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -71.46 68.79 0.57 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 127.324 2.25 . . . . 10.0 109.681 171.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -145.38 66.27 1.23 Allowed 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.579 -1.326 . . . . 10.0 112.192 178.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 59.4 mt 56.31 77.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.856 1.662 . . . . 10.0 110.457 170.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -135.48 111.99 9.93 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.65 -0.87 . . . . 10.0 108.65 178.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -115.86 4.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.512 0.577 . . . . 10.0 113.994 171.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 115.538 -2.172 . . . . 10.0 105.692 -169.937 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_